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Abstract
TetratricoPeptide Repeats or TPRs are a class of repeat proteins made up of -
helices. Each repeat contains 34 amino acids that form a helix-turn-helix motif and
is stabilised by short range interactions creating a non-globular fold. Tandem arrays
of these repeats form stable superhelical structures. The modular nature of the
TPR fold has allowed a series of consensus TPRs (CTPRs) to be designed where
the number of repeat units has been varied.
We have exploited the modular nature of CTPR proteins in order to create fibres
via a bottom-up approach. Using Native Chemical Ligation (NCL) we have been
able to trigger specific assembly of monomeric CTPR units to form extended fibrous
structures up to microns in length (as viewed by TEM). This reaction proceeds at
room temperature and neutral pH, with filaments observed within 12 hours.
The equilibrium unfolding of CTPRs is prone to the population of partially folded
states. Through studying the stability of a series of deletion mutants and using a
Heteropolymer Ising model to analyse the unfolding data we have been able to design
a CTPR with a conformational ‘switch’. This new CTPR was designed to populate
a stable intermediate, with an exposed dimerisation interface, under certain condi-
tions. When this new construct was analysed using 2D NMR and CD spectroscopy,
it was found to selectively unfold its C-terminal α-helix at a specific concentration
of GuHCl. Our aim is to develop a system in which a ‘switching’ CTPR is used
as a sensor that, when triggered by environmental conditions, partially unfolds and
oligomerises.
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Chapter 1
Introduction
1.1 Proteins
Proteins are one of the four biopolymers that are essential to life. They perform
a crucial role in most biological processes. This ranges from catalysing reactions
within cells to forming the structure of the cells themselves [1, 2]. The ability to
understand the important role that proteins play in biological processes was vastly
increased when X-ray crystallography made it possible to see their atomic level
structure. This allowed the relationship between the structure of proteins and their
function to be better understood. For example by defining the active sites of an
enzyme we can better understand the mechanism of catalysis [3, 4].
Since the first reported structures fifty years ago, there are now nearly a hun-
dred thousand structures, solved through X-ray crystallography and NMR analysis.
These have revealed that there are a limited set of common motifs. The wealth of
structural data has led to the classification of proteins by specific folds. Protein
structures are deposited to the RCSB protein database, where they are arranged
into categories according to their origin and function. Other databases, like SCOP
(Structural Classification of Proteins) have grouped proteins together that share
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common structural characteristics [5, 6]. In doing this, it is possible to construct
common sequences that tend to define certain folds. By classifying proteins in this
manner it is possible to characterise how structure and to some extent ‘function’ are
related to the primary sequence of the protein. Comparison of amino acid sequences
using such databases have shown that sequences that are highly homologous form
similar motifs and domains. It is now possible to take a sequence of a proteins with
an unknown structure and search the structural databases for proteins with similar
sequences and, if a match is found, the fold can be estimated.
1.1.1 Classification of Protein Structure
We can divide proteins into 2 main categories: (i) globular (the machinery of cells)
and (ii) fibrous (the structural components).
(i) Globular proteins typically contain a mix of different motifs, where the fold-
ing is driven by the need to create a hydrophobic core and a hydrophilic surface
on the outside of the protein [1, 7]. The free energy between the folded and the
unfolded states of globular proteins is usually between 5-15 kcalmol-1. This is quite
small considering that the energy from a single hydrogen bond is 2-5 kcalmol-1 [7].
The large variation in structures mean that globular proteins can provide a large
variety of functions, such as catalysis, molecular recognitions and cellular transport.
(ii) Fibrous proteins, in contrast to globular, form elongated repetitive structural
elements and typically serve as structural materials within cells because of their
strength. An example is collagen, which is comprised of 3 chains a thousand residues
long that coil around each other [1]. These chains then form larger fibrous structures
that give cell walls strength [7].
Interestingly there are some protein scaffolds that seem to bridge both of these def-
18
initions, such as linear repeat proteins. These ‘novel’ folds (discovered in the 1990s)
possess a hydrophobic core like globular proteins but are repetitive in sequence and
structure like fibrous proteins.
1.1.2 Linear Repeat Proteins
1.1.2.1 Structure of Repeat Proteins
Linear repeat proteins are characterised as tandem arrays of short structural motifs
that form a single protein chain [8–10]. Repeat motifs are between a 10-40 amino
acids long and can be repeated from as little as twice to over 20 times. The arrayed
structural motifs form either a domain of a protein or simply the whole protein.
Repeat proteins are typically classified according to their tertiary structure [10].
Repeat motifs can be all α-helical, β-helical or a combination of both. For example,
Figure 1.1 shows the crystal structures of an α-helical Tetratricopeptide protein (B),
a β-helix repeat (D) and a α-helix and β-strand-containing Leucine-rich protein (F)
with each repeat coloured differently.
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Figure 1.1: Repeat motifs can be all α-helical, β-helical or a combination of both.
Structure of a single repeat (A) from a consensus Tetratricopeptide (1NA0) with
each repeat shown in a different colour (B). Structure of a single repeat (C) from a
β-helix repeat (1EZG) with each repeat shown in a different colour (D). Structure
of a single repeat (E) from a Leucine-rich repeat (1A4Y) with each repeat shown in
a different colour (F).
The principal feature of linear repeat proteins is that the final 3D fold is formed
and stabilised only through interactions between residues that are close in primary
sequence, Figure 1.2. Thus the N and the C-terminus rarely interact. In contrast, the
final folded structure of globular proteins are stabilised by local contacts but also
from interactions between amino acids that are distant in primary sequence [11],
Figure 1.2. This means that globular proteins can be thought of as more ‘complex’
structures. As repeat proteins are formed through sequence-local contacts, they are
tolerant to the addition or subtraction of whole repeat units [8, 11–13]. It is this
modularity makes repeat proteins distinctive and different from globular proteins
[10].
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Figure 1.2: Contact order maps for (A) CTPR3 (1NA0), (B) a globular protein,
FKBP12 (2PPN), (C) an Ankyrin repeat protein (1N0Q) and (D) and a β-helix pro-
tein (1LXA). These diagrams plot a point for every interaction between 2 residues,
using their position in the primary sequence as the co-ordinates. These diagrams el-
egantly show how in globular proteins, interactions occur between residues that are
distant in primary sequence. Where as in repeat proteins the contacts are formed
between residues that are close in primary sequence. Diagram from reference [13]
1.1.2.2 Functions of Repeat Proteins
Repeat proteins are important for many biological processes such as cell adhe-
sion [14], signal transduction [15] and disease resistance [16–18]. They perform
this wide range of roles by mediating protein-protein interactions [13, 19]. This ex-
citing binding repertoire of proteins and peptides is enabled through hyper-variable
positions within their sequence that can be varied without affecting the fold [13,19].
In the next section we will describe a representative selection of repeat proteins and
their functions, shown in Figure 1.3.
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Figure 1.3: (C) Crystal structure of the Ankyrin repeat domain of Bcl-3 (1K1A).
(B) Crystal structure of a Leucine-rich repeat protein that is a human placental
RNase inhibitor (1A4Y). (C) Crystal structure of the HEAT repeat protein from
PR65A (1B3U). (D) The solution structure of a TPR of human smooth muscle cell
associated protein-1, isoform 2 (2DBA). (E) Crystal structure of a TAL effector
DNA-binding domain of dHax3 (3V6P) in 2 orientations. (F) Crystal structure
of the alkaline protease of Pseudomonas aeruginosa, that contains a parallel β-roll
motif (1KAP), that is bound to Ca2+.
1.1.2.2.1 Ankyrin
The Ankyrin class of repeat proteins were first discovered in 1987 [20] and are
named after the human erythrocyte protein Ankyrin [10]. A single repeat consists
of 33 amino acids, which form 2 α-helices and a β-hairpin. Ankyrin repeats bind to
protein surfaces through a hyper-variable loop region. For example, 53BP2, contains
a domain 4 Ankyrin repeats and binds to the tumour suppressor p53 through residues
on the β-hairpin loop between the 3rd and 4th repeats [21], Figure 1.4. Thus binding
motifs are located on the loop region, on the concave face of the protein.
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Figure 1.4: The protein 53BP2 in complex with the p53 tumour suppressor (grey)
(1YCS). The 53BP2 contains a 4 repeat Ankyrin domain (blue), the loop that binds
to the p53 protein is highlighted in red.
1.1.2.2.2 Leucine-Rich Repeat
The first crystal structure of the Leucine-rich repeat proteins was reported in 1993.
The repeat is defined by a conserved sequence of leucine (or valine or isoleucine)
residues either 11 or 12 in length, with the general formula: LxxLxLxxNxL or
LxxLxLxxCxxL, n= asparagine, threonine, cysteine or serine and C= cysteine or
serine [22]. A single repeat is typically between 20-30 amino acids long and they
form a β-strand-turn-α-helix motif [10,22]. As the repeats stack together they form
an arch, where the binding site is usually located [10]. LRR proteins are involved in
a wide variety of functions such as disease resistance in plants, enzymatic activity
and cell adhesion [23]. An example of a LRR protein is the GTPase-activating
protein, rna1p. This protein contains 11 repeats, in the loop region after the 3rd
repeat there is an insertion of the motif GRLxxE. This solvent exposed loop contains
the conserved residues arginine and glutamate are required for binding to the Ran
protein and the former is required for the catalytic activity [24], Figure 1.5.
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Figure 1.5: LRR protein is the GTPase-activating protein, rna1p (1YRG)
1.1.2.2.3 TetraTricopeptide Repeat
The TetraTricopeptide Repeat (TPR) represents a large family of linear repeat pro-
teins. Identified in 1990 the TPR fold is ubiquitous and is known to be involved in
a variety of functions including protein transport and protein folding [9, 25]. Each
repeat contains a minimum of 34 amino acids, which form a helix-turn-helix motif.
The two α-helices, often referred to as the A and B helix. In naturally occurring
proteins this motif is repeated from 3 to 16 times, with each repeat stacking on top
of the other to form an extended structure that is superhelical [13]. TPR proteins
often bind peptides. For example the Hop protein contains 3 TPR domains that
bind to the C-terminal regions of Hsp70 and Hsp90. The binding pocket is located
on the concave face of the TPR and forms electrostatic interactions with the motif
EEVD [26], Figure 1.6.
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Figure 1.6: Crystal structure of the TPR domain of Hop in complex with the
C-terminal peptide sequence of Hsp90 (1ELR)
1.1.2.2.4 HEAT/Armadillo repeat
Armadillo [27] and HEAT [28] repeats were first identified in 1989 and 1995 respec-
tively. Structurally they share the same C-terminal helix, but differ in the rest of the
structure. Armadillo repeats contain 3 α-helices and HEAT repeats contain 2 [10].
These repeats bind to proteins via interactions on the concave face. An array of
HEAT repeats form the importin-β that binds to the IBB domain of importin-α.
The inner surface of the super helix that the HEAT repeat creates the binding pocket
for the IBB domain. The IBB binds through contacts between its basic residues and
the acidic residues on the inner helix of repeats 12-19, and also through the acidic
loop on repeat 8 [29].
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Figure 1.7: The HEAT repeat protein, importin-β, bound to the IBB domain
(grey) of importin-α (grey) (1QGR).
1.1.2.2.5 Transcription Activator–Like
Transcription activator–like (TAL) effectors were first identified in 1989 and are se-
creted by plant bacteria [30]. Once secreted into cells, the TAL binds to specific DNA
promoters leading to protein expression [31]. The TAL repeats are characterised by
an α-helix-turn-α-helix motif that is 34 amino acids long. The repeats stack to form
a superhelical structure that binds to DNA [32]. The interesting feature of the TAL
repeats is that the sequence is highly conserved between repeats [30]. Hyper-variable
residues are found at positions 12 and 13, located in the loop region between the
α-helices and on the inside face of the superhelical structure. The residue at po-
sition 13 binds to the DNA base and residue 12 stabilises the conformation of the
DNA binding residue [33]. When bound around DNA, the superhelical structure
contracts into a helix with a shorter pitch [30], Figure 1.8. Each TAL repeat binds
specific bases thus the TAL proteins can define a binding site to any specific DNA
sequence. TALs have been designed to bind to DNA sequences in order to suppress
or activate transcription of specific genes [33].
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Figure 1.8: A Transcription activator–like effector unbound (A) (3V6P) or bound
(B) (3V6T) to DNA. There is a dramatic decrease in the pitch of the helix when
the TAL is bound DAN.
1.1.2.2.6 β-helix and β-roll motif
The β-helix and β-roll motif were first discovered in 1993. These repeat proteins
consist of β-strands that align to form parallel β-sheets, along the length of the helix
[34, 35]. They exist in a diverse range of lengths from the small antifreeze proteins,
with only 12 residues per repeat to the 18 residue repeats of the β-roll motifs. The
β-roll motifs are stabilised by binding Ca2+ atoms on the loop region [36]. The
β-helix from the Tenebrio Molitor is used to non-colligatively suppress the freezing
point of water. Each turn of the helix has a single β-strand that has a TCT motif,
the threonine residues are solvent exposed and positioned to bind to the face of an
ice crystal [37], Figure 1.9.
Figure 1.9: A β-helix antifreeze repeat (1EZG), the threonine residues along the
β-strands bind to the surface water molecules of ice.
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1.1.3 Designing Repeat Proteins
As can be seen from the previous section, it is clear that repeat proteins have an
extremely flexible structure, i.e. they can be increased or decreased in size through
addition or subtraction of whole repeat units and form the most amazing protein-
protein interaction motifs. Significantly, the residues that are important for repeat
binding are easily delineated from those important for structure. This makes them
similar to antibodies and consequently they are exciting design targets which have
generated great interest.
1.1.3.1 Consensus Design
The first successfully designed repeat proteins were achieved through a consensus
design approach. Consensus design involves collating all the available sequences
of proteins that adopt a particular repeat fold. The sequences are divided into
repeat motif and a multiple sequence alignment is performed to produce a consensus
sequence that defines the most common residues at each position in the motif. The
designed repeat can then be repeated within a gene to produce a protein with
identical motifs. This technique was first successfully used to design the Ankyrin [38]
and TPR [8] proteins. Figure 1.10A and B shows the consensus sequence for an
Ankyrin and a CTPR from references [39] and [8] respectively. Both proteins contain
2 α-helices per repeat and the Ankyrin repeat also has a -hairpin, Figure 1.10E and
F.
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Figure 1.10: (A) Sequence of a single CTPR repeat, that contains 2 α-helices
separated by a short loop. The highly conserved residues are highlighted in red.
Semi-conserved residues are highlighted in blue in the consensus sequence. These
residues are divided into two types where either the high frequency residues for
that position share the same properties (dark blue) or have different properties
(pale blue) [13]. (B) Sequence of a single designed Ankyrin repeat, that contains 2
α-helices and a -hairpin. The highly conserved residues are highlighted in red. Semi-
conserved residues are highlighted in blue in the consensus sequence. These residues
are divided into two types where either the high frequency residues for that position
share the same properties (dark blue) or have different properties (pale blue) [39].
(C)The conserved structure-forming residues mapped onto the structure of CTPR3
(1NA0). (D)The conserved structure-forming residues mapped onto the structure of
ANK4 (1N0R). (E) Structure of CTPR3 (1NA0). (F) Structure of ANK4 (1N0R).
Consensus designed proteins were found to be much more stable than their naturally
occurring counterparts [8,39]. This is because consensus design selects residues that
are structure forming. However, a consensus design approach removes the functional
binding motifs, to leave a bare structural scaffold. Since the initial design studies,
there has been development of the consensus repeat protein scaffold into functional
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proteins, through re-engineering of binding surfaces.
1.1.3.2 Re-engineering in Binding Motifs
The two most studied systems (Ankyrins and TPRs) were also the first designed
proteins to have binding motifs re-engineered onto the bare scaffold. A binding site
for the C-terminal section of the Hsp90 protein was grafted onto a CTPR scaffold
through a rational design approach. This method involved comparing the sequence
for the Hsp90 binding TPR with that of CTPR3, and identifying the residues that
are important for binding to the sequence MEEVD. These residues were then grafted
onto the CTPR scaffold to give protein, CTPR390. This protein was able to bind
to the pentapeptide with a Kd of 200 µM [40]. The structure of CTPR390 is nearly
indistinguishable from that of CTPR3 and the thermostability is also similar, this
demonstrates that the addition of the binding motif does not require a compromise
to the structure or the stability [40].
In contrast, designed Ankyrin repeats (DARPins) have been engineered to bind
to specific protein targets through the directed-evolution technique: ribosome dis-
play. This technique involves creating a library of DARPin genes, where 7 residues
in each repeat are randomised, these are expressed by the ribosome in vitro [41].
Successful binders are selected by ’panning’, this involves mounting the binding
target to a solid support and incubating with the DARPin library. Once washed
with the buffer those proteins that aren’t successful will not bind and can be dis-
carded [41]. Those which bind can be eluted and amplified and the binding process
repeated. In this way strong binding proteins are evolved. DARPins were ini-
tially selected and shown to bind to the human epidermal growth factor receptor
2 (Her2) [42]. Since the platform technology has been commercialised by the com-
pany Molecular Partners. Now the technology is being further used as antibody
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replacements and are being developed for the treatment of a variety of diseases in-
cluding retinal diseases such as wet age-related macular degeneration. DARPins
have been designed to bind many targets for example: either the inactive (non-
phosphorylated) or the active (phosphorylated) form of ERK2, a mitogen activated
protein kinase [43]. In another study DARPins with an extended loop region able to
bind specific targets was developed. These LoopDARPins were successful in binding
ERK2 and the BCL-2 family of proteins, which are essential for regulating apopto-
sis [44].
The ability to introduce functionality into designed repeat proteins, either through
directed evolution or rational design makes them attractive as systems to engineer
and design. Moreover, their high stability and modular architectures make them
suitable as potential building blocks for biomaterials.
1.2 Biomaterials
Biomaterial is a broad term that encompasses any material that is composed of bi-
ological components. For example, spider silk is a biomaterial made of polypeptide
fibres containing repeating sequences of non-polar and hydrophobic amino acids [45].
The term can also be used to describe biocompatible materials such as titanium-
polyethylene joint replacements. The focus of this thesis is biomaterials made from
proteins, therefore we will only discuss biomaterials made from polypeptides.
Engineered biomaterials comprised of peptides and proteins can be ordered into
3 categories [46]. (1) Recombinant proteins designed from naturally occurring
biomaterial-forming proteins, such as silk [45] and elastin [47]. (2) Peptide-polymer
materials that are composed of short peptides with a polymer attached at one end,
for example peptide amphiphiles [48]. (3) Self-assembling peptide systems, such as
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coiled coils [46].
There are many potential uses of biomaterials, particularly in the area of drug
delivery [49] and tissue engineering [50]. Self-assembling coiled coils have been en-
gineered to form nanocages that have the potential to be used as delivery vessels
for therapeutic drugs [49]. Engineered Elastin-based proteins have been used to
form self-assembling hydrogels [51] and films [52] and have also been used for tissue
engineering [50]. Biomaterials can also be engineered to change their structure on
demand, such as stimuli-responsive peptide hydrogels [53,54]. These systems involve
hydrogels that react to specific environmental stimuli such as changes in pH or tem-
perature. These materials have the potential to be used as drug delivery systems
for example, a smart gel that releases a drug only when placed in contact with the
skin.
Repeat proteins have scope to be extremely useful as building blocks in bioma-
terials as their modular structures can be stacked to create extended arrays. In
addition, they can be functionalised through the engineering of binding sites. For
example DARPins have been developed as antibodies [43] and CTPRs have been
engineered to posses peptide binding sites [40]. In an interesting study, the peptide-
binding ability of CTPRs was used as a way to create hydrogels [55]. CTPR proteins
containing 18 repeats with 3 peptide binding sites reversibly form hydrogels when
mixed with a PEG-peptide crosslinker. These CTPR hydrogels can be dissolved
by increasing the salt concentration demonstrating responsiveness to environmental
stimuli. The hydrogel complexes were also able to encapsulate a fluorescent protein
and a smaller ‘drug-mimetic’ fluorescent marker, which was released by increasing
the ionic strength. This demonstrated the potential of the CTPR hydrogels to be
used for protein or drug delivery [55]. The CTPR hydrogel system uses proteins that
were expressed recombinantly, which limits the length of protein. In Chapter 3 we
will discuss the successful self-assembly of CTPR proteins into fibres up to microns
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in length. A fibre that is 1 µm in length contains approximately 100 repeat units.
This method greatly expands the repertoire of structures that can be used in the
assembly of biomaterials. For example the fibres could be used to make hydrogels
by using bi-functional peptide crosslinkers. The use of longer CTPR filaments could
create hydrogels with different properties to those presented by Grove et al [55]. In
addition, fibres could be decorated using metal-binding peptides providing a syn-
thesis route to creating nano-wires.
Biomaterials can be produced through the bottom-up assembly of smaller build-
ing blocks or the top-down assembly of a larger structure [56]. Bottom-up assembly
exploits the structural features of the monomeric units that promote self-assembly
and uses them to create larger structures [56, 57]. The process of self-assembly is
found extensively throughout biological systems, for example cellular cytoskeletons,
cilia and flagella in eukaryotic cells [57]. The cytoskeleton of cells is supported
largely by actin filaments. The fibres measure up to microns in length and are
formed from the specific head to tail association of actin [58]. In a similar system
the association of tubulin forms microtubules, which make up the internal structure
of cilla and flagella. Thus, nature provides us with a large database from which we
can design new self-assembling biomaterials, either through copying and modifying
existing systems or through generating new building blocks that have the potential
to self-assemble [59].
As can be seen from the above discussion, peptides and proteins are lead candi-
dates in this burgeoning field, whose structural characteristics can be exploited in
the creation of biomaterials. The information needed to form the final 3D structure
of a peptide or protein is contained within the primary sequence of amino acids.
This means that interesting structural subunits can be chosen and used as the basis
for a monomeric building block [59]. In addition, by studying the self-assembly of
designed synthetic systems we may gain a greater understanding of how natural
33
systems self-assemble.
1.2.1 Self-Assembling Peptide Biomaterials
At present there are several different self-assembling systems that use peptide build-
ing blocks and have been extensively studied, these include: Amyloid-like struc-
tures [60]; α-Helical assemblies [61] and Peptide amphiphiles (PAs) [48,62].
1.2.1.1 Amyloid-like Assemblies
The amyloid-like structures consist of peptides and proteins that have a propensity
for forming β-strands; these strands can then assemble into sheets and eventually
form fibrils [56]. Amyloid is commonly associated with diseases such as Alzheimer’s
[57] however, this scaffold has recently been engineered into a functional biomaterial
by decorating the amyloid fibres with enzymes [63, 64]. In one example, Alkaline
phosphatase and Horseradish peroxidase were attached via a linker to an amyloid-
forming sequence. This oligomerised to produce a fibril with the enzyme decorating
the surface of the fibril. These enzymes still displayed enzymatic activity when
attached to the amyloid fibrils [63].
Figure 1.11: Structure of amyloid beta 1-42 fibrils (2BEG) [65].
1.2.1.2 Coiled coils
Coiled coil assemblies make use of α-helix-forming peptides that associate via favourable
helix-helix interactions to form α-helical coiled coils. The motif consists of a heptad
34
repeat, where residues a and d in the sequence are non-polar, Figure 1.11. When
2 helices interact there is a hydrophobic interaction between the a and d residues,
forming the main hydrophobic core. In addition, the residues adjacent to these (e
and g) have an electrostatic interaction, which dictates the register between the he-
lices. The propensity for the helices to self-associate has been exploited to create
systems where components are linked together through a network of coiled coils,
these include hydrogels [66] and fibres [67]. The hydrogel system used 2 compli-
mentary heptad repeats attached to a hydrophilic polymer, when mixed in equal
quantities the peptides formed a coiled coil crosslinking the polymer together to
form a hydrogel [66]. In an interesting study, coiled-coils hydrogels have been shown
to increase the proliferation and differentiation of neural stem cells and have the
potential to be used for in vivo repair of nerve tissue [68]. Coiled coils fibres were
produced by designing a pair of peptides that possess complementary charged groups
in addition to the hydrophobic pair of residues. When mixed together, the peptides
spontaneously self-assemble [67]. It was also possible to design spherical cages of
coiled coils by combining different types of coiled coil peptide together [69].
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Figure 1.12: (A) Schematic of a dimer of 2 heptad repeats, showing how the 2
non-polar residues a and d form an interface between the 2 α-helices. (B) Structure
of a coiled coil dimer (1ZIL).
1.2.1.3 Peptide Amphiphiles
In Peptide amphiphiles, a long alkyl chain is attached to the N-terminus of a pep-
tide (Figure 1.13). These monomers assemble into micelles where the alkyl chains
form a hydrophobic core and hydrophilic amino acids decorate the outside [56]. The
shape of the self-assembled structure can be determined by altering the size and
composition of the hydrophilic peptide group as well as through environmental fac-
tors [70]. Peptide amphiphiles have the potential to help form bioactive implants.
For example, hybrid titanium-peptide amphiphiles implants were found to adhere
more successfully to bone than the titanium implants alone [71]. The peptide am-
phiphiles present in the pores of the titanium allow growth of preosteoblastic cells
inside the implant, leading to bone formation within the implant after 4 weeks [71].
Reduction in bone density at the interface between bone and implant is responsible
for reducing the life-span of implants and therefore this technology has the potential
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to improve the longevity of metal implants [71].
Figure 1.13: Structure of a peptide amphiphile monomer. There is an alkyl chain
attached to a 11 residue peptide. This amphiphile reversibly forms a gel when
treated with acid. [70]
1.2.2 Repeat Proteins as Building Blocks for Biomateri-
als
Repeat proteins provide a good structural basis from which to design novel self-
assembling systems. The characteristic folds are often stable and rigid and are
reproducible, even when the repeat units are isolated from larger structures [59].
Moreover, repeat proteins should provide excellent building blocks for self-assembly
as they have the ability to be combined in a modular fashion to create novel and
scalable chimeras/nanostructures with predictable structures, topologies, stabilities,
linear length and function. For example, proteins produced from consensus TPR
modules (CTPRs) can be recombinantly synthesised to form highly thermodynam-
ically stable, very rigid rod-shaped superhelical arrays of up to 20 repeats [55,72].
The driving force for self-assembly in the peptide based systems is the stabilisa-
tion energy that is gained on formation of an interface. The energetic gains from
the formation of an interface between the repeat units is one of the driving forces of
the folding of repeat proteins, where the intrinsic energies of the folding units are
often less than the interface energy [73]. The importance of interactions between
repeat interfaces was demonstrated by the spontaneously self-assembly of a pair en-
gineered armadillo repeat fragments [74]. An armadillo repeat protein consisting of
37
3 internal repeats and an N and a C capping repeat was split into two components.
When mixed together the N-terminal section spontaneously folds and associates with
the C-terminal unit with a nanomolar Kd [74]. As it was possible to form dimers
using the interfaces as the driving force, it is plausible that this mechanism could
be exploited to drive the self-assembly of extended arrays of repeat modules.
Moreover, it has been shown that both the kinetic and equilibrium repeat protein
folding is prone to the population of partially folded intermediate states [9,72,75,76].
Both the kinetic folding pathway and the population of the intermediate states can
be changed by engineering changes in stability to individual repeats and/or the
whole protein [75, 77–79]. This interesting feature could be used to create systems
where the engineered unfolding of part of a repeat protein (for example a single ter-
minal repeat) to leave a folded intermediate unit with a compatible oligomerisation
interface. Thus such a system could respond to external stimuli, partially unfold
and polymerise via compatible interfaces. However such a system has not yet been
developed as most repeat proteins do not oligomerise even when compatible inter-
faces are present. One reason for this could be because the process to form ordered
oligomers also competes with non-specific aggregation. At present other methods
have been used to drive specific oligomerisation, such as metal chelation, peptide
binding and covalent bonds.
1.2.2.1 Metal mediated Self-assembly
The β-roll motif often binds divalent metals (commonly Ca2+) within the turn re-
gions and, when tandemly arrayed, form a β-helical structure. Interestingly, if the
divalent cations are removed they unfold and form disordered chains [44] [80]. This
response to divalent metal ion concentration has been harnessed in two studies to
produce novel triggerable fibre formation and a smart hydrogel [81, 82]. For fibre
formation, Davies and co-workers designed minimized β-roll motifs that contained
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either three β-strands and two Ca2+ binding sites (34 aa) or 5 β-strands and four
Ca2+ binding sites (50 aa) [82]. Originally these constructs had been designed to fold
into monomeric scaffolds on addition of Ca2+. However, after being produced using
peptide synthesis no structural change was observed on Ca2+ addition. However
when lanthanum was added, filaments of approximately 3 nm in diameter and many
nm in length were formed. The metal ion mediation oligomerisation was found to
be reversible, as removing the La2+ through chelation with EDTA could disassemble
the filaments. Some control of filament length was also obtained by introducing a
further β-roll peptide that was capped at one end with biotin. In order to create
a calcium responsive hydrogel Banta and co-workers also used a β-roll based pro-
tein [81]. Although here they created a chimera that possessed a leucine zipper
domain N-terminally attached to modified β-roll array. The modified β-roll array
was engineered to contain a leucine rich face. Once recombinantly produced, the
leucine zipper/β-roll chimera form is soluble. However when calcium is added the
β-roll arrays fold, exposing the leucine rich face. This causes the β-roll arrays to
interact and oligomerise. The β-roll arrays oligomerisation, coupled with existing
leucine zipper interactions, enable a weak hydrogel to form.
1.2.2.2 CTPR proteins as Biomaterials
Designed TPRs have been used to create both hydrogels [55], films [83] and fibres
(as will be discussed in this thesis in Chapter 3). To form a hydrogel, an 18 repeat
CTPR was used (termed CTPR18). This protein is extremely rigid and 18 nm long.
Each CTPR18 was composed of alternating CTPR3 (a 3 repeat CTPR) units, one
was a peptide binding CTPR3 and the other was a non-binding ‘spacer’ [55]. The
CTPR18s were monomeric in solution, but could be triggered to create smart hy-
drogels or macroscopic solid films. To produce the hydrogels the CTPR18 proteins
were incubated with a multivalent cognate peptide-PEG cross-linker. This caused
multiple CTPR18s to be crosslinked together via the PEG-peptide component and
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form a gel. The stimuli responsive ‘smart’ element was encoded through the peptide
binding modules. When subjected to salt, the gel disassembles due to disruption of
the electrostatic peptide/protein interaction.
Macroscopic solid films were formed by subjecting a solution of CTPR18 with 1 %
w/v polyethylene glycol (PEG) 400 and leaving it to evaporate on Teflon tape [83].
Interestingly, this produced a 100 µM multilayered film that retains its α-helical con-
tent and functional ability to bind cognate peptide (when generated in its presence).
X-ray scattering, coupled with birefringence of the film also suggested that the film
possessed some macroscopic alignment and thus ordering of the CTPR18s.
1.2.3 Using covalent bonds to link monomeric units
In the examples we discussed in the previous sections, the monomeric units are
not covalently linked together. The association is driven by a number of different
mechanisms including: the formation of a hydrophobic core, the chelation to metals
and protein-protein interaction. However, these systems often require that the con-
ditions used for formation to be maintained in order to keep the assembly intact.
For example the addition of salt to the CTPR18/peptide-peg crosslinker hydrogel
becomes unstructured with the addition of NaCl, due to the disruption of the elec-
trostatic effects. In order to form more robust structures that are tolerant to changes
in conditions, the monomeric units could be covalently bonded together. There are
a variety of methods for forming bonds between peptide/protein units. In Chapter
3 of this thesis we will discuss the use of a genetically encoded thioester that can
undergo Native Chemical Ligation to link CTPR monomers covalently together, an
example of Expressed protein ligation. However there are other methods available:
for example isopeptide bonds and click chemistry.
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1.2.3.1 Inteins for Expressed Protein Ligation or trans-splicing
Native Chemical ligation (NCL) is a reaction between two peptides that results in
the formation of a peptide bond. This reaction requires an N-terminal cysteine and
a C-terminal thioester. The thioester is required to increase the reactivity of the C-
terminus, so that the cysteine can attack the carbonyl. Introducing a thioester to the
C-terminus of proteins was difficult to achieve until the development of Expressed
protein ligation (EPL) [84]. EPL exploits a naturally occurring protein splicing
mechanism. The protein splicing mechanism involves the self-excision of an intein
protein followed by the ligation between the C-terminal and N-terminal extein, Fig-
ure 1.14 Scheme A. In the first step of this process there is a slow N→Sacyl transfer,
then nucleophilic attack occurs at the carbonyl. EPL removes the sequence that at-
tacks the thioester, which leaves the protein open to attack from other nucleophiles,
such as Mercaptoethanesulphonate (MESNa). The modified intein sequence can be
combined with an affinity chromatography tag in order to combine purification and
introduction of a thioester. Figure 1.14 Scheme B shows how the IMPACT purifica-
tion system uses a modified intein sequence to produce proteins with a C-terminal
thioester ready for ligation.
Intein trans-splicing uses an intein sequence that is split between the two fragments
of protein to be joined together. When these fragments are mixed together the intein
sequence catalyses the formation of a peptide bond between the C-terminal and the
N-terminal fragment. This method has been used to ligate synthetic peptides with
recombinant proteins. For example, GFP was labelled with the FLAG peptide
through a trans-splicing reaction [85]. The GFP was expressed with the larger
N-terminal section of the intein, the FLAG peptide was synthesised with the C-
terminal remainder of the intein. When mixed together the GFP and the FLAG are
ligated together and the intein sequence is excised.
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Figure 1.14: Scheme B: The full length fusion protein, target protein (blue) and
intein and CBD (green), is bound via the CBD to chitin resin (red). The protein
undergoes a spontaneous S → N acyl shift this generates a thioester. The thiol
group of the reducing agent, Mercaptoethanesulphonate Sodium salt (MESNa), at-
tacks the carbonyl group in a transthioesterification reaction. The protein is released
from the resin and now possess a thioester at the C-terminus. The intein sequence
remains bound to the chitin resin.
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1.2.3.2 Using Isopeptide Bonds to Link Proteins
Isopeptide bond formation results in a covalent linkage between the amine group
of a lysine residue and the carboxylate group of an aspartate or glutamate or the
amide group of an asparagine. One example of this type of linkage is found in the
surface philli of the Gram positive bacteria Streptococcus pyogenes [86]. Here the
isopeptide formation between an aspartate and a lysine residue is catalysed by a
nearby glutamate residue within a domain comprised of β sheets.
The discovery of this naturally occurring example has led to the re-design and op-
timisation of this system to form the SpyCatcher/SpyTag pair [87], Figure 1.15.
This redesign involved splitting the protein into two components: the bulk of the
protein was the SpyCatcher (138 residues) and the smaller fragment became the
SpyTag (13 residues). This protein-peptide pair spontaneously form an isopeptide
bond between a lysine on the SpyCatcher and an aspartate on the SpyTag. This
reaction is rapid and results in the formation of the isopeptide bond between 40 %
of the protein/peptide pairs within the first minute of reaction. Once reacted the
pair is very stable, and remains folded down to pH 2 and up to a temperature of
100 oC. The tolerance to such a diverse range of conditions presents the possibility
of utilising this reaction as a labelling or protein purification system.
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Figure 1.15: Crystal structure of SpyCatcher (A) and SpyTag (B) (4MLI). When
mixed together they form complex (C), that is held together by hydrogen bonding
between the β sheets and an isopeptide bond (circled) between a lysine residue on
the SpyCatcher and an aspartate residues on the SpyTag.
This system was developed further to create SpyLigase [88]. Here the requirement
for a catalytic glutamate residue for isopeptide bond formation was exploited and the
SpyCatcher protein was divided into: SpyLigase (containing the glutamate residue)
and KTag (containing the lysine residue). When all 3 components were mixed to-
gether the SpyLigase mediated the isopeptide bond formation between the SpyTag
and the KTag peptides.
In the groups most recent work, SpyTag and SpyCatcher were combined with dead
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streptavidin (a non-biotin binding variant of streptavidin) to create SpyAvidin [89].
These were then mixed with Traptavidin (a stronger binding variant of streptavidin)
to form tetramers that contained mixtures of the Traptavidin and the SpyAvidin.
Complex structures were formed by isolating selected isomers and then reacting the
SpyTag variant with the SpyCatcher variant. An octamer, capable of binding up to
6 biotin ligands was formed from two tetramers: one containing 3 traptavidin units
and a dead streptavidin with a SpyTag and one containing 3 traptavidin units and
a dead streptavidin and a SpyCatcher. When these 2 tetramers are mixed together
they form an isopeptide bond between the SpyTag/SpyCatcher pair. By mixing dif-
ferent tetramers together it was possible to form an Eicosamer (20 subunits). The
Eicosamer is capable of binding 12 biotinylated MHC units, which interact with
T-cell receptors on T-cells [89].
In another study fibrils were formed by re-engineering the SpyCatcher/SpyTag sys-
tem to promote directional polymerisation [90]. The Spytag peptide was transferred
from the C-terminus to the N-terminus of the Spy protein, leaving a binding pocket
that can accommodate the spytag from another monomer. The binding pocket was
protected from reaction by a capping peptide tag, held in place by a disulfide bond.
When the disulfide was reduced the pocket was free to bind to the Spytag and was
bonded irreversibly by the formation of an isopeptide bond [90].
1.2.3.3 Using Click chemistry to link proteins
Click chemistry is a reaction that produces a covalent carbon-heteroatom bond.
Although this is not one specific reaction it is used to describe a reaction that:
produces high yields, can be performed under mild conditions (i.e. in water) and
where any by-products can be removed without using chromatography [91]. The
most widely used ’Click’ reaction is a Huisgen [3+2] cycloaddition between an azide
and an alkyne, see Figure 1.16.
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Figure 1.16: An example of a [3+2] azide-alkyne cycloaddition
The example shown in Figure 1.16 A requires a Cu(I) catalyst in order to react at
low temperatures. Copper-free cycloadditions have been developed by increasing
the reactivity of the alkyne. By placing the alkyne as part of a strained ring sys-
tem the reactivity is increased and the reaction can proceed without a catalyst. As
click chemistry reactions can be performed under mild conditions in water they have
been used for a variety of bioconjugation reactions involving proteins. As well as
the favourable reaction conditions the reactive groups required for click chemistry
are orthogonal to the functional groups possessed by canonical amino acids [92].
Click chemistry has been used to attach spectroscopic tags to proteins. For exam-
ple, the Cowpea mosaic virus (CPMV) was decorated with fluorescein. The virus
protein was functionalised with azides or alkynes via reaction with surface lysine or
cysteine residues. Fluorescein was linked to the protein via the complementary azide
or alkyne [93]. Achieving the fluorescent labelling via several routes demonstrates
the versatility of the click cycloaddition in protein decoration.
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Click chemistry-compatible non-natural amino acids can now be genetically pro-
grammed into proteins. Site-specific incorporation is achieved by using an orthogo-
nal pair of t-RNA synthetases and the amber codon, TAG [94]. To create proteins
using this method, they are grown in media that includes the non-natural amino
acid and when the amber stop codon is encountered, the non-natural amino acid is
inserted by the orthogonal t-RNA. Plunckthun and co-workers developed a tumour-
binding DARPin into one that was labelled using Click Chemistry [95]. The DARPin
was expressed using a system that incorporated the non-natural amino acid azido-
homoalanine at the N-terminus, in place of methionine. This azide reacts with a
cyclooctyne without the need for a copper catalyst, which would be toxic to cells.
This reaction is specific and orthogonal to any other side reactions, so only the target
azide reacts with the clickable reagent. The result is that the DARPin can be specif-
ically tagged at the N-terminus with polyethylene glycol (PEG). The advantage of
functionalising proteins with PEG is that it has been shown to increase the serum
persistence of proteins, however this addition can decrease the binding ability of the
protein. This DARPin was also functionalised at the C-terminus with a fluorophore
tag, which was linked through a maleimide linkage to a cysteine. The addition of the
fluorophore allowed more detailed studies of the binding kinetics, where PEGylation
was found to decrease binding rate but not the dissociation rate.
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1.3 Aims
The aim of this thesis is to develop the CTPR scaffold into a self-assembling bio-
material. In Chapter 3 we engineered a CTPR protein that, when triggered, would
polymerise. Repeated reaction between the monomers/oligomers lead to the for-
mation of fibres. We began the development of this system by investigating the
properties of a 3 repeat CTPR that lacks the C-terminal helix. This C-terminal
helix was originally engineered into the CTPR proteins as a capping helix, to re-
duce aggregation. This CTPR3∆S was then developed into a system that could be
triggered to undergo Native Chemical Ligation, using a genetically encoded intein
domain that is cleaved using the thioester, Mercaptoethanesulfonate.
In Chapter 4 we investigated the stability of deletion mutants of 2 series of CTPR
proteins. These mutants were designed to lack either the N-terminal or C-terminal
helix, i.e. half a repeat unit. This data was used to develop a Heteropolymer Ising
model, where the contribution to the stability of the protein was assessed for the
terminal helices. The knowledge gained was used to model a chimera of the 2 protein
series containing the stabilising inter-repeat loop sequence PNN in the main body of
the protein and the less stable sequence PRS in the last loop before the C-terminal
helix. The aim of this was to create a protein that could, under certain conditions,
populate a partially folded intermediate. The goal of this is to develop a system
that can partially unfold and then oligomerise.
In Chapter 5 we explore using a photoisomerisable linker to disrupt the stability
of the C-terminal helix. This linker is attached to the helix via 2 cysteine residues
and when exposed to UV light, isomerises from trans to cis.
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Chapter 2
Methods and Materials
2.1 Vectors
The genes encoding for the various CTPR proteins used in this thesis were inserted
into the multi-cloning site of either pProEx HTb, pBAD HisA or pTrcHis-TOPO
(Figure 2.1) The pProEx HTb vector was used to express and purify CTPR proteins
used in Chapters 3, 4 and 5. When used this produced a CTPR protein with an
N-terminal His-Tag. The pTrcHis-TOPO was used to express CTPR proteins for
intein mediated protein polymerisation used in Chapter 3. At the start of this thesis
Dr E. Main, Dr J.J. Philips and Dr Y. Javadi provided a number of CTPR genes in
either the pProEX HTb or pTrcHis-TOPO vector (Table 2.1).
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Figure 2.1: Vectors used for expression of recombinant proteins during this the-
sis. (A) pProEX HTb. This was used for expression of CTPR proteins, the gene
was ligated between the BamHI and HindIII sites. Features include an ampicillin
resistance gene, allowing for selection of cells that contain the plasmid and the Trc
promoter and LacI sequence allows for over-expression of the protein using isopropyl
β-D-1-thiogalactopyranoside (IPTG). Vector map from Invitrogen Life Technologies
manual [96]. (B) pTrcHis-TOPO. This vector was used in the expression of the
CTPR3∆S-Intein-Chitin Binding Domain. The vector contains the ampicillin resis-
tance gene. The LacI sequence allows the protein to be over-expressed using IPTG.
Vector map of B from Invitrogen Life Technologies instruction manual [97]
Table 2.1: Plasmids available at the start of the project
Vector Gene
pProEX HTb CTPR2
CTPR3
CTPR3∆S2
CTPRa21
CTPRa2∆S12
CTPRa31
pTrcHis TOPO CTPR3∆S-Intein-
Chitin Binding Domain2,3
1CTPRan proteins (n=number of repeats) the loop
sequence between the repeats has been changed
from PNN to PRS
2∆S mutants do not possess the C-terminal helix.
This was achieved by placing a stop codon at
position 73 in CTPR2 and 106 in CTPR3.
3The intein domain allows for cleavage of the
protein to be induced using a reducing agent.
The chitin binding domain allows for affinity
purification using chitin resin.
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2.1.1 Mutant CTPR Proteins
In order to undertake the work in this thesis a number of CTPR proteins were cloned
using the genes listed in Table 2.1. These new CTPR proteins are summarised and
described in Table 2.2.
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2.2 Construction of CTPR mutants
2.2.1 Construction of CTPR mutants without the N-terminal
helix
2.2.1.1 Polymerase Chain Reaction (PCR) Amplification of CTPR gene
Polymerase Chain Reaction (PCR) amplification was used to create truncated ver-
sions of the CTPRn and CTPRan proteins, where the N-terminal α-helix is absent.
The gene that was created with this method contained a BamHI restriction site at
the 5’ end and a HindIII restriction site at the 3’ end. This was to allow ligation
between the corresponding sites in the pProEX HTb vector. Four mutants were
created in total: CTPR2∆A, CTPRa2∆A, CTPR3∆A, CTPRa3∆A. A schematic
of the primer design for this type of PCR is shown in Figure 2.2. Primers were de-
signed to have a melting temperature of between 60-65 oC and be the same length
(± 1-3 bases). The primers were 33 and 34 bases in length. Primers were purchased
from Integrated DNA Technologies. The forward primer anneals where the sequence
encodes for the residues at position 16, in order to remove the N-terminal helix and
the 3 residue loop before the start of the second helix. A BamHI restriction site
was incorporated into the coding primer at the 5’ end, which does not anneal to the
template sequence (shown in red in Figure 2.2).
Figure 2.2: Schematic showing the where primers were designed to anneal to the
template sequence. Restriction enzyme sites were incorporated at the ends of the
primers (shown in red). A BamHI site was added to the forward primer and HindIII
was added to the reverse primer.
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The reverse primer anneals where the sequence encodes for the C-terminus of the
CTPR. A HindIII restriction site was added to the 5’ end of the primer. The restric-
tion enzyme sites were incorporated into the ends of the primers to allow digestion
and ligation into the pProEX HTb vector.
The PCR reaction mixture contained the following: 5 µl 10X Reaction buffer, 2
µl template DNA, 1 µl Forward primer (50 µM stock), 1 µl Reverse primer (50 µM
stock), 1 µl dNTPs (10mM stock), 39 µl ddH2O and 1µl Polymerase (typically Taq
or Pfu Turbo) to give a total volume of 50 µl. The reaction was cycled through the
temperatures shown in Table 2.3.
Table 2.3: PCR program for reaction described in Section 2.2.1
Segment Temperature Time
1 95oC 60 s
2*
95oC 30 s
50-55oC 30 s
68-72oC 60 s
3 68-72oC 10 minutes
*Segment 2 was repeated 25 times.
2.2.1.2 Agarose Gel Electrophoresis
Following the PCR, the success of the reaction was judged using electrophoresis on a
1 % (w/v) Agarose gel (preparation is described in the Appendix Section 7.0.4. The
running buffer was 1x Tris-Borate EDTA (TBE). DNA samples were mixed with 6X
Loading Buffer (30% Glycerol, 0.25% Bromophenol Blue) before loading onto the
gel. The running voltage was between 60-100 V, and the voltage was applied until
the dye had progressed 2/3 of the way across the gel. DNA bands were visualised
using UV at 230 nm.
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2.2.1.3 Restriction Enzyme Digestion
After a successful PCR reaction, the gene and pProEX HTb vector was digested
with BamHI and HindIII to produce the correct complementary overhanging ends
to allow ligation.
The digest mixture was as follows: 16 µl DNA (PCR reaction mixture, vector),
2 µl 10X reaction buffer, 1 µl BamHI and 1 µl HindIII to a volume of 20 µl. The
reaction mixture was incubated for 1 hour (for digestions performed with NEB en-
zymes) or between 5-60 minutes (when using Fermentas Fastdigest enzymes).
2.2.1.4 Dephosphorylation of Digested pProEX HTb
To prevent the possibility of false positives caused by vector re-ligation, digested
pProEX HTb were dephosphorylated prior to ligation with the inserts. The follow-
ing was a typical reaction mixture: 16 µl Digested Vector, 2 µl 10X reaction buffer
and 1 µl Alkaline Phosphatase to a volume of 20 µl. The reaction was incubated at
37 oC for 10 minutes, followed by deactivation at 75 oC for 5 minutes.
2.2.1.5 Gel Purification of Digested Vectors and Inserts
The digested pPROEX HTb and inserts were purified using agarose gel electrophore-
sis. The agarose gel was prepared as described in Appendix 1 Section 7.0.4. The
concentration of the Agarose was varied according to the length of the DNA, with
smaller fragments <500bp requiring a higher concentration (1.5-2 % w/v) and larger
fragments >4kb requiring a lower concentration (0.7 %)
DNA bands were visualised using UV at 230 nm. Where a band of the correct
size was observed, it was cut from the gel using a scalpel. The DNA was recovered
from the gel using a Fermentas GeneJet Gel Extraction kit. The suggested protocol
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was followed [98], except the final elution was achieved using 20 µl ddH2O. DNA
was stored at -20 oC after purification.
2.2.1.6 Ligation of Purified Vector and Inserts
Ligation reactions were performed using the following volumes: 8 µl DNA (1 µl
vector and 7 µl insert), 1 µl 10X Reaction buffer and 1 µl T4 DNA Ligase to a give
a total volume of 10 µl. A ratio of 1:7 (vector: insert) was used. The reaction was
incubated at 4 oC overnight or 16 oC for 2 hours.
2.2.1.7 Transformation of Ligation reaction into E.coli Cells
Ligations were transformed into electrocompetent XL2 Blue Ultracompetent E.coli
cells from Agilent Technologies. Electrocompetent cells were kept frozen at -80 oC
in aliquots of 50-100 µl until required. To perform a transformation an aliquot of
cells was thawed on ice and 1 µl of ligation reaction mixture was added and placed
in a 0.2 mm MicroPulsar cuvette. A Biorad Genepulsar, set to bacteria, was used
to electroshock the cells. A successful pulse gave a reading of > 4ms. Cells were
recovered with 1 ml of LB broth and incubated for 45 minutes at 37 oC. After
incubation, 20-100 µl of the cells was spread onto L-Agar containing Ampicillin (0.1
mg/ml). The plate was incubated overnight at 37 oC. If the transformation was
successful, 10-200 discrete colonies will be seen on the plate.
2.2.1.8 Extraction of DNA from E.coli
Single colonies were picked and grown overnight in LB Broth. The cells were har-
vested and a DNA extraction was performed using either a Qiagen QiaJet or Fer-
mentas GeneJet plasmid purification kit. The suggested protocol in the Qiagen
QiaJet [99] or Fermentas GeneJet [100] manual was followed except the DNA was
eluted with 100 µl ddH2O.
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2.2.1.9 DNA Sequencing
To confirm the success of a cloning reaction, a sample of the plasmid (15 µl at
a concentration of 100 ng/µl) was sent for sequencing to Beckman Coulter Ge-
nomics.
2.2.2 Creating 1-4 Base Mutations in CTPRn and CTPRan
using Site-directed Mutagenesis
Site-directed mutagenesis was used to generate small mutations of between 1 and
4 bases. This method was used to create the CTPRyn, CTPRn∆S and the double
Cysteine mutants CTPR3i4, CTPR3i11 and CTPRy3i11 (Table 2.2). Primers were
designed as directed by the Stratagene Quik-Change kit [101] (see Figure 2.3) and
were purchased from Integrated DNA Technologies (IDT). For each mutation the
primers were designed to be between 25-45 bases in length. In this technique the
primers are designed so that the mutation is included as a loop between 2 annealing
sections, the mutation is shown in red in Figure 2.3, and the annealing portions are
shown in black.
Figure 2.3: Schematic showing where the primers for Site-directed mutagenesis
anneal to the template gene. The primers are designed with the mutation site in
the centre of the primer (shown in red)
A typical reaction mixture contained: 5 µl 10X Pfu buffer, 2 µl template DNA, 1.25
µl Forward primer (10µM), 1.25 µl Reverse primer (10µM), 1 µl dNTPs (10mM)
38.5 µl ddH2O and 1 µl Pfu Turbo DNA Polymerase to give a total volume of 50 µl.
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The reaction was cycled through the temperatures shown in Table 2.4 The annealing
temperature was varied between 50-55 oC according to the melting temperature of
the primers.
Table 2.4: Site-directed mutagenesis PCR temperature cycle
Segment Temperature Time
1 95oC 60 s
2*
95oC 50 s
50-55oC 60 s
68oC 7 minutes
3 68oC 10 minutes
*Segment 2 was repeated 18 times
Following IPCR, DpnI was used to digest the methylated parental strands of DNA
(from the plasmid template). 1 µl of DpnI was added to the 50 µl reaction mix-
ture and incubated at 37oC for 1 hour. 1 µl of this mixture was transformed into
XL2 Blue E.coli cells as described in Section 2.2.1.7. The DNA was extracted and
sequenced as described in Sections 2.2.1.8 and 2.2.1.9.
2.2.3 Round-the-horn Mutagenesis
As an alternative to Site-directed mutagenesis, Round-the-horn mutagenesis was
used to create small mutations of 1-5 bases. Like site-directed mutagenesis, this
technique is also a type of Inverse Polymerase Chain Reaction (IPCR), where the
whole plasmid is amplified.
This technique was used to create CTPRy3i11 I97C (Table 2.2). Primers were de-
signed to start from the desired mutation site, with the mutated sequence included
at the 5’ end of the forward primer, shown in red in Figure 2.4.
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Figure 2.4: Schematic showing where the primers for Round-the-horn mutagenesis
anneal to the template gene. Primers are designed so the mutation is at the 5’ end
of the Forward primer (shown in red). After the PCR, blunt ended linear strands
of DNA containing the mutation are produced.
2.2.3.1 Phosphorylation of Primers for use in Round-the-horn mutage-
nesis
Round-the-horn mutagenesis PCR produces linear, blunt-ended DNA that needs to
be ligated before transformation. To ligate linear DNA the ends need to contain
phosphate groups. The primers were purchased without phosphorylated ends, there-
fore these were added using the following protocol. A reaction mixture containing
the following was prepared: 5 µl Primer (100 µM Stock), 5 µl 10X Reaction buffer,
1 µl 50mM MgSO4, 37 µl ddH2O, 1 µl ATP (100mM stock) and 1 µl PNK to give a
total volume of 50 µl. The reaction was incubated at 37 oC for 1 hour followed by
deactivation at 65 oC for 10 minutes.
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2.2.3.2 IPCR of Phosphorylated Primers
After phosphorylation of the primers, the mutant gene was amplified using the
following reaction mixture: 5 µl 10X reaction buffer, 2 µl template DNA, 1.5 µl
Phosphorylated Forward primer (10 µM), 1.5 µl Phosphorylated Reverse primer
(10 µM), 1 µl dNTP mix (10mM stock), 38 µl ddH2O and 1 µl Pfu Turbo DNA
Polymerase to give a total volume of 50 µl. The reaction was cycled through the
temperatures shown in Table 2.5. After the IPCR, the DNA was gel purified and
Table 2.5: Round-the-horn mutagenesis PCR temperature cycle
Segment Temperature Time
1 95 oC 60 s
2*
95 oC 30 s
50-58 oC 30 s
72 oC 12 minutes
3 95 oC 60 s
*Segment 2 was repeated 25 times
ligated as described in Section 2.2.1.5. The DNA was transformed, extracted and
sequenced as described in Sections 2.2.1.7 to 2.2.1.9.
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2.3 Protein Expression and Purification
2.3.1 Media for Culturing E.coli
Two types of media were used: LB Broth and 2XYT. LB broth was purchased
from Melford and dissolved according to the instructions (20 g/L). 2XYT was also
purchased from Melford and dissolved according to the instructions (32 g/L). Media
was always dissolved in dH2O and autoclaved the same day. LB broth was used for
overnight starter cultures and 2XYT was used for protein expression.
2.3.2 Expression and purification of CTPRn and CTPRan
proteins from pProEX HTb
2.3.2.1 Expression of recombinant CTPR protein
The plasmid was transformed into the E.coli expression cell line OverExpress C41
(DE3) (Lucigen) as described in Section 2.2.1.7. 10ml starter cultures were grown
from single colonies overnight at 37 oC. Each 10 ml of starter culture was added to
a 2 L flask (containing 1 L of 2YT media and 0.1 mg/ml Ampicillin). The culture
was incubated at 37 oC with shaking at 210 rpm until the optical density at 600 nm
was between 0.6-1.0. A final concentration of 100 µM IPTG was added to induce
expression and the cells were grown for a further 3-5 hours at 30 oC, or 18-25 oC
overnight. The cells were harvested by centrifugation (5 minutes at 7000 rpm) and
re-suspended in phosphate buffered saline (1xPBS) pH 7. The cells were either flash
frozen (for purification at a later date) or lysed immediately.
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2.3.2.2 Cell Lysis
Cells were lysed using either an Emulsiflex or Sonication (5 minutes at 30 s on 30 s
off). Cell debris was removed from the soluble protein through centrifugation at 17
000 rpm for 1 hour. The supernatant contained the protein of interest.
2.3.3 Affinity Purification of His-tagged fusion CTPR pro-
teins
All pProEX HTb proteins were expressed as fusions with an N-terminal Histidine
tag. To purify the protein, a Nickel-containing agarose resin was used. Approxi-
mately 10 ml of resin was used for every 4 L of culture grown. The Ni-containing
agarose was produced by charging iminodiacetic acid resin (Sigma-Aldrich) with
100 mM NiSO4 and washed with 2-3 column volumes (CV) of 1xPBS pH 7. The
crude mixture of soluble protein was either bound by gravity flow or batch bound by
shaking the resin and protein for 1 hour. The protein bound resin was washed with
at least 250 ml of 1xPBS. Protein was eluted using 1-5 CVs of 250 mM Imidazole in
PBS at pH 7. To cleave the His-tag, TEV protease was added to the eluted protein
and incubated overnight at room temperature. The resin was cleaned after use by
washing with 2-3 CV of 100 mM EDTA, 4-5 CV ddH2O and finally 2-3 CV of 20 %
Ethanol before being stored at 4 oC.
2.3.4 Gel Filtration of Cleaved CTPR Proteins
A HiLoad 26/600 Superdex 75 pg column (GE Healthcare) was used to purify the
proteins after affinity chromatography and cleavage of the His-tag. The column was
attached to an Akta FPLC machine with an automated fraction collector. A flow
rate of 3 ml/minute was used. The column was equilibrated with 2 CV of PBS pH 7
and the concentrated protein (volume 10-20 ml) was loaded via a superloop. Elution
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of the protein was monitored using UV absorbance at 280 nm. The fractions were
analysed using SDS-PAGE, and fractions containing the desired protein were pooled
and concentrated.
2.3.5 Buffer Exchange
Proteins were buffer exchanged using dialysis or desalted with a PD-10 column as
follows.
2.3.5.1 Dialysis
Snakeskin dialysis membrane was purchased from Fisher. The Molecular Weight
Cut Off (MWCO) used was 3000 Da. The tubing was cut to the desired size and
wet with the new buffer. A 4 L volume of the new buffer was prepared. The protein
was loaded into the dialysis membrane, with clips at each to prevent leakage. The
dialysis was performed overnight with stirring at 4 oC.
2.3.5.2 Desalting Columns
A PD-10 desalting column was used to buffer exchange protein volumes of less than
2.5 ml. The column was equilibrated using gravity flow with 25 ml of the new
buffer. The protein was applied to the column in a 2.5 ml aliquot. Once the protein
had fully entered the column, 3.5 ml of the elution buffer was added to elute the
protein.
2.3.6 Storage of CTPR Proteins
Purified proteins were concentrated to a minimum of 100 µM and flash frozen and
stored at -80 oC. The buffer was either 1xPBS or 50 mM phosphate at pH 7.
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2.3.7 N15 Labelled CTPR Proteins from pProEX HTb
N15 labelled proteins were prepared from the pPROEX HTb vector to allow 2D
NMR data to be collected.
2.3.7.1 N15 Enriched Media
To produce N15 protein, the E.coli was cultured in media where the only nitrogen
source is enriched N15. The following media recipe was used. A litre of M9 minimal
media was prepared by autoclaving 950ml of ddH2O containing: 6 g Na2HPO4, 3
g KHPO4, 5 g NaCl and 10ml of 100X trace element solution. A 50 ml in ddH2O
additive was prepared containing:1 mg thiamine, 1 mg biotin, 20 mM MgSO4, 8 mM
CaCl2, 1 g 15NH4Cl2 and 4 g Glucose.
2.3.7.2 Expression of N15 Labelled Proteins
The expression and purification of the N15 labelled proteins follows the same pro-
cedures as those described in Section 2.3.3 with the following exceptions described
below:
A starter culture of 25 ml was pelleted and re-suspended in 5 ml 1xPBS pH 7
and added to 1 L of M9 minimal media, enriched with N15. This was grown at 37
oC for 6-10 hours until an OD of between 0.6 and 1.0 was reached. 100 µM IPTG
was added and the culture incubated at 18 oC overnight.
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2.3.8 Expresssion and Purification of the His-Xa-CTPR3∆S-
Intein-Chitin binding domain protein
The pTrcHis-TOPO vector protein was expressed as a fusion with an N-terminal
His-tag and a C-terminal chitin binding domain (His-Xa-CTPR3∆S-Intein-Chitin
binding domain in pTrcHis-TOPO vector). The same expression protocol was fol-
lowed as described in Section 2.3.2. The cells were lysed as described in Section
2.3.2.2.
Chitin resin (New England Biolabs) was used to purify the protein. The soluble
protein fraction was bound by gravity flow. The resin was washed with 25 CVs of
1xPBS pH 7. Elution was accomplished by adding 1.5 CVs of cleavage solution (0.5
M MercaptoethansulphonateNa (MESNa), 50 mM Tris, 150 mM NaCl, and 1 mM
EDTA at pH 7) and incubating overnight with rotating at room temperature. The
cleaved protein was washed off the column with a further 2-3 CV of cleavage solution.
The reducing agent MESNa cleaves the protein from the resin and leaves the chitin
binding domain attached to the column and generates a thioester at the C-terminus
of the fusion protein to produce the construct: His-Xa-CTPR3∆S-MESNa. The
protein was further purified using Size Exclusion Chromatography as described in
Section 2.3.4 and the purified protein analysed using SDS-PAGE.
The Chitin resin was regenerated by washing with 4-5 CV of 0.3 M NaOH, 4-5
CV of ddH2O and was stored in 20 % Ethanol at 4 oC.
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2.4 Protein Purity and Identity
2.4.1 Protein Concentration Determination
The concentration of purified proteins was calculated using the Beer-Lambert Law.
A UV spectrum was measured between 200-400 nm and the absorbance at 280 nm
was used with equation 2.1 to calculate the concentration.
A = εcl (2.1)
Where A is the absorbance at 280 nm, ε is the Molar Extinction coefficient(M-1cm-1),
c is the concentration (in M) and l is the pathlength of the cuvette. The Molar Ex-
tinction Coefficient was calculated for each protein using Equation 2.2 [102]. This
is based on the number of tryptophan, tyrosine and cysteine residues and the ex-
tinction coefficient for each of these residues.
ε = (no. Tyr)(1490) + (no. Trp)(5500) + (no. Cys)(125) (2.2)
2.4.2 Polyacrylamide Gel Electrophoresis (PAGE)
2.4.2.1 SDS-PAGE Analysis of Proteins
Denaturing SDS-PAGE gels were used to assess the purity of protein samples. SDS-
PAGE gels used during this thesis were 18% and were prepared as described in
Appendix 1, Section 7.0.4.1. Gels were run at a constant voltage of between 150-200
V until the dye front had reached the bottom of the gel.
To visualise the bands, gels were stained with Coomassie brilliant blue (2.5 g Coomassie,
450 ml Methanol, 450 ml ddH2O and 100 ml Acetic acid). The gel was submerged
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and heated for 1 minute and incubated with shaking for 10-30 minutes. Gels were de-
stained using the following solution: 10 % (v/v) Acetic acid and 10 % (v/v) Methanol
in ddH2O. The gel was incubated with shaking until sufficiently de-stained.
2.4.2.2 Native PAGE
Native PAGE gels were prepared in the same manner as non-native except SDS was
substituted with water in the buffer recipes. DTT was removed from the loading
buffer.
2.4.3 Mass Spectrometry
Purified proteins were analysed using MALDI-TOF mass spectrometry on a Bruker
Daltonics Autoflex. Samples were first de-salted using a Millipore C18 ZipTip before
being mixed with a matrix of sinapinic acid. The matrix was made by saturating
acetonitrile with sinapinic acid. A 3 µl sample of matrix and protein samples (1:1
ratio) was spotted onto the MALDI sample plate and allowed to air dry before being
loaded into the machine. The Laser power and gain was varied until the best signal
output was observed.
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2.5 Equilibrium Unfolding Studies of CTPR Pro-
teins
Analysing the reversible equilibrium unfolding of a protein yields information about
the thermodynamic stability. Here, the unfolding equilibria of the CTPR proteins
were induced by either changing the temperature (thermal) or by addition of the
chemical denaturant GuHCl. The unfolding reactions were monitored through the
change in the proteins in Fluorescence or ellipticity. Data collected was analysed
using the equations described in Section 2.9.
2.5.1 Probes to Measure CTPR Unfolding
2.5.1.1 Circular Dichroism
Far UV Circular Dichroism monitors the secondary structure of proteins. CTPR
proteins are very α-helical and this structural feature yields a negative peak for the
ellipticity at 222 nm. When the CTPR is unfolded it loses its α-helical structure
and the ellipticity increases until it reaches zero, at this point the protein is fully
unfolded.
2.5.1.2 Fluorescence
Fluorescence can be used to monitor the tertiary structure of a protein that contains
tryptophans and tyrosines. The protein samples is excited at 280 nm (the absorbance
of tryptophan and tyrosine) and the fluorescence produces a peak at 340 nm. As the
protein is unfolded the peak wavelength of the fluorescence reduces in intensity.
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2.5.2 Chemical Denaturation
2.5.2.1 Sample Preparation
A stock solution of 8 M Guanidinium Hydrochloride (GuHCl) was made up in ddH2O
and the accurate concentration was measured using a refractometer. A Hamilton Mi-
crolab autotitrator was fitted with two 1 ml Hamilton syringes and used to dispense
ddH2O and GuHCl (800 µl total volume) into 68 tubes varying the concentration of
GuHCl linearly from 0-8 M. To each 800 µl tube of denaturant mixture, 100 µl of
concentrated protein stock was added. The stock solution was 9 times the desired
final concentration of protein, typically 45 µM. 1 M phosphate buffer (or 1 M MOPS
depending on the protein buffer) was added to adjust the buffer to a final concen-
tration of 50 mM. The protein samples were incubated at 10 oC for a minimum of
30 minutes to obtain equilibrium. The final protein concentration was 1-5 µM and
buffer conditions were 50 mM phosphate pH 7 unless otherwise stated.
2.5.2.2 Chemical Denaturation followed by CD
An Applied Photophysics Chriascan spectrophotometer with a thermostated cuvette
holder was used to collect data. The temperature used was 10 oC unless otherwise
stated. A 5 mm pathlength cuvette was used for all experiments. The spectrum of
each sample was recorded between 210-230 nm at an interval of 0.5 nm, scanning at
1 s per point. The ellipticity at 222 nm was plotted as a function of the denaturant
concentration.
2.5.2.3 Chemical Denaturation followed by Fluorescence
Fluorescence was also used to follow the chemical denaturation. The sample prepa-
ration was the same as described in Section 2.5.2.1. A 5 mm pathlength cuvette
was used. A Hitachi Fluostar F-2500 FL Fluorimeter with a thermostated cuvette
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holder was used for all measurements. The samples were excited at 280 nm and the
emission spectrum recorded between 320-360 nm at a scan speed of 300 nm/min.
The Fluorescence at 340 nm was plotted as a function of the denaturant concentra-
tion.
2.5.3 Thermal Denaturation
2.5.3.1 Thermal Denaturation followed by CD
The protein sample, at a concentration of 5 µM, was prepared in 50 mM phosphate
pH 7. A 5 mm pathlength cuvette was used. The temperature was ramped from
20-90 oC at intervals of 1 oC, with 30-60 s equilibration time at each temperature.
The ellipticity was recorded at 222 nm and plotted against the temperature.
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2.6 2-Dimensional Nuclear Magnetic Resonance
(2D NMR)
The proteins: CTPR2, CTPR3, CTPRy2 and CTPRy3 were expressed and purified
as N15 labelled samples (as described in Section 2.3.7.2)
2.6.1 Preparation of Protein Samples
N15labelled protein samples were dialysed into 50 mM phosphate with 150 mM
NaCl at pH 6.8. The samples were concentrated to 400-800 µM. For native state
measurements: 10% (v/v) of D2O was added. For partially denatured samples:
concentrated GuHCl (8 M) was added to give the desired final concentration of
denaturant, 10% (v/v) of D2O was also added. CTPR2 and CTPRy2 were measured
with 0.8 and 1.6 M GuHCl. CTPR3 and CTPRy3 were measured with 0.8, 1.6 and
2 M GuHCl. All samples were centrifuged at 14.1 krpm for 10 minutes to remove
particulates prior to pipetting into an NMR tube.
2.6.2 Data Acquisition
Data was collected at 25 oC using a Bruker AV600 600 MHz spectrophotometer and
processed using TopSpin 2.1 patch level 6. 2D 1H-15N HSQC spectra were acquired
using Echo/Antiecho-TPPI gradient selection with decoupling during acquisition,
using water flip-back pulse with gradients in reverse-inept. Acquisition parameters
as follows: spectral widths, 15N, 60 ppm, 1H, 14 ppm; 2048 x 128 complex points
acquired; acquisition time, 0.12 s; relaxation delay, 1 s.
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2.6.3 Cross-peak Assignments
Spectra were analysed in TopSpin 2.1 patch level 6 Assignment of the cross-peaks
was achieved by comparing the spectra of CTPR3 with published spectra for that
construct.
2.6.4 Comparing data sets using Chemical Shift Perturba-
tions
Chemical shift perturbations (CSP) values are used to quantify the changes observed
between data sets for individual 2D NMR crosspeaks. For each crosspeak, the change
in chemical shift for both the N15 and the H1 spectra is calculated. These values are
used in Equation 4.8 to calculate the CSP for each crosspeak.
CSP =
√√√√√√
(
δN
5
)2
+
(
δH
2
)2
2 (2.3)
δN is the change in the chemical shift between the N15 spectra. δH is the change in
the chemical shift between the H1 spectra.
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2.7 Triggered Polymerisation of His-Xa-CTPR3∆S-
MESNa Proteins
The fusion protein His-Xa-CTPR3∆S-MESNa was prepared as described in Section
2.3.8. Cleavage from the Chitin resin generates a thioester at the C-terminus. Fac-
tor Xa cleavage of the His-tag leaves a cysteine at the N-terminus. The cleavage
of the His-tag triggers polymerisation of the monomers through Native Chemical
Ligation (NCL) between the cysteine at the N-terminus and a thioester moiety at
the C-terminus. The NCL reaction does not occur until the His-tag has been cleaved.
A standard reaction mixture contained 100µM protein in 50 mM phosphate pH
7 with 150 mM NaCl and 100 mM MESNa. However, various buffers conditions
were trialled, including: 50 mM phosphate (pH 5, 6 and 7) with and without 150
mM NaCl; 50 mM Tris (pH 7 and 8) with and without NaCl. MESNa was included
at a concentration of between 100-500 mM. The concentration of protein was varied
from 50-500 µM. The reaction was performed at room temperature, with or without
shaking.
2.7.1 Analysis of the Polymerisation mixture
The polymerisation reaction was followed by taking samples of the reaction mixture
and analysing these samples using: SDS-PAGE, Transmission Electron Microscopy
(TEM) and Size Exclusion Chromatography.
2.7.1.1 SDS-PAGE
Samples of the polymerisation mixture were analysed using SDS-PAGE. The same
method was used as described in Section 2.4.2.1.
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2.7.1.2 Transmission Electron Microscopy (TEM) of CTPR fibres
Time points of the polymerisation were analysed using TEM. The microscope used
was a Jeol 1100. Samples were diluted 1:100 with ddH2O. Various types of Carbon
Formvar grids were trialled but typically a 400 mesh was used. Grids were glow
discharged before use, to make them more hydrophilic to increase the binding of
the sample. 4 µl of sample was dropped onto the grid, incubated for 1 minute and
the excess removed using filter paper. 4 µl of Uranyl acetate stain (2 % w/v in
ddH2O) was added to the grid and incubated for 1 minute and the excess removed
with filter paper, this step was repeated. The grid was allowed to fully dry before
observation.
2.7.1.3 Size Exclusion Chromatography
A 10/300 Superdex 75pg (GE Healthcare) column (equilibrated with PBS pH 7)
was used. 100 µl time point samples (at 50 µM) were loaded using a sample loop.
The flow-rate was set at 0.5 ml/min and the elution was followed using UV at 280
nm.
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2.8 AB-photolinker Ligation and Isomerisation
2.8.1 Ligation of the AB-photolinker onto the CTPR3 scaf-
fold
The protein was dialysed into 50 mM Tris pH 8, 2 mM TCEP. A concentrated stock
solution of 5 mM AB-photolinker in ddH2O was prepared immediately before use.
In total 500 nmol of AB-photolinker was reacted with 90 nmol of protein (approx-
imately a 5 fold excess of linker). The linker was added to the 900 µl of protein
(100 µM) in 3 aliquots (30, 30 and 40 µl) with an incubation of 20 minutes between
each addition. The reaction was performed in the dark, at room temperature, with
shaking, this was to ensure the linker was in the trans conformation. The linker was
added in 3 aliquots, to reduce the likelihood of intermolecular cross-linking.
2.8.1.1 Assaying Ligation of the AB-photolinker using the Ellman’s
Reagent Test for free thiols
A solution of Ellman’s reagent was prepared before each experiment by dissolving
4 mg of 5,5’-dithiobis-2-nitrobenzoic acid (DTNB) in 3 ml of reaction buffer (100
mM phosphate with 1 M EDTA at pH 8). Each reaction contained 940 µl reaction
buffer and 10 µl of protein sample. 50 µl of Ellman’s reagent was added shortly
before UV absorption spectra were collected between 300-600 nm. The number of
free thiols can be calculated by using the Molar Extinction Co-efficient of TNB (14
150 M-1cm-1) and the Beer-Lambert law, Equation 2.1.
2.8.2 Isomerisation of the AB-photolinked-CTPR3
The isomerisation was accomplished using a 6 Watt 365 nm UV lamp. The protein
sample was exposed to the light for 10-15 minutes.
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2.8.2.1 Characterisation of Isomerisation of AB-photolinked-CTPR3 by
UV Absorbance
UV absorbance wavelength scans were performed on a U-3010 Spectrophotometer
scanning between 200-600 nm at room temperature. The protein concentration was
between 15-25 µM in 50 mM Tris pH 8. Samples were measured in a 10 mm path-
length cuvette. The trans isomer absorbs at 350 nm, thus the isomerisation reaction
was monitored by observing the change in absorbance at this wavelength.
2.8.2.2 Characterisation of Isomerisation of AB-photolinked-CTPR3 by
CD
CD spectra were collected on an Applied Photophysics Chriascan spectrophotome-
ter. A 5 mm pathlength cuvette was used in a thermostated cuvette holder held at
10 oC. Samples were diluted to a concentration of either 5 µM or 10 µM. The sam-
ple buffer was 50 mM Tris at pH 7 or pH 8. All CD scans were performed between
200-300 nm. An initial scan was performed in order to measure helical content of
the fully folded protein. The sample was then isomerised using UV light at 365 nm
as described in Section 2.8.2 and another wavelength scan performed. The α-Helical
content of the protein was analysed by observing the Ellipticity at 222 nm.
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2.9 Analysis of Equilibrium unfolding data
2.9.1 Two-state Analysis of Chemical Denaturation Unfold-
ing
The simplest model to explain the thermodynamics of the unfolding of a protein
is the two-state model. This states that the protein undergoes a single reversible
transition from the folded to the unfolded state. The proteins studied during this
thesis all displayed a single transition and were all fit according to the two-state
model. Two-state unfolding is described as:
N
KD←→D (2.4)
Where N is the folded protein and D is the unfolded protein. The equilibrium
constant for the transition from folded to unfolded can be described as:
KD =
[D]
[N ] (2.5)
The equilibrium constant KD is related to the free energy of unfolding ∆GD−N via
the following equation:
∆GD−N = −RTlnKD (2.6)
The rate constant for unfolding can also be described as a function of the spectro-
scopic signal, λobs:
KD =
λN − λobs
λobs − λD (2.7)
By rearranging Equation 2.6 for KD we can substitute this into Equation 2.7 to
give:
λN − λobs
λobs − λD = exp
(
−∆GD−N
RT
)
(2.8)
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When rearranged this gives:
λobs =
λN + λDexp−
∆GD−N
RT
1 + exp−
∆GD−N
RT
(2.9)
As λD and λN are assumed to be linearly dependent on the denaturant concentration
[D] (λN = αN + βN [D] and λD = αD + βD[D]):
λobs =
(αN + βN [D]) + (αD + βD[D]) exp−
∆GD−N
RT
1 + exp−
∆GD−N
RT
(2.10)
Here αN and αD are the y-intercepts and βN and βD are the gradients of the folded
and unfolded baselines respectively.
Denaturant concentration varies linearly with ∆G, this is an empirical relation-
ship [103]. The ∆G of unfolding can be expressed by Equation 2.11.
∆GDD−N = ∆GH2OD−N −m[D] (2.11)
The gradient through the transition between folded and unfolded is defined as m.
The m value is a constant of proportionality related to the change in solvent ac-
cessible surface area (SASA) of the protein as it transitions between the native
and unfolded state. Equation 2.11 can be substituted into Equation 2.10 to give
Equation 2.12:
λobs =
(αN + βN [D]) + (αD + βD[D]) exp−
∆GH2O
D−N−m[D]
RT
1 + exp−
∆GH2O
D−N−m[D]
RT
(2.12)
At the midpoint of denaturation ([D]50%) in a two-state approximation, half of the
population of the protein molecules are folded and half are unfolded. Thus Equation
2.11 can be rearranged to:
∆GH2OD = m[D]50% (2.13)
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Equations 4.3 can be substituted in to Equation 2.11 to give:
∆GDD−N = m[D]50% − [D] (2.14)
Equation 2.14 can be substituted into Equation 2.12 to give:
λobs =
(αN + βN [D]) + (αD + βD[D]) exp
(
−m([D]−[D]50%)
RT
)
1 + exp
(
−m([D]−[D]50%)
RT
) (2.15)
To calculate [D]50% and m, the spectroscopic signal (λobs) was plotted against the
denaturant concentration in Kaleidagraph version 4 (Synergy Software). The data
was fitted to equation 4.2 using linear regression analysis in Kaleidagraph. Once
[D]50% and m are known, Equation 4.3 is used to calculate ∆GD.
2.9.2 Normalisation of the Chemical Denaturation Equilib-
rium Unfolding Data
The Fluorescence or Circular Dichroism spectroscopic signal of a CTPR varies with
the number of repeats. When comparing CTPR2 and CTPR3, CTPR2 contains less
tryptophans or tyrosines and produces a lower Fluorescence signal. CTPR2 has less
α-helices and produces a lower CD signal.
λnorm =
λ222 − αN
αD − αN (2.16)
The values for αD and αN are the y-intercept values of the unfolded and folded
baselines. This equation allows for the data to retain the sloping baselines.
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2.9.3 Analysis of Thermal Unfolding
The observed signal for thermal denaturations varies with temperature according to
Equation 2.9. As λD and λN are assumed to be linearly dependent on the temper-
ature T , this gives the following equation:
λobs =
(αN + βNT ) + (αD + βDT ) exp−
∆GD−N
RT
1 + exp−
∆GD−N
RT
(2.17)
The free energy of unfolding ∆GD−N can be expressed using the Gibbs-Helmholtz
relationship, shown in Equation 2.18.
∆GD−N = ∆Hm
(
1− T
Tm
)
+ ∆Cp
[
T − Tm −
(
T.ln
T
Tm
)]
(2.18)
Where ∆GD−N is the enthalpy of unfolding, ∆Hm is the enthalpy of denaturation
at the midpoint, ∆Cp is the change in heat capacity of denaturation and Tm is the
midpoint of the denaturation. ∆Cp is unique to each protein and can be determined
through calorimetry. Values for ∆Cp were not determined as part of this thesis,
therefore ∆Cp was taken to be zero. This changes Equation 2.18 into:
∆GD−N = ∆Hm
(
1− T
Tm
)
(2.19)
When Equation 2.19 is substituted into Equation 2.17:
λobs =
(αN + βN [T ]) + (αD + βD[T ]) exp
−∆Hm
(
1− T
Tm
RT
)
1 + exp
−∆Hm
(
1− T
Tm
RT
) (2.20)
Thermal denaturation data was plotted with λobs against temperature in Kaleida-
graph 4.0 and globally fit to Equation 2.20
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2.9.4 Normalisation of the Thermal Denaturation Equilib-
rium Unfolding Data
The ellipticity of a CTPR varies with the number of repeats. When comparing
CTPR2 and CTPR3, CTPR2 has less α-helices and produces a lower CD sig-
nal.
λnorm =
λ222 − αN
αD − αN (2.21)
αD is the λ222 at 90 oC and αN is the λ222 at 20 oC. This equation allows for the
data to retain the sloping baselines.
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Chapter 3
Self-Assembly of CTPR
Modules
In this chapter I will describe the self-assembly of CTPR3∆S modules into fibrous
nanostructures. The fibres are formed using Native Chemical Ligation (NCL) be-
tween monomers. NCL generates a peptide bond from the reaction between an
N-terminal cysteine and a C-terminal thioester.
3.1 Experimental Approach
The formation of the CTPR fibres was monitored using SDS-PAGE and Analyt-
ical Size Exclusion Chromatography. The fibres were imaged using Transmission
Electron Microscopy (TEM). The size and morphology was analysed from the TEM
images.
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3.2 Motivation for using the TPR motif to Create
Nanostructures
A TetratricoPeptide Repeat (TPR) is a 34-residue helix-turn-helix motif, which
when stacked together forms elongated domains [13]. Unlike globular proteins, TPRs
do not rely on topologies stabilised by interactions of residues distant in primary
sequence. Instead, their modular, non-globular structures are dominated by regular-
ized interactions of residues close in primary sequence [13]. These distinctive features
have made designing proteins that contain arrays of repeats composed of consensus
residues extremely successful [13] [8]. Significantly for biomaterial synthesis, these
designs have shown that the consensus proteins can be easily lengthened or shortened
by the addition or removal of identical repeat motifs [8, 75, 104]. In particular, we
and the Regan laboratory have recombinantly produced soluble, monomeric proteins
with up to 20 consensus TPR modules [8], [9, 72, 105]. Strikingly, as you increase
consensus TPR motifs within a protein, large elongated super-helical structures with
identical inter and intra repeat interactions are produced [105]. Moreover, increasing
the number of stacked repeats gives proteins that increase in stability [9,105]. Thus if
an arbitrarily large structure comprised of consecutively arrayed linear repeat units
could be produced, it should form helical filaments with a free-energy stability orders
of magnitude greater than that of the soluble monomers. One method of producing
larger superstructures would be through further recombinant expression of repeat
proteins with greater repeat numbers within a single gene. However such a process
is severely limited, not least in the size and yield of protein that can be produced.
Therefore, we chose a strategy of bottom-up directed self-assembly. Specifically, the
polymerisation of recombinantly produced, discretely folded, TPR protein domains.
These monomers were based on the original designed CTPR3 protein (3 consensus
TPR motifs of 34 amino acids each) [8]. CTPR3 was chosen as it is extremely
easy to recombinantly synthesize [8], is highly stable (12.0 ± 0.7 kcalmol-1, at pH
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7 [78]), is structurally very rigid 20 and contains a minimal 3 TPR motif unit that is
used ubiquitously throughout nature as a peptide binding motif [25]. These features
are important as they provide abundant building blocks that remain folded under
a range of conditions, whose rigidity prevents futile intra-protein cyclisation and
present a viable route for future decoration and functionalisation.
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3.3 Results
3.3.1 Developing CTPR3 into a Suitable Building Block for
Polymerisation
The CTPRs were designed to be monomeric through the addition of a C-terminal
‘capping’ helix. This was added to aid stability and cap the hydrophobic core. The
C-terminal helix in CTPR3 is equivalent to half a repeat and consequently blocks a
potential dimerisation interface at the C-terminus, Figure 3.1.
Figure 3.1: (A) Crystal structure of CTPR3 (1NA0) (B) Schematic diagram of
CTPR3 with the helices represented as circles. (C) CTPR8 (2FO7) showing the
super-helix that is formed when the number of repeats exceeds 7.
To make a monomer suitable for further polymerisation you need compatible inter-
faces and the first step towards redesigning CTPR3 was to remove the C-terminal
helix. Removing this helix exposes a surface that is identical to that seen between
repeats and is compatible with the interface at the N-terminus of another CTPR3
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monomer, thus allowing specific head-to-tail association.
3.3.2 Cloning, Expression and Purification of CTPR3∆S
This mutant that lacks the C-terminal helix is termed CTPR3∆S and was created by
inserting a stop codon at position 106 in the CTPR3 sequence (see Section 2.1, Table
2.1 for a full description). It was expressed and purified as described in Chapter
2.3.2 and gave high yields of approximately 10 mg/L of culture.
Figure 3.2: Structure of CTPR3∆S, generated from the crystal structure of
CTPR3 (1NA0)
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3.3.3 Characterisation of the CTPR3∆S Protein
Removal of the C-terminal helix from CTPR3 produces a protein that has compat-
ible dimerisation interfaces at both the N and the C-terminus. Therefore it was
assumed that removal of this helix would lead to specific head-to-tail association
between CTPR3∆S units. An increase in non-specific aggregation was also an-
ticipated as when naturally occurring TPR proteins were expressed and purified,
they displayed low solubility without the addition of an extra C-terminal helix [8].
To determine if these previous assumption are correct, CTPR3∆S was analysed.
Size Exclusion Chromatography was used to analyse if it was monomeric. Circular
Dichroism was used to investigate the structure. Thermal and GuHCl denaturations
(followed by CD) were carried out to assess the stability.
3.3.3.1 Size-Exclusion Chromatography of CTPR3∆S
CTPR3∆S was analysed using size exclusion chromatography to determine if it
is monomeric. A 100 µl sample at a concentration of 50 µM was loaded onto a
GE Healthcare Superdex 75pg 300/10 column (equilibrated with 50 mM phosphate
pH 7, 150 mM NaCl). The flow rate was set at 0.5 ml/minute. The elution of
the protein was monitored using UV absorbance at 280 nm. The chromatogram
for CTPR3∆S was compared with that of CTPR3 (Figure 3.3) because CTPR3
has been confirmed as monomeric [8]. Both proteins show a single peak (CTPR3:
10.6 ml and at CTPR3∆S: 10.9 ml), the variation in retention volume is because
CTPR3 is a larger protein due to having an extra helix. CTPR3∆S was judged
to be monomeric up to a concentration of 50 µM. The removal of the C-terminal
helix didn’t result in an increase in non-specific aggregation, and CTPR3∆S was
monomeric as judged by size exclusion chromatography under the conditions that
were used here, see Figure 3.3.
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Figure 3.3: Analytical size exclusion chromatograms of CTPR3 (blue) and
CTPR3∆S (red). Conditions were: 50 mM phosphate pH 7, 150 mM NaCl, buffer
flow rate was set at 0.5 ml/minute. The column used was a GE Healthcare Superdex
75pg 300/10.The elution of the protein was monitored using the absorbance at 280
nm and the retention on the column measured in ml. The increased retention time
for CTPR3∆S is due to the removal of the C-terminal helix, this makes it a smaller
construct than CTPR3.
3.3.3.2 Analysing the Secondary Structure of CTPR3∆S using Circular
Dichroism
A CD wavelength scan was performed on CTPR3∆S to assess the secondary struc-
ture, Figure 3.4. The wavelength scan was performed on a 5 µM sample, dissolved
in 50 mM phosphate pH 7. The sample was held in a thermostated cuvette holder at
10 oC. The scan showed a single negative peak at 222 nm, indicating that the protein
is highly α-helical. This is what was expected given the highly α-helical content of
other CTPR proteins. This confirms that CTPR3∆S displays the characteristic fold
of the CTPRs.
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Figure 3.4: Far UV wavelength scan of CTPR3∆S at 5 µM dissolved in 50 mM
phosphate pH 7. The sample was held in a thermostated cuvette holder at 10 oC.
The scan showed a single negative peak at 222 nm, indicating that the protein is
highly α-helical.
3.3.3.3 Assessing the Stability of CTPR3∆S Through Equilibrium Un-
folding
The stability of CTPR3∆S was assessed via thermal and GuHCl denaturations
followed using Circular Dichroism at 222 nm (Figure 3.5). Through comparison with
data for CTPR3 and CTPR2 we can judge the effect of removing the C-terminal
helix on the stability of the protein (Figure 3.5).
3.3.3.3.1 Chemical Denaturation of CTPR3∆S
CTPR3∆S underwent a single reversible transition from the folded to the unfolded
state. The data for CTPR3∆S can be qualitatively compared to data for CTPR2 and
CTPR3 by fitting to a two-state two-sloping baseline equation 4.2. The mid-points
of the fit of the data can be used to compare the stability of the different proteins.
These were: CTPR2 2.6 M ± 0.01 M; CTPR3∆S 3.2 M ± 0.01 M and CTPR3 3.4
M ± 0.1 M (errors are calculated from the fit of the equilibrium unfolding curve).
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Thus removing the C-terminal helix reduces the stability of the protein.
Figure 3.5: Normalised chemical denaturation curves for CTPR2 (red circles),
CTPR3 (Blue diamonds) and CTPR3∆S (black squares), there are 2 data sets for
each construct. All the proteins undergo a single reversible transition from the
folded to unfolded state. Initially, the data was fit using a two-state two-sloping
baseline equation (Section 2.9). However, to allow for easier comparison the data
has been normalised (using Equation 4.1) to account for the variation in ellipticity
that arises from the different number of helices for each construct. Data was fit using
linear regression analysis in Kaleidagraph 4.0. The data shows that the stability
increases with the size of the protein, as judged by the mid-point of the denaturation.
Experimental conditions were: 5 µM protein in 50 mM phosphate pH 7. Guanidine
HCl was used to denature the proteins and the progress was monitored using the
CD ellipticity at 222 nm. Data was recorded on a Photophysics Chirascan using a
5 mm pathlength cuvette held in a thermostated holder set at 10 oC.
3.3.3.3.2 Thermal Denaturation of CTPR3∆S
CTPR3∆S underwent a single reversible transition from the folded to the unfolded
state. Reversibility was confirmed by comparing CD wavelength scans before and af-
ter the denaturation, Figure 3.6A. The variance of the ellipticity at 222 nm between
the wavelength scans was within 5%. The data for CTPR3∆S can be qualitatively
compared to data for CTPR2 and CTPR3 by fitting to a two-state two-sloping base-
line equation 2.20. The mid-points of the fit of the data can be used to compare the
stability of the different proteins.
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CTPR3∆S has the same mid-point (Tm) as CTPR2 (69 oC ± 0.2 oC). This is in
contradiction to the GuHCl denaturation data, where the mid-point of CTPR3∆S
is between that of CTPR2 and CTPR3. The explanation for this is that the thermal
transition is not a two-state mechanism and the protein unfolds partially before the
transition, Figure 3.6B.
Although the C-terminal helix was added to reduce non-specific aggregation and
block specific oligomerisation, CTPR3∆S did not display either of these effects.
CTPR3∆S is stable and monomeric at pH 7 and didn’t undergo any non-specific
aggregation under the conditions examined here. Although CTPR3∆S did not spon-
taneously oligomerise, it is very stable and doesn’t aggregate thus making it a suit-
able building block for creating nanostructures.
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3.3.4 Using a Bi-functional Chemical Crosslinker to test for
Associations Between CTPR3∆S Proteins
Although CTPR3∆S was monomeric as judged by Size Exclusion Chromatogra-
phy, it’s possible that the protein is weakly associating, which won’t be observed
using Size Exclusion Chromatography. To examine if CTPR3∆S does form weak
or transient interactions, a bi-functional crosslinker was selected. Cysteine residues
are the most common target for crosslinking reagents. However because CTPRs
do not contain any cysteines, the lysine reactive linker: Suberic acid bis(3-sulfo-N-
hydroxysuccinimide ester) was chosen (Figure 3.7). CTPR proteins contain 2 lysine
residues per repeat and these are both solvent accessible according to the PDB data,
Figure 3.8.
Figure 3.7: Chemical structure of the bi-functional linker, Suberic acid bis(3-sulfo-
N-hydroxysuccinimide ester) sodium salt. The sulfo groups allow the linker to be
dissolved in water.
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Figure 3.8: Structure of CTPR3∆S (modified 1NA0) with the lysine residues
highlighted in blue.
Crosslinks between protein molecules are only formed when the protein molecules
are near in space. This allows us to observe any weak or transient interactions that
are occurring between the proteins. If the CTPR3∆S proteins form constructive
head-to-tail associations then dimers and trimers will form.
3.3.4.1 Crosslinker Reaction Conditions
The protein and linker were reacted in a 1:50 mole ratio to give final concentrations
of 90 µM protein and 4.5 mM BS3. The reaction was performed at 25 oC and 50 oC
in 20 mM phosphate pH 7. CTPR3 was reacted with the linker in a separate vessel
to serve as a control. The lysine residues are located throughout the structure of
CTPR3 and CTPR3∆S, therefore it is possible for non-specific dimers to be formed
on reaction of the crosslinker with the protein. CTPR3 is prohibited from forming
specific head-to-tail associations because of the C-terminal helix but will still form
non-specific dimers. The reaction was performed at 50 oC to determine if the C-
terminal helix of CTPR3 could be specifically unfolded and yield a similar result as
CTPR3∆S. Samples of the reaction were analysed using SDS-PAGE and are shown
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in Figure 3.9.
Figure 3.9: 18% SDS-PAGE gel of samples crosslinked with BS3. The protein and
linker were reacted in a 1:50 mole ratio to give final concentrations of 90 µM protein
and 4.5 mM BS3. Dimers are seen for both CTPR3 and CTPR3∆S but trimers are
only seen for CTPR3∆S. The reaction was performed at different temperatures to
assess if temperature can destabilise the C-terminal helix in CTPR3. The control
sample on the gel is a sample of the protein without any crosslinker added, the
apparent difference in size is caused by single attachment of the crosslinker to the
protein, this increases the negative charge thus increasing the speed.
When this linker was reacted with CTPR3 and CTPR3∆S there were some dimers
seen for both proteins but a higher number was seen with CTPR3∆S. There were
some trimers formed from CTPR3∆S but not for CTPR3. This indicates that
the CTPR3∆S is associating constructively to form trimers. When the reaction
was performed at 50 oC, there was a reduction seen in the number of higher order
oligomers. The reaction between the crosslinker and the free amines competes with
hydrolysis. Hydrolysis is the dominant effect seen at 50 oC resulting in less crosslinks.
This shows that there are some transient associations formed between CTPR3∆S
monomers. However, this would not be a suitable system for creating nanostructures
as there are many non-specific crosslinks formed and the reaction is very susceptible
to hydrolysis. To ensure that only constructive oligomers are formed, a way of
driving specific head-to-tail polymerisation needed to be devised.
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3.3.5 Redesigning CTPR3∆S so that it can be triggered to
polymerise
The next step towards inducing CTPR3∆S polymerise is to engineer orthogonal
chemistry into both ends to drive polymerisation in the desired head-to-tail direc-
tion. We wanted to use a semi-synthetic approach that could be genetically encoded.
For this reason Native Chemical Ligation was chosen. NCL has several distinct ad-
vantages over other chemistries as it requires no protecting groups, can be genetically
encoded, works at neutral pH in aqueous buffer, kinetics are productive within a
temperature range in which the proteins are natively folded, it requires no catalyst
and results in the formation of a native peptide bond, such that the site of ligation
is indistinguishable from the rest of the polypeptide chain.
3.3.5.1 Native Chemical Ligation
Native Chemical Ligation (NCL) is used to link proteins by forming a peptide bond
between proteins. The pre-requisites for inter-molecular NCL are: a cysteine residue
at the N-terminus and a thioesterified C-terminus. Figure 3.10 shows the ligation
of two proteins via NCL. In step 1 the thiol group of an N-terminal cysteine residue
attacks the thioester at the C-terminus of another protein. Next, the amine group
attacks the carbonyl giving an S → N acyl shift, that leaves a native peptide bond
at this site. If CTPR3∆S is redesigned to possess an N-terminal cysteine and a
C-terminal thioester then NCL can occur between these monomers and result in
polymerisation.
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Figure 3.10: Reaction mechanism for a Native Chemical Ligation between two
protein molecules (shown in blue) at pH 7. Step 1: The thiol group of a cysteine
at the N-terminus attacks the carbonyl of the thioesterified C-terminus of another
protein. This step is reversible and only proceeds to the next step when the R-group
of the thioester is released. Step 2: The S → N acyl shift results in the formation
of an amide bond.
3.3.5.2 IMPACT™Intein-mediated Protein Ligation kit
The IMPACT™kit from New England Biolabs is used to express proteins ready
for use in a Native Chemical Ligation reaction. This system utilises the vectors
pTWIN1 and pTWIN2. These vectors are used to express fusion proteins with
intein domains. An intein is a self-cleaving protein domain and this system uses this
feature to cleave the affinity tag as an alternative to using proteases. A gene can be
ligated into the vector to produce fusion proteins with either an N-terminal intein, a
C-terminal intein or both. A chitin binding domain (CBD) allows the fusion protein
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to be purified using chitin resin. The mechanism for cleavage from the chitin resin
depends on whether an N or C-terminal tag is being removed. The mechanism for
cleavage of a C-terminal tag requires a thiol reducing agent, Figure 3.11A-C. The
process for cleaving the fusion protein from the chitin resin starts with the N → S
acyl shift (Figure 3.11A). The reducing agent, Mercaptoethanesulphonate Sodium
salt (MESNa), is added and this attacks the carbonyl in the protein backbone (Figure
3.11B) and the protein is released from the resin with a thioester at the C-terminus
(Figure 3.11C). The process for removing an N-terminal tag is achieved through a
shift in pH, Figure 3.11D-E. The change in pH results in the amide group of an
upstream asparagine residue attacking the backbone cleaving the protein here. The
advantage of this mechanism of cleavage over that of a protease is that the choice
of N-terminal residue isn’t constrained to that required by the protease. A cysteine
can be placed at the N-terminus, this is what is required for NCL.
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3.3.5.3 Developing CTPR3∆S into a protein that can undergo Trigger-
able Cleavage
A cysteine residue was added to start of the CTPR3∆S sequence and this was lig-
ated into the pTWIN vector from the IMPACT™kit, so that the fusion protein that
was expressed contained the N and C-terminal intein domains. This was so that
MESNa induced cleavage introduced a thioester at the C-terminus and a change in
pH would cleave the N-terminal tag.
However, when CTPR3∆S was expressed as this fusion the protein underwent a
significant amount of non-specific aggregation on cleavage of the N-terminal tag.
The cleavage of the C-terminal intein was successful. Therefore, the construct was
redesigned to retain the intein (Mxe GyrA [106]) and the chitin binding domain
sequence at the C-terminus but the N-terminal intein was removed. Instead the
N-terminal cysteine is generated through Factor Xa cleavage. Factor Xa was chosen
as the protease to remove this N-terminal cap as it cuts after its recognition se-
quence, allowing a cysteine to be located as the very first residue at the N-terminus
following cleavage. This gene was ligated into the pTrcHis-TOPO vector, this adds
a His-tag to the N-terminus. This means that polymerisation is triggered by the
addition of this protease. This strategy produced protein (A) in Figure 3.12. The
reaction scheme in Figure 3.12 shows how the reactive monomer (C) is formed from
the fusion protein (A).
The mechanism for polymerisation between activated CTPR3∆S monomers is shown
in Figure 3.12D-F. After the NCL reaction between the monomers the CTPR3∆S
units rearrange and dock so that the newly formed dimer adopts the characteristic
TPR fold.
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Figure 3.12: Reaction scheme showing how the reactive monomer is formed from
the fusion protein (A). First, MESNa-mediated cleavage generates a thioester at the
C-terminus (B), then Factor Xa cleavage leaves a cysteine at the N-terminus (C).
(D) Shows the NCL reaction between 2 units of the active monomer to form a dimer
(E). This dimer can rearrange and the CTPR3∆S units will dock together (F), this
dimer has reactive ends and can undergo further polymerisation.
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3.3.6 Expression of the His-Xa-CTPR3∆S-Intein-Chitin
binding domain protein
The full length fusion protein (His-Xa-CTPR3∆S-intein-Chitin binding domain) was
expressed using the same protocol as described in Section 2.3.2. The cells were lysed
under native conditions as described in Section 2.3.2.2.
3.3.7 Purification of the His-Xa-CTPR3∆S-thioester
Protein
The His-Xa-CTPR3∆S-intein-CBD protein was bound to chitin resin using gravity
flow. Cleavage is accomplished by incubating the resin bound protein overnight in
a solution that contains 0.5 M of the reducing agent MercaptoEthaneSulfonateNa
(MESNa). The His-Xa-CTPR3∆S-thioester protein is released from the resin after
undergoing intein-mediated cleavage, Figure 3.11. MESNa is required to generate
the thioester at the C-terminus of His-Xa-CTPR3∆S-thioester as the protein is
cleaved from the intein-CDB-Chitin resin complex. The high specificity of the chitin
binding domain allows for the purity of the His-Xa-CTPR3∆S-thioester protein to
be >95 %, see Figure 3.13. The intein-CBD largely remains bound to the resin but
small amount is released along with the His-Xa-CTPR3∆S-thioester protein. This
is seen in the gel in Figure 3.13 at 27 kDa in lanes 5-9.
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Figure 3.13: 18% SDS-PAGE gel of the purification of the intein fusion protein.
The marker is in the left-hand Lane 1-4, form left to right are: lysed cells soluble
fraction; lysed cells insoluble fraction; Wash of the soluble fraction through the col-
umn. Lanes 5-9 show the 4 elution fractions of protein (His-Xa-CTPR3∆S-thioester
at approximately 17 kDa) after it have been cleaved from the chitin column using
MESNa. The band at 27 kDa that is present in lanes 5-9 is the intein-CBD protein,
most of the concentration of this protein stays bound to the chitin resin but a small
amount is released.
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3.3.8 Native Chemical Ligation Reaction of the His-Xa-
CTPR3∆S-thioester Protein
The Native Chemical ligation reaction is triggered by the addition of Factor Xa
to the His-Xa-CTPR3∆S-thioester protein. This cleaves the His-tag from His-Xa-
CTPR3∆S-thioester to leave an N-terminal cysteine, Figure 3.12. The CTPR3∆S-
thioester protein then undergoes repeated NCL reactions to form long oligomers.
The reaction was studied by taking samples of the mixture periodically during the
polymerisation and monitoring the progress of the reaction through a variety of
techniques including: SDS-PAGE, Analytical Size Exclusion Chromatography, Mass
Spectrometry, Circular Dichroism and Transmission Electron Microscopy (TEM),
these are discussed in the following sections.
3.3.8.1 Following the Polymerisation using SDS-PAGE
The most convenient way of monitoring the polymerisation reaction was using SDS-
PAGE. This allows us to visualise the distribution of oligomers in the reaction mix-
ture. To investigate the how the reaction proceeds a sample of His-Xa-CTPR3∆S-
thioester was initiated with Factor Xa and the reaction followed by removing samples
at set times.
Figure 3.14 shows a reaction with time points taken at 0, 1 and 3 days. Prior to
initiation, at 0 days, the sample contains the protein, His-Xa-CTPR3∆S-thioester
seen at 15 kDa. A small concentration of intein-CBD protein is visible at 27 kDa,
this is a by-product of the purification of the His-Xa-CTPR3∆S-thioester protein
from the MESNa induced cleavage of His-Xa-CTPR3∆S-intein-CBD. The majority
of the intein-CBD protein remains bound to the chitin resin, however some is re-
leased along with the His-Xa-CTPR3∆S-thioester. After addition of the Factor Xa
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the His-tag is cleaved and this is shown by the disappearance of the band at 15 kDa.
Also observed is the emergence of larger oligomers, seen at 17 kD (dimer) and 21
kDa (trimer). Further oligomers are seen at higher molecular weights. After 3 days
of reaction the cleavage product has fully reacted (marked by the absence of the
band previously seen at 12 kDa).
Figure 3.14: 18% SDS-PAGE gel of samples taken from a polymerisation reaction.
The conditions were: 100 µM protein in 50 mM phosphate pH 7, 150 mM NaCl and
10 mM MESNa. Prior to initiation, at 0 days, the sample contains the protein His-
Xa-CTPR3∆S-thioester at approximately 15 kDa and a smaller concentration of the
intein-CBD protein at 27 kDa. After addition of the Factor Xa the reaction proceeds
for 1 day. At this point the His-tag has been fully cleaved to produce CTPR3∆S-
thioester, shown by the absence of a band at 15 kDa. Also observed is the emergence
of larger oligomers, seen at 17 kD (dimer) and 21 kDa (trimer). Further oligomers
are seen at higher molecular weights. After 3 days the cleavage product has fully
reacted and the concentrations of the smaller oligomers has decreased as these units
react to form larger structures.
To confirm the reproducibility and probe the finer details of the the polymerisation
the reaction was repeated and samples removed at set time points. Samples were
removed from the reaction at the following times: 0, 4, 8 and 12 hours and at 1, 2,
and 7 days, Figure 3.15. The same trend is seen as before. As the Factor Xa cleaves
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the His-tag, the band for the His-Xa-CTPR3∆S-thioester (seen at 15 kDa) reduces
in intensity. We can see the presence of a cleavage product that appears at 12 kDa,
4 hours after the initiation. After one day there is the emergence of dimers at 17
kDa and trimers at 25 kDa. After 2 days there are larger structures visible above
27 kDa, and the intensity of each band decreases as the size of the oligomerisation
products become polydisperse.
Figure 3.15: 18% SDS-PAGE gel of samples taken from a polymerisation reaction.
The conditions were: 200 µM protein in 50 mM phosphate pH 7, 150 mM NaCl
and 10 mM MESNa. The same volume of sample was loaded for each time point
to allow a relative comparison of the concentration of each species in the sample.
Prior to the addition of Factor Xa, at 0 hours, the His-Xa-CTPR3∆S-thioester can
be seen as a bright band at approximately 15 kDa. The intein-CBD protein is also
present in a lower concentration at 27 kDa. As the Factor Xa cleaves the His-tag,
the band for the His-Xa-CTPR3∆S-thioester (seen at 15 kDa) reduces in intensity.
We can see the presence a cleavage product that appears at 12 kDa, 4 hours after
the initiation. In addition we see a band for the His-tag (seen at 6.5 kDa) increase
in intensity as it is cleaved from the His-Xa-CTPR3∆S-thioester protein. After one
day there is the emergence of dimers at 17 kDa and trimers at 25 kDa. After 2
days there are larger structures visible above 27 kDa, and the intensity of each band
decreases as the size of the oligomerisation products become polydisperse.
It is interesting to note that the bands on the gel appeared to be smaller than
the predicted molecular weights. Table 3.1 shows the calculated molecular weights.
Whilst there is a linear trend between the molecular mass and retention on the
gel, there are several factors that can alter a proteins’ mobility. One factor that
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strongly influences how proteins migrate is how well they bind to SDS [107]. Proteins
that bind poorly to SDS migrate faster through the gel matrix and appear to have
a smaller molecular mass [107]. The CTPR proteins always appear at a smaller
molecular mass on an SDS-PAGE gel than the calculated weight. Appendix Section
7.0.5 shows an example of how different length CTPRs appear on an SDS-PAGE
gel. This trend has been observed consistently throughout the research conducted
on CTPRs [Personal communication, Regan and Main research groups]. Previous
studies have confirmed via mass spectrometry that various CTPRs are the intended
mass, however they appear to be have a smaller mass as judged by SDS-PAGE. We
conclude that the shift in the weights seen here for the oligomers is due to reduced
binding of SDS. This gel-shift observation is consistent with that typically observed
for CTPRs. Samples were analysed using MS and this confirmed that the proteins
are the intended mass, see Section 3.3.8.3.
Table 3.1: Predicted molecular weights of polymerisation products
CTPR Species Molecular Mass (Da)1
His-Xa-CTPR3∆S-thioester-intein-CBD 44867
intein-CBD 27858
His-tag 4459
His-Xa-CTPR3∆S-thioester 17126
CTPR3∆S-thioester 12719
Dimer 25303
Trimer 37887
1Masses Calculated from the sum of the average isotopic mass
of each amino acid.
3.3.8.2 Analytical Size Exclusion Chromatography
Size exclusion chromatography was used to analyse the size of species present in
the polymerisation reaction. A polymerisation reaction was set up using 200 µM
His-Xa-CTPR3∆S-thioester in 50 mM phosphate pH 7 with 150 mM NaCl and 100
mM MESNa. Samples were removed and frozen at the following times: 0, 4 and 8
hours and at 1, 2, 5 and 6 days. The samples were defrosted, diluted down 1 in 4
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and spun at 14 000 rpm for 10 minutes to remove any large aggregates. The samples
were loaded onto a GE Healthcare Superdex 75pg 300/10 and the elution monitored
using the absorbance at 280 nm..
Figure 3.16A shows the chromatograms of the time points: 4 hours (black), 2 days
(blue) and 5 days (red). Inset are the chromatograms of CTPR3∆S (green) and CT-
PRa6 (red). Figure 3.16B is a SDS-PAGE gel of the samples taken from the same
polymerisation reaction as the samples shown in Figure 3.16A. The SDS-PAGE gel
shows that this polymerisation did not proceed as successfully as previous reac-
tions, such as that shown in Figure 3.14. There is still a high concentration of the
CTPR3∆S-thioester protein present in the later samples, showing that the protein
hasn’t oligomerised. We now know that the decreased reaction rate is likely to be
because the His-Xa-CTPR3∆S-thioester protein was stored before reaction rather
than being used immediately after purification. Storage of the His-Xa-CTPR3∆S-
thioester protein was found to result in hydrolysis of the thioester leading to loss of
reactively at the C-terminus, see Section 3.3.9.3 for further discussion. Despite this
problem, the size exclusion chromatograms provide us with some insight into the
polymerisation reaction, albeit at a slower reaction rate.
In the chromatogram in Figure 3.16A, there are two prominent peaks for the 4 hour
time point: one at 10.0 ml and one at 9.2 ml with a lower intensity. We can identify
these peaks by comparing their retention volumes with those of CTPR3∆S (10.9
ml) and CTPRa6 (9.5 ml). These are more suitable size comparisons than standard
size exclusion calibrants due to the elongated structures of CTPRs. CTPR3∆S is
approximately the size of the proteins His-Xa-CTPR3∆S-thioester and CTPR3∆S-
thioester. Therefore the peak at 10.0 ml corresponds to the His-Xa-CTPR3∆S-
thioester and CTPR3∆S-thioester proteins. CTPRa6, which elutes at 9.5 ml, is
approximately the size of the dimer formed by the polymerisation reaction. Thus
the peak at 9.2 ml corresponds to the dimer. Two days after initiation, the peak at
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9.2 ml has increased in intensity signifying that there is an increase in the number
of dimeric species. A shoulder also appears on the left side of this peak, which is
the result of trimers being formed. After 5 days, the peak at 10.0 ml has shifted
to 10.3 ml, this is the result of the cleavage of His-Xa-CTPR3∆S-thioester into
CTPR3∆S-thioester. Also the intensity of this peak has reduced when compared
with the earlier time point samples. The reduction in intensity is due to the de-
crease in concentration of the CTPR3∆S-thioester protein as it oligomerises into
larger species.
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Figure 3.16: (A) Analytical size exclusion chromatograms for the time points: 4
hours (black), 2 days (blue) and 5 days (red). All 3 chromatograms show two promi-
nent peaks: one at approximately 10 ml and a further peak with a lower intensity
at 9.2 ml. The peak at 10 ml decreases in intensity as the reaction progresses. The
peak at 9.5 ml increases in intensity between the 4 hour and 2 day time points. Inset
are the chromatograms for CTPR3∆S (green) and CTPRa6 (red) with retention vol-
umes of 10.9 ml and 9.5 ml respectively. CTPR3∆S is a similar size to the reactive
monomer, CTPR3∆S-thioester. CTPRa6 is close to the expected size (half a repeat
larger) of the dimer. A GE Healthcare Superdex 75pg 300/10 column (equilibrated
with 50 mM phosphate pH 7, 150 mM NaCl) was used. The flow rate was set at 0.5
ml/minute. The elution of the protein was monitored using the absorbance at 280
nm and the retention on the column measured in ml. (B) 18 % SDS-PAGE gel of
time course samples used for the size exclusion chromatography. Prior to initiation,
at 0 days, the sample contains the protein His-Xa-CTPR3∆S-thioester at approx-
imately 15 kDa and a smaller concentration of the intein-CBD protein at 27 kDa.
As the Factor Xa cleaves the His-tag, the band for the His-Xa-CTPR3∆S-thioester
(seen at 15 kDa) reduces in intensity. We can see the presence a cleavage product
that appears at 12 kDa, 4 hours after the initiation. In addition we see a band for
the His-tag (seen at 6.5 kDa) increase in intensity as it is cleaved from the His-Xa-
CTPR3∆S-thioester protein. After 2 days there are dimers and trimers visible at
20 kDa and 26 kDa respectively.
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Larger oligomers (> trimers) were not observed on the chromatograms, possibly be-
cause only a small concentration of these species were present in samples as judged
by the SDS-PAGE gels. Another contributing factor is the inclusion of a centrifu-
gation step in the preparation of the sample. This step was included in the protocol
to protect the column from damage by particulates. However, high speed centrifu-
gation will reduce the concentration of larger oligomers present in the sample and
hinders a direct comparison with the SDS-PAGE gels.
3.3.8.3 Mass Spectrometry (MS)
MALDI-TOF mass spectrometry was used to confirm the mass of the His-Xa-
CTPR3∆S-thioester and to investigate the sizes of the products formed during the
polymerisation reaction. All samples were prepared by desalting with a C18 zip-tip
and were mixed in a 50 % ratio with sinapinic acid matrix. Figure 3.17 shows a
sample of the His-Xa-CTPR3∆S-thioester protein. The spectrum shows a peak at
the expected mass, (17026 MW measured, 17129 MW calculated). Additional peaks
at approximately 8.5 kDa and 6.4 kDa are the +2 and +3 ions respectively.
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Figure 3.17: Mass spectrum of the His-Xa-CTPR3∆S-thioester protein (17026
MW measured, 17126 MW calculated). Peaks seen at approximately 8.5 kDa and
6.4 kDa are the +2 and +3 ions respectively.
Figure 3.18 is a sample of a polymerisation reaction taken 6 hours after initiation.
Here we can see the presence of the active monomer CTPR3∆S-thioester (12873
MW measured, 12719 MW calculated). In addition there are dimers (25503 MW
measured, 25303 MW calculated) and trimers (40859 MW measured, 37887 cal-
culated) visible. We know from SDS-PAGE that there are oligomers larger than
trimers produced by the polymerisation, however we were unable to observe these
via MS. This is because the larger oligomers do not ionise from the matrix.
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Figure 3.18: Mass spectrum of the polymerisation reaction after 6 hours. This
spectrum shows the 3 significant species: active monomer CTPR3∆S-thioester
(12873 MW measured, 12719 MW calculated), dimer (25503 MW measured, 25303
MW calculated) and trimer (40859 MW measured, 37887 calculated).
Figure 3.19 is a sample of the reaction taken at 3 days, taken from the same poly-
merisation reaction as that shown in Figure 3.14. This spectrum showed peaks at 12
and 15 kDa (the smaller mass peaks are 2+ ions). The active monomer, CTPR3∆S-
thioester, is 12 kDa therefore we can conclude that Factor Xa cleavage is yielding
the correct product. However, the presence of another peak at 15 kDa suggests
that the Factor Xa is sometimes cleaving at 2 locations in the protein. A review of
the literature revealed that Factor Xa can be promiscuous and frequently cleaves at
alternative sites [108,109].
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Figure 3.19: Mass spectrum of the polymerisation reaction after 3 days shows
that the His-Xa-CTPR3∆S-thioester protein (16967 MW measured; 17129 MW
calculated) is cleaved by the Factor Xa at the desired cleavage site (12314 MW
measured; 12719 MW calculated) and also at a second site to give a peak at (15131
MW). Peaks at 8.5 kDa and below are the +2 and +3 ions of the 3 species observed.
It should be noted that the intensity of the peaks observed in MS are all relative
and are not an indicator of the concentrations present in the sample. The mass
spectra presented here is limited by the poor calibration of the machines, leading to
variation between the calculated and the observed masses.
Figure 3.20 compares the designed site for Factor Xa cleavage (A) with a proposed
alternative site (B). Only the intended cleavage site yields the N-terminal cysteine
that is needed for NCL, therefore cleavage at the upstream site is unproductive and
inhibits the oligomerisation.
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Figure 3.20: Comparison of intended Xa cleavage site (A) and proposed alternative
site (B) at the N-terminal section of the full-length intein protein. The intended site
shown in (A) leaves the N-terminal cysteine residue necessary for NCL. However,
MS data suggests that there is cleavage at an upstream site as a larger species (15.1
kDa) was detected via this method. Reviews of the effectiveness of Factor Xa show
that the enzyme is promiscuous and often cleaves at different sites from its normal
site of IEGR↓. We propose that Factor Xa cleaves at the site shown in (B), as this
would produce the same size fragment as was seen via MS.
These data confirms that the protein purified from the chitin resin is His-Xa-
CTPR3∆S-thioester. When we analysed samples of the polymerisation reaction
we can see that cleavage of the His-tag results in oligomerisation to yield dimers and
trimers.
3.3.8.4 Circular Dichroism
Circular Dichroism was used to assess the secondary structure of the monomer and
the products of the polymerisation reaction. Circular Dichroism scans were mea-
sured for the same samples as those shown in Figure 3.16(B). Samples were diluted
down by a factor of 16 (approximate protein concentration 12.5 µM) and the ellip-
ticity of the samples was measured in a 1 mm cuvette.
The 0 day time point has a negative peak at 222 nm this confirms that the His-
Xa-CTPR3∆S protein is α-helical. There is an increase in the ellipticity at 222 nm
that is observed as the reaction proceeds, with the 5 day sample displaying a more
negative value. This is indicative of an increase in the helical content of the protein
within the sample which is caused by the increased length of the CTPR oligomers.
This confirms that the polymerised CTPR units are docking together and aligning
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into an extended TPR fold, as designed.
Figure 3.21: CD wavescans for the 0 day (red squares) and 5 day (black circles)
time points. Conditions were: 50 mM phosphate pH 7, 150 mM NaCl, 10 mM
MESNa, protein concentration was 12.5 µM and a 1 mm cuvette was used. There
is an increase in the ellipticity at 222 nm as the reaction proceeds, indicating an in-
crease in the helical content of the protein within the sample caused by the increased
length of the CTPR oligomers.
3.3.8.5 Transmission Electron Microscopy (TEM)
Transmission electron microscopy is used to visualise biomolecules, typically the
sample is applied to a carbon grid followed by a stain that coats the outside of
the sample. We decided to use TEM to assess the morphology of the structures
formed by the polymerisation reaction. A sample of His-Xa-CTPR3∆S-thioester
(100 µM in 50 mM phosphate pH 7, 150 mM NaCl, 10 mM MESNa) was initiated
with Factor Xa and samples were removed at 2, 8, 12 and 96 hours. These samples
were also analysed using SDS-PAGE, this confirmed that the polymerisation reac-
tion proceeded in the same way as previous reactions. Samples were prepared for
TEM by dilution to approximately 2 µM using ddH2O. Samples were stained with
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2% (w/v) uranyl acetate. Dilution was necessary because of the high protein con-
centration and the phosphate buffer. Phosphate buffers interact with uranyl stain to
form crystalline precipitates that can obscure the sample. Glow Discharged Carbon
Formvar 400 mesh grids were used.
The micrographs in Figures 3.22 and 3.23 are representative of the fibrous structures
that were observed via TEM as a result of repeated NCL reactions. We observed
these fibres on multiple grids prepared from the various time points. We also pre-
pared samples from other polymerisation reactions to confirm the reproducibility
of the fibre formation and the same fibrous structures were seen. In Figure 3.22
the progression of the NCL reaction can be observed. At 0 hours, 3.22A, there are
no visible structures as the His-Xa-CTPR3∆S-thioester protein is too small to be
observed (>3 nm long) using TEM. However, after 2 hours, small granular species
with a narrow size distribution are visible, Figure 3.22B. After 12 hours, Figure
3.22C, the micrographs show structures that were growing in size, gaining in aspect
ratio such that some of them corresponded to short filaments. These species appear
to be 7 nm across, but have differing lengths. By 96 hours, Figure 3.22D, the dis-
tribution of sizes had completely changed from the earlier time points. There was
no clear modal size and many fibrous structures were observed. These include indi-
vidual fibres that range in size up to 1 µm in length but are still only 7 nm across.
Also visible are fibres that appear to have co-associated to form thicker filaments
as judged by the increased width of the fibres. Inset in Figure 3.22D is an enlarged
image showing the branch point between 2 fibres.
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Figure 3.22: TEM images of samples of the polymerisation mixture (stained with
uranyl acetate) removed from the reaction vessel at set time points: 0 hours (A), 2
hours (B), 12 hours (C), and 96 hours (D). (A) At the start of the reaction there
are no visible structures as the monomeric units of His-Xa-CTPR3∆S-thioester and
the cleaved CTPR3∆S-thioester are too small to be observed. After just 2 hours
(B) there is the emergence of a narrow size range of small granular species. At 12
hours (C) there are fibres visible that are approximately 7 nm in width and variable
lengths. After 96 hours (D) there are fibres up to microns in length. The width
of the fibres is variable, some are 7 nm and some are wider, up to 17 nm wide.
This could be the result of co-association of the fibres. Inset is a enlarged image
of the 96 hour time point, showing a branch point between 2 fibres. Position (a)
measures 17 nm where 2 fibres are associated, positions (b) and (c) measure 7 and
8 nm respectively. Samples were prepared for TEM by dilution to approximately 2
µM using ddH2O. 2% (w/v) uranyl acetate stain was used.
The diameter of a CTPR superhelix was measured as 5 nm via X-ray crystallographic
studies [110]. Our CTPR fibres are 7 nm in diameter when measured from the TEM
images (the larger size is due to the negative stain). This close agreement shows
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that the CTPR3∆S-thioester protein oligomerises, as designed, to form fibres that
are a single protein chain. We observed that these fibres are only linear for lengths
of less than 30 nm, this suggests that the fibres can flexible or perhaps is due to
improper docking of the CTPR3∆S units following oligomerisation. Though flexible
single filaments were predominantly observed, thicker fibres were also seen. Figure
3.23 is an example of the clustered filaments that were observed. They possessed
diameters ranging up to 17 nm. This indicates that the individual filaments of
CTPR polymer are not only flexible, but may also co-associate to form higher-order
assemblies. However, the appearance of associated fibres could be an artefact of the
staining process, the result multiple fibres are deposited on top of one another.
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Figure 3.23: TEM image of a sample of polymerisation reaction taken after 8
hours after initiation. The width of an individual fibre is 7 nm, which is close to
the width of a single CTPR superhelix (5 nm). Some fibres appear to co-associate
to form thicker filaments, however this could be an artefact of the staining process.
Samples were prepared for TEM by dilution to approximately 2 µM using ddH2O.
Samples were stained with 2% (w/v) uranyl acetate.
To ensure that any species observed on the TEM grids was the product of oligomeri-
sation, grids were prepared using samples of the reaction buffer and none of these
showed small or fibrous species. Also we observed that the micrographs at the start
of the reaction do not show any fibrous structures. The fibres only appear after
8 hours confirming that they are the product of the polymerisation reaction. Al-
though we did not perform this experiment a further control could use a mutant of
the His-Xa-CTPR3∆S-thioester protein lacking the crucial cysteine. This protein
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could be cleaved by the Factor Xa but NCL would not occur and fibres should not
be seen.
Using a representative sample of images from the time points: 2, 8, 12 and 96 hours,
the distribution of sizes was calculated. The length of each fibre was recorded and
expressed as a relative frequency of the total number of fibres that were imaged,
Figure 3.24. From this we are able to see how the distribution of sizes changes as
the reaction proceeds. At the start of the oligomerisation the range of sizes is narrow
with only small species present. After 12 hours the average size increases and by 96
hours there is no clear average size.
Figure 3.24: Relative frequency of CTPR oligomer lengths observed at time points
2, 8, 12 and 96 hours. The distribution of lengths of the growing CTPR oligomer
was narrow after two hours, a similar distribution was observed after eight hours,
with occasional detection of longer species. After 12 hours, a significant shift in the
size of the oligomers was detected. After 96 hours, the distribution is completely
different from the earlier the earlier time points with no clear modal size. Data were
derived from measurements of TEM images, processed in EMAN2 and measured
in GIMP (Graphical Image Manipulation Program). Analysis conducted and figure
produced by Dr JJ Phillips.
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3.3.9 Optimising the Fibre Growth Conditions
After assaying numerous polymerisation reactions we identified a number of factors
that appeared to influence the polymerisation reaction. These include: (1) non-
specific aggregation of the fibres/monomers; (2) rate of cleavage of the His-tag and
(3) hydrolysis of the C-terminal thioester (leading to loss of reactivity). We decided
to investigate how altering the buffer conditions affect factors (1) and (2). Factor (3)
seemed to be largely be influenced by how quickly the His-Xa-CTPR3∆S-thioester
protein was used after purification from the chitin resin.
3.3.9.1 Aggregation
To test if aggregation was affecting the reaction, a sample was taken of a poly-
merisation reaction after 2 weeks. The sample was centrifuged at 14 000 rpm for
20 minutes and a visible pellet was observed. Samples of the supernatant and the
pellet were prepared for analysis via SDS-PAGE. The gel in Figure 3.25 shows that
there is a much higher percentage of larger species in the sample of the pellet verses
the supernatant. This indicates that some of the larger species are aggregating and
precipitating out of solution.
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Figure 3.25: (A) 18% SDS-PAGE of the supernatant and the pellet from a sample
of a reaction that had been progressing for 2 weeks. Conditions: 200 µM protein
in 50 mM phosphate pH 7, 100 mM MESNa. (B) 18% SDS-PAGE gel of reaction
with and without 1% triton in 50 mM phosphate pH 7, 500 mM MESNa. There is
no discernible difference between the 2 samples.
Adding detergent can stabilise proteins and reduce aggregation, so a polymerisation
reaction was set up with and without 1% triton in 50 mM phosphate pH 7, 500
mM MESNa. Several samples were taken over the course of 6 days and prepared for
analysis via SDS-PAGE, see Figure 3.25. No difference was observed upon addition
of 1% triton.
3.3.9.2 Effect of NaCl on the reaction
Observation of various polymerisation reactions seemed to indicate that addition of
NaCl increased the speed of the reaction. To investigate this effect, an experiment
was set up using 200 µM protein, in 50 mM phosphate 500 µM MESNa and either no
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NaCl or 150 mM NaCl. After initiation, samples were removed for analysis via SDS-
PAGE. In Figure 3.26B it is possible to see that after a month there is a significant
increase in the number of higher order species in the 150 mM NaCl reaction. This
shows that the reaction is more successful in the presence of NaCl. The increase in
reaction rate may be due to increased reactivity of the Factor Xa, as the suggested
buffer for the enzyme includes 150 mM NaCl.
Figure 3.26: 18% SDS-PAGE gel of the polymerisation reactions performed with
and without 150 mM NaCl after 1 week (A) and after 1 month (B). After 1 week
there appears to be no difference between the samples. However after 1 month there
is a significant increase in the number of higher order species in the 150 mM NaCl
sample.
3.3.9.3 Hydrolysis of the thioester
The thioester at the C-terminus is susceptible to hydrolysis and this process is irre-
versible. Therefore once hydrolysis has occurred NCL cannot take place, resulting in
the deactivation of that C-terminus. In some reactions the hydrolysis of the thioester
resulted in a significant proportion of the CTPR3∆S-thioester protein remaining un-
reacted, Figure 3.16B. Although buffer conditions do affect the rate of formation of
fibres, the most successful reactions involved initiating the polymerisation as soon as
possible after cleaving the His-Xa-CTPR3∆S-thioester protein from the chitin resin.
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Also important is adding enough Factor Xa to cleave the His-tag within 24 hours.
For example the polymerisation reaction shown in Figure 3.14, involves a ’fresh’
sample of His-Xa-CTPR3∆S-thioester. Here the reaction has produced many larger
structures after 3 days. However, the reactions shown in Figure 3.25B and Figure
3.16B used His-Xa-CTPR3∆S-thioester protein that had been stored at 4 oC for 2
days and 5 days respectively after elution from the chitin column. Both of these re-
actions show a much slower rate with a higher concentration of the cleavage product
present at 12 kDa and fewer larger oligomers.
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3.4 Conclusions
Our aim was to self-assemble CTPR3∆S proteins into larger structures and we
have shown that this was successful. We have shown that our CTPR3∆S-thioester
monomers successfully and reproducibly undergo multiple rounds of NCL to yield
oligomeric species, some of which are long enough to form fibres. Using TEM, we
were able to visualise the fibres that were 7 nm wide and up to microns in length.
In addition, the reaction only occurs when triggered by the cleavage of the His-tag
by Factor Xa. The fibres can be formed under mild conditions: near neutral pH,
at room temperature and in a variety of buffers. NCL has been used to synthesise
oligomeric species such as collagen from short peptide chains [111]. Our system is
the first to employ NCL in the formation of high order oligomers using recombinant
repeat protein monomers.
The oligomerisation reaction was followed using TEM, SDS-PAGE, size exclusion
chromatography and MS. The combination of these techniques gives us an under-
standing of the heterogeneous mix of products that are formed. TEM cannot show
the monomeric species as it is below the detectable size (< 3 nm) but was used to
show that fibrous structures were formed following repeated NCL. When stained
with coomassie, SDS-PAGE can detect protein amounts as low as 100 ng allowing
us to see very small concentrations of the higher order oligomers (>tetramers). Our
size exclusion protocol included centrifugation of the samples prior to injection to
avoid damaging the column by loading particulates. However this will alter the
distribution of sizes in the sample as the very large oligomers will be removed for
the sample, see Section 3.3.8.2 for more discussion.
When observed via TEM, the CTPR fibres were 7 nm in diameter, which is in
close agreement with the diameter of a single CTPR superhelix seen by X-ray crys-
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tallographic studies [8, 105] (once negative stain is accounted for). This shows that
the CTPR3∆S-thioester units oligomerise, as designed, via defined head-to-tail as-
sociation to form single protein chain filaments. Interestingly, these filaments are
only measurably linear for distances of less than 30 nm. This is in contrast to SAXS
measurements that show CTPR proteins of up to 20 consensus TPR motifs are very
rigid [55]. Flexibility beyond this length suggests that the CTPR polymer has some
degree of freedom. This may be attributed either to a lack of rigidity in the superhe-
lical structure or to incomplete docking together of units following covalent linkage.
To conclude, we have presented the synthesis by Native Chemical Ligation of a
novel fibrous biopolymer from designed consensus repeat protein monomers. These
structures have the potential to be used in the construction of biomaterials as they
are both (1) formed from simple, soluble modular building blocks recombinantly ex-
pressed in large quantities and (2) each monomer contains a putative pentapeptide
binding to allow functionalisation. The CTPR polymers thus represent a system
that could be adapted for synthesis of nano- or micro-scale assemblies, decorated
through binding of peptides with high affinity. One immediate application would
stem from the recent interest in the use of TPR proteins to form hydrogels by
constructing 18 CTPR motif sequences by recombinant approaches [55]. Our sys-
tem allows the synthesis of much larger structures than those that can be formed
recombinantly, offering the possibility of forming hyrdogels that have different prop-
erties. With a naturally occurring library of TPR protein scaffolds, each with their
specific cognate peptide ligand, there are many opportunities for exploiting these
self-assembling fibres by decorating them with peptide linkers.
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Chapter 4
Introducing a Thermodynamic
Switch into CTPR2 and CTPR3
In this chapter I will describe the characterisation of a series of CTPR deletion mu-
tants and the introduction of a thermodynamic switch into CTPR2 and CTPR3.
4.1 Experimental Approach
A range of deletion mutants were produced and their stability was assessed using
chemical equilibrium unfolding data. This data was fit using a Heteropolymer Ising
model to analyse the multistate characteristics of the equilibrium unfolding. This
model was then used to simulate the effect of introducing a thermodynamic switch
into CTPR3, to selectively unfold the C-terminal helix, termed ‘S-Switch’. This
mutant (CTPRy3) was cloned, expressed and purified. Its ability to undergo a
partial unfolding event was assessed using chemical and thermal denaturation data
and 2D NMR. The equivalent mutation was introduced into CTPR2 and this mutant
(CTPRy2) was assessed and compared with CTPRy3.
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4.2 Motivation for Designing a Thermodynamic
Switch
A TetratricoPeptide Repeat or TPR contains 34 amino acids that form a helix-
turn-helix motif; each alpha helix is approximately 14 amino acids long [8], Figure
4.1. Several repeats stack together to form a tandem array and the hydropho-
bic core is capped at the C-terminus by a solvating helix (S helix). In Chapter 3
we have shown how CTPRs have been used to create fibrous nanostructures, where
CTPR3∆S monomers were triggered to react together in a specific head-to-tail man-
ner. This method utilises enzymatic cleavage to induce the polymerisation.
A different approach to polymerising CTPR units could involve a specific unfolding
event triggered by environmental factors that results in a compatible dimerisation
interface being exposed. This could be made possible as the CTPR proteins have
been shown to exhibit multistate folding [9, 78, 112], and therefore have access to
partially folded stable intermediates. Although only small populations of these in-
termediates are ever present at a time, through engineering this percentage could
be increased. The terminal helices are the best target for redesign into a switchable
unit as this requires the least amount of structural change leaving the majority of
the protein folded. To achieve this a series of deletion mutants were designed and
their stability assessed using a Heteropolymer Ising model. This allowed us to sim-
ulate the population of partially unfolded intermediates at a given concentration of
denaturant. This led to the design of the mutants CTPRy3 and CTPRy2, which
undergo a partial unfolding event to reveal a polymerisation interface. These con-
structs unfold their C-terminal α-helix at a specific concentration of GuHCl. These
intermediates are equivalent to a CTPRn∆S protein and possesses oligomerisation
interfaces at both termini.
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Figure 4.1: (A) A CTPR repeat is made up of two α helices (A and B), separated
by a short loop, this sequence is repeated n number of times before there is a C-
terminal capping helix, this is referred to as the ‘solvating helix’ or ‘S helix’. There
are 2 CTPR series: CTPRn and CTPRan. The sequences are the same except the
last 2 residues in each repeat (positions 33 and 34) are NN in the CTPRn series and
RS in the CTPRan series. (B) Crystal structure of CTPR3 (1NA0), with the helices
coloured according to their sequence (A=green; B=red and C=blue). (C) Schematic
showing the relationship and nomenclature between the mutants. Mutating out the
N-terminal A helix produces ∆A. Mutating out the C-terminal helix produces ∆S.
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4.3 Results
4.3.1 Design of Deletion mutants
Previous studies have shown that the stability of a CTPR increases with repeat
number [9]. However, the effect of removing half of a repeat, i.e. 1 helix, had not
been investigated. Thus to assess this, a series of mutants was devised, Figure 4.1
C. By studying the effect of removing terminal helices we will be able to determine
the contribution to stability and thus determine the most suitable termini to situate
a thermodynamic switch. The ∆A mutants lack the first 16 residues, that form
the N-terminal helix. The ∆S proteins are truncated at position 34 and lack the
C-terminal helix.
There are two series of CTPR proteins, CTPRn and CTPRan, n is the number
of repeats. They possess almost identical sequences, except in each repeat, the last
2 residues (positions 33 and 34) are NN in the CTPRn series and RS in the CTPRan
series 4.1 A. The CTPRan series of proteins is less stable when compared to CTPRn
proteins of the same length as changing NN to RS at positions 33 and 34 results in
the loss of a stabilising interaction between asparagine and a tyrosine in the A-helix
of the preceding repeat, Figure 4.2.
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Figure 4.2: (A) Crystal structure showing the last 3 helices of CTPRan (2F07).
The final loop before the C-terminal S helix has the sequence PRS. The helices are
coloured according to the sequence: A helix (green), B helix (red) and S helix (blue).
(B) Crystal structure showing the last 3 helices of CTPRn (1NA0). The final loop
before the C-terminal S helix has the sequence PNN. The interaction between the
asparagine and the pi system of the tyrosine residue stabilises the CTPRn series
relative to the CTPRan series.
4.3.2 Cloning of Deletion Mutants
Deletion mutants were cloned as described in Section 2.1 and Table 2.1. ∆A pro-
teins were created using the PCR amplification technique described in section 2.2.1.
∆S proteins lack the C-terminal helix and were created using Site-directed Mu-
tagenesis as described in Section 2.2.2. The mutations were confirmed via DNA
sequencing.
4.3.3 Expression and Purification of Deletion Mutants
The proteins were expressed and purified under native conditions as described in
Chapter 2.3.2. All give high yields of approximately 10 mg/L of culture.
4.3.4 Characterisation of Deletion Mutants
All proteins were monomeric as judged by the chromatograms for the size exclusion
purification (data not shown). Figure 4.3A shows the far UV Circular Dichro-
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ism wavelength scans of the deletion mutants displayed a negative peak at 222
nm, which indicates that they are α helical, as is expected for a CTPR. The
molar ellipticity (expressed as mdeg cm-2dmol-1) for each protein was as follows:
CTPR2 -1.72x105; CTPR2∆S -1.31x105; CTPR2∆A -1.37x105; CTPR3 -2.44x105;
CTPR3∆S -2.06x105 and CTPR3∆A -2.00x105. The data shows that the ellipticity
of those mutants that consist of the same number of helices, for example CTPR2∆S
and CTPR2∆A, exhibit the same ellipticity. Also the ellipticity of the deletion
mutants is lower than the full length an amount that equates to 1 helix.
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4.3.5 Equilibrium Unfolding Studies
The series of deletion mutants were unfolded using GuHCl, the change in secondary
structure was monitored through the change in CD signal at 222 nm. These experi-
ments were conducted to assess the stabilities of the deletion mutants and compare
the effect of removing the different terminal helices.
4.3.5.1 Chemical Denaturation
GuHCl denaturations were performed as described in Section 2.5.2.2. All the pro-
teins underwent a single transition from the folded to unfolded state, Figures 4.4
and 4.5. The transition occurred at higher GuHCl concentrations as the number
of helices was increased. The CTPRan series exhibited transitions at lower GuHCl
concentrations than the equivalent size mutants form the CTPRn series. CTPR
proteins have been shown to undergo reversible unfolding [9] and therefore refold-
ing experiments were not conducted. The denaturations were performed in 50 mM
phosphate pH 7. The samples were measured in a 5 mm pathlength cuvette held at
10 oC in a thermostated cuvette holder.
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Figure 4.4: Chemical denaturation curves for CTPR2∆A (A), CTPR2∆S (B),
CTPR2 (C), CTPR3∆A (D), CTPR3∆S (E) and CTPR3 (F).
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Figure 4.5: Chemical denaturation curves for CTPRa2∆A (A), CTPRa2∆S (B),
CTPRa21 (C), CTPRa3∆A (D), CTPRa3∆S (E) and CTPRa31 (F). 1Data collected
by Dr Javadi
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4.3.5.1.1 Normalisation of Chemical Denaturation Data
The CD signal increases with repeat number making it hard to visually compare
equilibrium curves of mutants that are different lengths. Therefore to allow easier
comparison of data sets, the equilibrium curves were normalised using Equation 4.1.
Figure 4.6, shows the normalised equilibrium curves.
λnorm =
λ222 − αN
αD − αN (4.1)
The values for αD and αN are the y-intercept values of the unfolded and folded
baselines. This equation allows for the data to retain the slope of the folded and
unfolded baselines.
4.3.5.1.2 Two-state Model Analysis of Chemical Denaturation Data
The simplest model to explain the thermodynamics of the unfolding of a protein is
the two-state model. This states that the protein undergoes a single reversible tran-
sition from the folded to the unfolded state (N  D). Proteins can be qualitatively
compared through comparison of the mid-point of denaturation, this value can be
obtained through fitting the data to a two-state model, Equation 4.2. Although the
unfolding of CTPR proteins is better explained through multistate unfolding [9], as
the data shows a single transition the data can be fit to a two-state model.
λobs =
(αN + βN [D]) + (αD + βD[D]) exp
(
−m([D]−[D]50%)
RT
)
1 + exp
(
−m([D]−[D]50%)
RT
) (4.2)
λobs is the ellipticity at 222 nm and [D] is the concentration of GuHCl at any given
λobs. Here αN and αD are the y-intercepts and βN and βD are the gradients of
the folded and unfolded baselines respectively. The gradient through the transition
between folded and unfolded is defined as m. The m value is a constant of pro-
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portionality related to the change in solvent accessible surface area (SASA) of the
protein as it transitions between the native and unfolded state. At the midpoint
of denaturation ([D]50%) in a two-state approximation, half of the population of
the protein molecules are folded and half are unfolded. To calculate [D]50% and m,
the spectroscopic signal (λobs) was plotted against the denaturant concentration in
Kaleidagraph version 4 (Synergy Software). The data was fitted to equation 4.2
using linear regression analysis in Kaleidagraph. Once these parameters are known,
they can be used in Equation 4.3 to calculate ∆GH2OD−N , which is the change in free
energy of unfolding in water. Data shown in Table 4.1.
∆GH2OD−N = m[D]50% (4.3)
4.3.5.1.3 Comparison of the Mid-points
The mid-point of denaturation was calculated from the fit of the equilibrium unfold-
ing curve for each experiment, Table 4.1. The mid-point of denaturation can be used
as a way of comparing the stability of different proteins. The data showed that the
stability increased with repeat number. However, mutants with the same number of
helices didn’t have the same stability. This shows that all helix deletions were desta-
bilising relative to their wild type proteins, with the greatest shift in midpoints and
thus destabilisation occurring on removal of the N-terminal A helix rather than the
C-terminal S helix. Therefore the N-terminal helix must contribute more favourable
interactions than the C-terminal helix. This is most likely due to a combination of
the difference in the primary sequence and the packing of the helices. Both the N-
terminal and C-terminal helices are based on the same consensus sequence, however,
the C-terminal helix was modified in the original design to increase solubility. This
was achieved by replacing all the solvent facing hydrophobic residues to hydrophilic
counterparts: AEAWYNLGNAYYKQG vs. AEAKQNLGNAKQKQG, respectively [8]. In addition
both have different packing interactions which cause the C-terminal S helix to be 25
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Table 4.1: Thermodynamic parameters for the GuHCl induced unfolding of CTPR
proteins in phosphate buffer
Construct Data Set 1 Data Set 2
a [D]50% a m-value b ∆GH2OD−N a [D]50% a m-value b ∆GH2OD−N
(M) kcalmol−1M−1 kcalmol−1 (M) kcalmol−1M−1 kcalmol−1
CTPR2∆A 1.94±0.01 2.08±0.05 4.0±0.1 1.99±0.02 2.08±0.08 4.1±0.2
CTPR2∆S 2.21±0.01 2.10±0.03 4.6±0.1 2.24±0.02 2.18±0.15 4.9±0.3
CTPR2 2.57±0.01 2.43±0.06 6.2±0.2 2.62±0.01 2.55±0.06 6.7±0.2
CTPR3∆A 2.97±0.01 2.82±0.10 8.4±0.3 2.99±0.01 2.50±0.99 7.5±3.0
CTPR3∆S 3.17±0.01 2.65±0.08 8.4±0.3 3.17±0.01 2.71±0.13 8.6±0.4
CTPR3 3.36±0.01 2.89±0.13 9.7±0.4 3.29±0.01 3.61±0.13 11.9±0.4
CTPRa2∆A 1.01±0.04 1.74±0.05 1.8±0.1
CTPRa2∆S 1.63±0.02 1.87±0.07 3.0±0.1
CTPRa2 1.71±0.04 2.07±0.19 3.5±0.3
CTPRa3∆A 2.18±0.01 2.34±0.08 5.1±0.2
CTPRa3∆S 2.31±0.01 2.30±0.09 5.3±0.2
CTPRa3 2.39±0.02 2.42±0.12 5.8±0.3
Errors are calculated from the fit of the graph. a Calculated from Equation 4.2.
b Calculated from Equation 4.3
% more solvent exposed than the next most solvent exposed helix. Interestingly, the
differing stabilities of the N-terminal and C-terminal helices explains why crystal
structures of certain CTPRs show the S helix being preferentially unfolded (missing
density) and its position occupied by an N-terminal A helix from another CTPR
protein [72] .
4.3.5.1.4 Chemical Denaturation in MOPS buffer
Recently, it was shown that MOPS is more tolerant to changes in salt concentration
than phosphate buffers at pH 7 [113]. The consequence of this is that as the GuHCl
concentration increases, the pH of the phosphate buffered samples decreases. This
lowers the pH of the sample closer to the pI of the protein (approximately 4 for
CTPR proteins). Denaturations in this thesis were performed in phosphate to allow
comparison with published data. Also phosphate is known to stabilise proteins,
therefore we wanted to confirm that the changes seen the data was not a consequence
of this effect. Therefore, the denaturations were repeated in MOPS buffer for the
CTPRn series. Figure 4.7 shows that the proteins display the same trends as that
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seen for the phosphate buffered samples, where the mid-point increases with repeat
number and that the ∆A mutants are less stable than the ∆S mutants. The samples
were prepared in the same manner as for the phosphate buffered samples except 50
mM MOPS at pH 7 was used as the buffer. Measurements were recorded with the
samples in a 5 mm pathlength cuvette held at 10 oC in a thermostated cuvette
holder.
Figure 4.7: Normalised chemical denaturation curves for the CTPRn series CTPR2
(red diamonds), CTPR2∆S (red squares), CTPR2∆A (red circles), CTPR3 (black
diamonds), CTPR3∆S (black squares) and CTPR3∆A (black circles). All proteins
undergo a single reversible transition from the folded to unfolded state. Data was fit
using linear regression analysis in Kaleidagraph 4.0. Experimental conditions were:
5 µM protein in 50 mM MOPS pH 7. Guanidine HCl was used to denature the
proteins and the progress was monitored using the CD ellipticity at 222 nm. Data
was recorded on a Photophysics Chirascan using a 5 mm pathlength cuvette held in
a thermostated holder set at 10 oC.
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When compared to the phosphate data for the same proteins we can see a decrease
in the mid-points of denaturation for all the proteins studied. The decrease is
consistently around 0.2 M. This shows that there is a stabilising effect from the
change in pH that would be observed when the denaturation is conducted in MOPS
instead of phosphate. However the same trend in stabilities was observed, the ∆A
mutation was more destabilising than the ∆S mutation.
Table 4.2: Thermodynamic parameters for the GuHCl induced unfolding of CTPR
proteins in MOPS buffer
Construct MOPS Data Set Phosphate Data Set 1
a [D]50% a m-value b ∆GH2OD−N a [D]50% a m-value b ∆GH2OD−N
(M) kcalmol−1M−1 kcalmol−1 (M) kcalmol−1M−1 kcalmol−1
CTPR2∆A 1.81±0.01 2.09±0.05 3.8±0.1 1.94±0.01 2.08±0.05 4.0±0.1
CTPR2∆S 2.04±0.01 2.01±0.05 4.1±0.1 2.21±0.01 2.10±0.03 4.6±0.1
CTPR2 2.42±0.01 2.44±0.07 5.9±0.2 2.57±0.01 2.43±0.06 6.2±0.2
CTPR3∆A 2.67±0.01 2.78±0.07 7.4±0.2 2.97±0.01 2.82±0.10 8.4±0.3
CTPR3∆S 3.07±0.01 2.96±0.11 9.1±0.3 3.17±0.01 2.65±0.08 8.4±0.3
CTPR3 3.14±0.01 3.00±0.17 9.4±0.5 3.36±0.01 2.89±0.13 9.7±0.4
Errors are calculated from the fit of the graph. a Calculated from Equation 4.2.
b Calculated from Equation 4.3
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4.3.6 The Ising Model
The Ising model was developed by Ernst Ising to describe the interactions between
magnetic dipoles [114]. Since then the model has been adapted and used to describe
a variety of systems that involve a linear array of interacting subunits, such as phase
transition within polymers [115].
4.3.6.1 Homozipper Ising Model
The modularity of repeat proteins means that their equilibrium unfolding has been
analysed using a 1D homozipper Ising model [9,73,105,116–118]. This models each
folding unit (helix or repeat depending on the complexity of the model) as an inde-
pendent folding motif that can be either folded or unfolded. Once the unit is folded
its nearest unfolded neighbour can gain favourable interactions by folding.
Homozipper Ising models treat each element of a repeat protein as an identical
individual folding unit, with the same intrinsic and interfacial energy. This captures
many aspects of the equilibrium unfolding and can successfully predict the denatu-
ration curves of other ensembles of the folding units. However, it cannot adequately
describe the unequal distribution of stabilities, that results from the different types
of helices that form a CTPR.
4.3.6.2 Heteropolymer Ising Model
By creating a set of deletion mutants lacking either the N-terminal A helix or C-
terminal S helix, it was possible to construct a more complex Heteropolymer Ising
model that differentiates between the contributions to stability by the N-terminal A
helix, C-terminal S helix and the helices that make up the rest of the protein [117].
This allows us to calculate/simulate any ‘switch-like functionality’ (S-switch) e.g.
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the population of a denatured C-terminal S-helix with the rest of the protein folded
relative to any other unfolding (within each protein) throughout the chemical un-
folding transition.
The Heteropolymer Ising was constructed of a linear algebraic series of equilibrium
constants that represent the intrinsic folding stability and the interfacial energy
terms of each helix in a nearest-neighbour array (∆Gi and ∆Gi−1,i respectively). In
our model, 9 variables delineate the contributions made by the N-terminal capping
A-helix (∆GAi , ∆GAi−1,i and mA), internal I-helices (∆GIi , ∆GIi−1,i and mI) and the
C-terminal capping S-helix (∆GSi , ∆GSi−1,i and mS). The m parameters gave a de-
naturant dependence to the intrinsic stabilities (mA, mI and mS).
The expressions defining the equilibrium constants (Equations 4.4 and 4.5) are given
below:
κi = e−(Gi+(mx))/RT (4.4)
Where Gi is the free energy of folding for the helix at position i, with denaturant
sensitivity m and at denaturant concentration x. R is the gas constant and T is
experimental temperature.
τi−1,i = e[−Gi−1,i/RT ] (4.5)
Where Gi−1,i is the free energy for the interface between helices at positions i − 1
and i. R is the gas constant and T is experimental temperature. The partition
function, q(n), is given by Equation 4.6.
q(n) = [1 0]
κA1 υ1
κA1 υ1

κB2 · τB1,2 υ2
κB2 υ2


κAi · τAi−1,i υi
κAi υi

κBj · τBi,j υj
κBj υj


(n−32 ) κSn · τSn−1,n υn
κSn υn
 [1 1]
(4.6)
The full partition function of the protein with n helices is given by q(n), where all
υ= 1. This defines the fully-folded state. The model allows for fitting of separate
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parameters (κ and τ , thus Gi, Gi−1,iand m) to describe behaviour of the A, B and
S-helices by globally fitting to data for degenerate CTPR protein compositions. A
subpartition function, q(i), must be calculated by considering only the folded state
of each helix in turn, given by iteratively parsing the value υ= 0 to the term for each
helix. The fraction folded, θF is then simply defined as the sum of the subpartition
functions divided by the number of terms (helices) multiplied by the full partition
function, Equation 4.7.
θF =
i=1∑
n
q (i)
n.q (n) (4.7)
A numerical solution of the Ising model was determined by globally fitting the
chemical denaturation of each CTPR series. This consisted of fitting 12 denaturation
curves of the CTPRn series (6 proteins with duplicated curves) and 10 denaturation
curves of the CTPRan series, Figure 4.8 (CTPRa2∆A removed due to lack of native
baseline and denaturations of CTPRa2, CTPRa3, CTPRa4, CTPRa5, CTPRa6,
CTPRa8 and CTPRa10 were completed by Dr Javadi).
A single global minimum was ensured by seeding 1000 random searches, each with
1000 trajectories, using the Mathoptimizer module of Mathematica (Wolfram). Our
model fit well to the experimental data with a root mean square of residuals from
the fit to CD data for the series of CTPRan was 0.44 and for the series of CTPRn
was 0.38, equivalent to <2 % of the data amplitude.
Table 4.3 lists the values obtained for the fitted parameters. These show that the in-
terfacial energies were all stabilising (∆GH2<0i−1,i ) and the intrinsic stabilities were not
(∆GH2O<0i ). From the fitted variables the stability of any TPR ensemble (∆GH2O<00→j )
can be calculated by simply adding energy terms.
Thus, to obtain a folded CTPR protein the additive effects of the favourable sta-
bilising interfaces only outweighed the energetically unfavourable intrinsic helix sta-
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bilities when ensembles of more than two helices are combined. This is in agree-
ment with previous experimental data and data analysed with the homozipper Ising
model [9,105]. Our new data and analysis can also discriminate between the differing
energetic contributions of N-terminal A-helix, C-terminal S-helix and the internal
repeat helices.
In agreement with the previous sections qualitative analysis, these show that the
removal of the N-terminal A-helix is more destabilising than removing an internal
helix or C-terminal S-helix. Interestingly, although the differences between helices
are not large in magnitude, they become more pronounced with addition of GuHCl
due to their differing m-values.
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4.3.6.3 Modelling of a Thermodynamic Switch in CTPR3
A ‘good/efficient’ switch is a product of a protein with a high overall stability and
with a suitable differential in stability between capping and internal helices. To test
this hypothesis and the Ising model’s predictive qualities it was logical to redesign
and model a chimera that combined the more stable core of the smaller CTPR3
from CTPRn series with the less stable final S-helix of the CTPRan series (i.e. in-
serting the PNN to PRS mutation). Figure 4.9A shows a schematic of CTPRy3 with
its C-terminal helix unfolded.
The new construct was termed CTPRy3 and its chemical denaturation and S-switch
function was simulated using the Ising model with the experimentally fitted values
for the A and I helices of CTPRn series and S-helix from the CTPRan series. The
model predicted that CTPRy3 would have a maximum S-switch of ≈ . 50 % and
further helical unfolding of only ≈ . 15 % at 2.8 M GuHCl, Figure 4.9.
Figure 4.9: (A) Proposed intermediate of CTPRy3, where the C-terminal helix
is unfolded (shown as a random coil in blue) leaving the rest of the protein folded
(constructed from 1NA0). (B) Simulated data from the Heteropolymer Ising model.
The population of CTPRy3 with the C-terminal helix unfolded as a function of
GuHCl concentration (blue line). Simulation of the chemical denaturation curve
of CTPRy3 (red line) and the fractional population of CTPRy3 that have the C-
terminal helix unfolded (black line). Interestingly, you can see that 90 % of the
population of CTPRy3 has the C-terminal helix unfolded by the mid-point of the
denaturation curve.
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4.3.7 Summary of Equilibrium unfolding characteristics of
the CTPRs
By studying the stability of a range of deletion mutants, we were able to determine
that removing the N-terminal helix caused a greater reduction in stability than
removing the C-terminal helix. Both series of CTPR displayed this trend. Due to
the smaller contribution to the stability of the protein, the C-terminal helix is the
more suitable target for redesign as a switch. We know that the PNN to PRS mutation
results in a decrease in the stability of the protein [9]. Conveniently, this is situated
in the loop region before the C-terminal helix. Thus constructing the chimera of the
two CTPR series (CTPRn core and CTPRan C-terminal sequence) we can create
a large enough difference in stabilities between the core of the protein and the C-
terminal helix to allow access to a partially populated state. A Heteropolymer Ising
model was used to simulate the fractional population with the C-terminal helix
unfolded at a given GuHCl concentration would be. According to the results of the
simulation this switching protein, CTPRy3, should give us access to a C-terminal
helix unfolded intermediate, at a GuHCl concentration of 2.8 M.
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4.3.8 CTPRy3
Following the development of the Heteropolymer Ising model, the proposed ‘S-
switch’ protein, CTPRy3 was produced and it’s stability and ability to ‘switch’
was assessed, using chemical and thermal denaturation and 2D NMR. Figure 4.10
shows the site of the NN→RS mutation in the crystal structure of CTPR3.
Figure 4.10: Crystal structure of CTPR3 (1NA0). Highlighted in green are the
two asparagine residues that are to be mutated to arginine and serine to create the
mutant CTPRy3.
4.3.8.1 Cloning, Expression and Purification of CTPRy3
CTPRy3 was cloned as described in Section 2.1 and Table 2.1 and the mutations
were confirmed via DNA sequencing. The protein was expressed and purified under
native conditions and purified as described in Chapter 2.3.2 and gave high yields of
approximately 10 mg/L of culture.
4.3.8.2 Characterisation of CTPRy3
CTPRy3 was analysed using size exclusion chromatography to confirm that it is
monomeric. A 100 µl sample at a concentration of 50 µM was loaded onto a GE
Healthcare Superdex 75pg 300/10 column (equilibrated with 50 mM phosphate pH
152
7, 150 mM NaCl). The flow rate was set at 0.5 ml/minute. The elution of the protein
was monitored using UV absorbance at 280 nm. The chromatogram for CTPRy3
was compared with that of CTPR3 (Figure 4.11A). The mutant was confirmed as
monomeric.
Far-UV CD wavelength scans of CTPRy3 were performed to assess the secondary
structure, Figure 4.11 B. The wavelength scan was performed on a 5 µM sample,
dissolved in 50 mM phosphate pH 7. The sample was held in a thermostated cu-
vette holder at 10 oC. The scans gave a single negative peak at 222 nm showing
that CTPRy3 is α-helical. The values for the molar ellipticity (expressed as mdeg
cm-2dmol-1) were CTPR3 -2.44x105 and CTPRy3 -2.35x105. As the values are so
close the CTPRy3 construct has the same helical content as CTPR3 and thus is
correctly folded.
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4.3.8.3 Chemical Denaturation of CTPRy3
The stability of CTPRy3 was assessed via GuHCl denaturations followed using Cir-
cular Dichroism at 222 nm (Figure 4.12). The GuHCl denaturations were performed
as described in Section 2.5.2.2. The denaturations were performed in 50 mM phos-
phate pH 7. The samples were held in a 5 mm pathlength cuvette held at 10 oC
in a thermostated cuvette holder. CTPRy3 underwent a single transition from the
folded to the unfolded state. The mid-point of denaturation was 3.2 M ± 0.01 M,
for all 3 experiments.
Figure 4.12: Normalised chemical denaturation curves for CTPRy3, there are 3
data sets. All data sets show that the protein undergoes a single reversible transition
from the folded to unfolded state. Initially, the data was fit using a two-state two-
sloping baselines equation (Section 2.9). However, to allow for easier comparison
the data has been normalised (using Equation 4.1) to account for the variation
that arises in concentration between data sets. Data was fit using linear regression
analysis in Kaleidagraph 4.0. Experimental conditions were: 5 µM protein in 50
mM phosphate pH 7. GuHCl was used to denature the protein and the progress was
monitored using the CD ellipticity at 222 nm. Data was recorded on a Photophysics
Chirascan using a 5 mm pathlength cuvette held in a thermostated holder set at 10
oC.
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4.3.8.3.1 Comparison of the Chemical Denaturations of CTPRy3 with
the Simulated Data from the Ising Model
When the data from the chemical denaturations of CTPRy3 was compared with
the simulated data from the Heteropolymer Ising model, the simulation is almost
indistinguishable from the experimental data, Figure 4.13. This shows that the
Heteropolymer Ising model can accurately predict the denaturation curves of CTPR
proteins.
Figure 4.13: Normalised chemical denaturation curves for CTPRy3 (from Figure
4.12) in red overlaid with the Ising model simulated data for the same construct in
black. The simulated data is almost indistinguishable from the experimental data.
4.3.8.3.2 Comparison of Chemical Denaturations of CTPRy3 with CTPR3
and CTPR3∆S
The denaturation of CTPRy3 showed a single transition from the folded to the un-
folded state, Figure 4.14 A. As predicted, this transition has a lower midpoint than
CTPR3, showing it is less stable. The data for CTPRy3 can be qualitatively com-
pared to data for the other CTPR3 mutants by fitting to a two-state two-sloping
baselines equation 4.2. The mid-points calculated from the fit of the data can be
156
used to compare the stability of the different proteins.
Interestingly, the mid-point of CTPRy3 is the same as that seen for CTPR3∆S,
indicating that, at this concentration of GuHCl, the CTPRy3 has the same heli-
cal content as CTPR3∆S. Moreover, there is an observable change in the slope of
CTPRy3’s folded baseline in comparison to CTPR3, Figure 4.14 B. The baselines
for CTPR3 and CTPR3∆S are flat, with almost a negative slope. This is in line
with what is observed for CTPR proteins. However, the baseline of CTPRy3 has
a noticeable slope before the first transition. This deviance from the trend that is
characteristic for the CTPR proteins is very significant and indicates that there is a
variation the structural changes that the CTPRy3 undergoes when compared with
the similar CTPR3 proteins. When the ellipticity was corrected for concentration,
the maximum difference in baselines between the two proteins occurs at approxi-
mately 2 M GuHCl and equates to 7 % of the signal at 222 nm. The complete loss
of the C-terminal helix would equate to a 14 % reduction in signal.
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4.3.8.3.3 Chemical Denaturation of CTPRy3 in MOPS
Previously we saw that changing the buffer system from phosphate to MOPS caused
an decrease in the stability of the proteins studied. To confirm that this same trend
was seen with CTPRy3, the denaturation was repeated in 50 mM MOPS pH 7,
Figure 4.15.
Figure 4.15: Normalised chemical denaturation curves for CTPRy3, in 50 mM
MOPS pH 7 (black) and in 50 mM phosphate pH 7 (red). All data sets show that
the protein undergoes a single reversible transition from the folded to unfolded state.
The MOPS denaturation shows the same transition, but has a lower mid-point. This
shift of approximately 0.15 M GuHCl is in agreement with the changes observed with
the other CTPR proteins. Initially, the data was fit using a two-state two-sloping
baseline equation (using Equation 4.1). However, to allow for easier comparison
the data has been normalised (using Equation 4.1) to account for the variation
that arises in concentration between data sets. Data was fit using linear regression
analysis in Kaleidagraph 4.0. Experimental conditions were: 5 µM protein in either
50 mM MOPS pH 7 or 50 mM phosphate pH 7. GuHCl was used to denature the
protein and the progress was monitored using the CD ellipticity at 222 nm. Data
was recorded on a Photophysics Chirascan using a 5 mm pathlength cuvette held in
a thermostated holder set at 10 oC.
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4.3.8.3.4 Comparison of CD Wavelength Scans of CTPRy3, CTPR3 and
CTPR3∆S
It was evident from the CD denaturation unfolding curves that there the CTPRy3
(in comparison to CTPR3 and CTPR3∆S) undergoes a different structural change
in the region before transition. To further investigate this, CD wavelength scans
were recorded for CTPRy3, CTPR3 and CTPR3∆S, with and without 2 M GuHCl,
Figure 4.16. These show that in 0 M GuHCl, the ellipticity of CTPRy3 is the same
as CTPR3, indicating that they have the same helical content. The molar ellipticity
(expressed as mdeg cm-2dmol-1) at 222 nm in 0 M GuHCl was: CTPR3 -2.4x105;
CTPRy3 -2.3x105 and CTPR3∆S -2.1x105 The molar ellipticity (expressed as mdeg
cm-2dmol-1) at 222 nm in 2 M GuHCl was: CTPR3 -2.5x105; CTPRy3 -2.2x105
and CTPR3∆S -2.2x105. However at 2 M GuHCl, the ellipticity of CTPRy3 has
reduced to the same as that seen for CTPR3∆S. At 2 M GuHCl the helical content
of CTPRy3 is equal to that of CTPR3∆S, indicating that, the C-terminal helix of
CTPRy3 is unfolding.
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4.3.8.4 2D NMR HSQC spectra of CTPRy3 and CTPR3
To determine whether the change in α-helical signal observed in CD spectra at low
GuHCl concentrations was due to the unfolding of CTPRy3’s C-terminal α helix,
2D NMR HSQC experiments were performed for both N15 CTPRy3 and N15 CTPR3.
N15 labelled CTPRy3 and CTPR3 were expressed and purified as described in Sec-
tion 2.3.7.2. Figure 4.17 shows an overlay of the spectra for CTPR3 and CTPRy3,
where there appears to be very little change in the number and position of the cross-
peaks. Samples were prepared for HSQC experiments, by dialysing the protein into
50 mM phosphate pH 6.8, 150 mM NaCl. The samples were concentrated to 400-800
µM. 10% (v/v) of D2O was added. These conditions were used to facilitate compar-
ison with published data, selecting a different buffer system could have significantly
changed the chemical shifts. Data was collected at 25 oC using a Bruker AV600,
600MHz spectrophotometer.
Figure 4.17: 2D HSQC NMR spectra of CTPR3 (blue) and CTPRy3 (red). Buffer
conditions were 50 mM phosphate pH 6.8, 150 mM NaCl, with 10% (v/v) of D2O.
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4.3.8.4.1 Assignment of CTPRy3 and CTPR3 spectra
Spectra were processed using TopSpin 2.1 patch level 6. Cross-peaks for CTPR3
were assigned by comparing spectra collected for CTPR3 with published assigned
data. Within CTPR3 there are 103 residues with assigned peaks out of a possible
117. There are 120 residues in total in CTPR3 but 3 of these are proline residues
that don’t have an amide proton and are therefore not visible to 2D NMR.
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Figure 4.18: (A) 2D NMR HSQC data for CTPR3 in 0 M GuHCl (blue) and 1.6
M GuHCl (red). (B) 2D NMR HSQC data for CTPRy3 in 0 M GuHCl (blue) and
1.6 M GuHCl (red). Buffer conditions were the same for both samples: 50 mM
phosphate pH 6.8, 150 mM NaCl. Data was recorded at room temperature.
CTPRy3 was assigned by comparing CTPRy3 with the CTPR3 data. A total of
91 peaks were able to be assigned in CTPRy3. Figure 4.17 shows an overlay of
the two spectra for CTPR3 and CTPRy3 at 0 M GuHCl. There is very little
difference between the two spectra confirming that CTPRy3 adopts the desired
164
CTPR fold. The proteins were partially denatured with GuHCl and the 2D NMR
HSQC recorded again. The assignment of the partially denatured data (red) was
accomplished through comparison with the 0 M sample (blue). When 1.6 M GuHCl
was added to CTPR3, the spectra showed a loss of 18 peaks, but overall the protein
remained folded. Figure 4.18A, shows the 0 M and 1.6 M GuHCl spectra. The data
for CTPRy3 at 1.6 M shows that there were 27 less peaks than in the 0 M spectra,
Figure 4.18B.
4.3.8.4.2 Comparison of CTPR3 and CTPRy3 2D NMR HSQC spec-
tra
In 0 M GuHCl, each protein gave well dispersed spectra, with little perturbation in
chemical shifts between the amide protons of CTPR3 and CTPRy3. Unique probes
were therefore available throughout CTPRy3 structure, specifically 12 residues out
of 15 in the C-terminal helix, to report on the dynamics and stability on per a
residue basis.
Initially both CTPR3 and CTPRy3 proteins were incubated with 2 M GuHCl and
the HSQC experiments repeated. These GuHCl concentrations were chosen as the
Heteropolymer Ising model predicted a 50% population of S-helix unfolded inter-
mediate at 2 M GuHCl (higher GuHCl concentrations were not used as the model
predicted that further helices of CTPRy3 would unfold). As predicted CTPR3 un-
dergoes little change between 0 and 2 M GuHCl; however this concentration resulted
in too great a change in the CTPRy3 to allow full assignment of the spectra. Con-
sequently, the experiments were repeated with a lower concentration of GuHCl (1.6
M). Here we observed a significant and specific change in the spectra of CTPRy3.
Upon addition of 1.6 M GuHCl 17 % of cross-peaks were lost overall in the CTPR3
(18 of 103 peaks) spectrum and 30 % were lost from the CTPRy3 (27 out of 91
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peaks). When we look specifically at the cross-peaks relating to the C-terminal he-
lix: we see that the CTPR3 lost 36 % of cross-peaks (5 out of 14 peaks), whereas the
CTPRy3 lost 83 % (10 out of 12). The number of cross-peaks that are lost from the
main body (i.e. a CTPR3∆S unit) from CTPR3 was 12 out of 89 and the number
lost from the CTPRy3 spectra was 17 out of 79. When expressed as a percentage
there is little change for either protein, CTPR3 loses 13 % and CTPRy3 loses 22 %,
indicating that the main body remains folded.
Figure 4.19: Changes in the HSQC spectra (between 0 M and 1.6 M GuHCl)
mapped onto the structure of CTPR3 (1NA0) (A and D). Cross-peaks that are
absent from the 1.6 M spectra are marked using a red sphere. CTPR3 (B and E)
undergoes less structural changes as shown by the smaller loss of peaks. CTPRy3
(C and F) has more significant changes in the structure and this is very strongly
seen in the loss of 10 of the 12 peaks from the C-terminus.
Chemical shift perturbations (CSP) values were used to quantify the changes ob-
served for individual cross-peaks between the two spectra. For each cross-peak, the
change in chemical shift for both the N15 and the H1 spectra is calculated. These
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values are used in Equation 4.8 [119] to calculate the CSP values.
CSP =
√√√√(δN
5
)2
+
(
δH
2
)2
(4.8)
δN is the difference in the chemical shift for an assigned cross-peak between the two
N15 spectra. δH is the difference in the chemical shift for an assigned cross-peak
between the two H1 spectra. The CSP values were plotted against the number in
the protein sequence (that the cross-peak relates too) to provide a visual illustration
of the changes that are occurring in the protein, Figure 4.20. The CSP value is
considered to be significant if it is greater than the average of the values plus 1
standard deviation [120]. Each CSP value is shown as a solid coloured bar in Figure
4.20 for CTPR3 (blue) and CTPRy3 (red). Where a cross-peak was present in the 0
M spectra but absent from the 1.6 M spectra there is an unshaded coloured bar with
a value of 0.20. Where there was no cross-peak to assign in either spectra a small
black bar with a value of 0.05 was added. From comparing the C-terminal section of
the proteins (residues 106-120), it is clear that CTPRy3 losses more cross-peaks from
the C-terminal helix than CTPR3, indicating that the C-terminal helix unfolds at 1.6
M GuHCl. In addition there are more cross-peaks that undergo a significant change
in CTPRy3 overall than in CTPR3. This suggests that the CTPRy3 structure
‘flexes’ when the C-terminal helix is unfolded. When we combine the observation of
the lost peaks with the CSP values we can conclude that the CTPRy3 unfolds its
C-terminal helix.
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Figure 4.20: Chemical Shift Perturbation values for each cross-peak in CTPR3
(A) and CTPRy3 (B). The CSP values were calculated to quantitatively compare
the change in chemical shift for each cross-peak that was observed between the
HSQC spectra with 0 M and 1.6 M GuHCl. Each solid coloured bar is the CSP
value calculated for each specific amide cross-peak. The CSP values are calculated
by inputting the change (i.e. the difference between the 0 M and 1.6 M GuHCl)
in chemical shifts for each cross-peak into Equation 4.8. Thus each CSP value
represents a change in chemical shift for an assigned cross-peak. The unshaded
coloured bars signify cross-peaks that are present in the 0 M spectra but absent
from the 1.6 M spectra. The black bars are residues for which there is no cross-peak
to assign in either spectra. The higher a CSP value is the greater the change in
chemical shift. A significant change in CSP values is defined as a value higher than
the average of the shifts plus 1 standard deviation. The horizontal black line marks
this point. In the data for CTPR3 the value is 0.078 and in CTPRy3 it is 0.065.
For CTPR3 we observe that there are less cross-peaks that have a significant shift
than there are in CTPRy3. In addition there are many peaks that are lost from
the CTPRy3 spectra, particularly those relating to the C-terminal helix (residues
106-120).
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4.3.8.5 Conclusions
The CD wavelength scans show that at 0 M GuHCl, the molar ellipticity of CTPRy3
equals that of CTPR3, however at 2 M GuHCl the ellipticity of CTPRy3 is the same
as CTPR2∆S. This indicates that CTPRy3 has partially unfolded to give a structure
that is identical to CTPR3∆S. The chemical denaturation data for the CTPRy3
was compared with the simulated data from the Heteropolymer Ising model and
was found to be almost indistinguishable, this confirms that this new version of
the Ising model can accurately describe the denaturation curves of CTPRs. When
comparing 2D NMR data, CTPRy3 showed specific unfolding of the C-terminal helix
at 1.6 M GuHCl. From comparing both equilibrium unfolding data and 2D NMR
HSQC experiments of CTPR3 and CTPRy3 we can see that CTPRy3 does possess
a thermodynamic switch.
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4.3.9 CTPRy2
Following the success of the switch design of CTPRy3 it is interesting to compare
the properties of the same mutation in CTPR2. Figure 4.21 shows the location of
the NN→RS mutation in the crystal structure of CTPR2.
Figure 4.21: Crystal structure of CTPR2 (1NA3). Highlighted in red are the
two asparagine residues that are to be mutated to arginine and serine to create the
mutant CTPRy2.
4.3.9.1 Cloning, Expression and Purification of CTPRy2
CTPRy2 was cloned as described in Section 2.1 and Table 2.1, the mutations were
confirmed via DNA sequencing. The protein was expressed and purified under native
conditions as described in Section 2.3.2 and gave high yields of approximately 10
mg/L of culture.
4.3.9.2 Characterisation of CTPRy2
CTPRy2 was analysed using size exclusion chromatography to confirm that it is
monomeric. The chromatogram for CTPRy2 was compared with that of CTPR2
(Figure 4.22 A. The mutant was confirmed as monomeric. A 100 µl sample at a
concentration of 50 µM was loaded onto a GE Healthcare Superdex 75pg 300/10
column (equilibrated with 50 mM phosphate pH 7, 150 mM NaCl). The flow rate
was set at 0.5 ml/minute. The elution of the protein was monitored using UV ab-
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sorbance at 280 nm.
Far-UV CD wavelength scans of CTPRy2 were performed to assess the secondary
structure, Figure 4.22 B. The wavelength scan was performed on a 5 µM sample,
dissolved in 50 mM phosphate pH 7. The sample was held in a thermostated cuvette
holder at 10 oC. The scans showed a single negative peak at 222 nm, therefore CT-
PRy2 displays the highly α-helical fold that is typical of CTPR proteins. The values
for the molar ellipticity (expressed as mdeg cm-2dmol-1) were CTPR -1.72x105 and
CTPRy2 -1.63x105. As the values are so close the CTPRy2 construct has the same
helical content as CTPR2 and thus is correctly folded.
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4.3.9.3 Chemical Denaturation of CTPRy2
The stability of CTPRy2 was assessed in the same way as CTPRy3, see Section
4.3.8.3. CTPRy2 underwent a single transition from the folded to the unfolded
state, Figure 4.23. The data for CTPRy2 can be qualitatively compared to data for
the other CTPR2 mutants by fitting to a two-state two-sloping baselines equation
4.2.
Figure 4.23: Normalised chemical denaturation curves for CTPRy2 (red circles),
there are 4 data sets. The protein undergoes a single reversible transition from the
folded to unfolded state. Initially, the data was fit using a two-state two-sloping
baselines equation (Section 2.9). However, to allow for easier comparison the data
has been normalised (using Equation 4.1) to account for the variation that arises
in concentration between data sets. Data was fit using linear regression analysis in
Kaleidagraph 4.0. Experimental conditions were: 5 µM protein in 50 mM phosphate
pH 7. Guanidine HCl was used to denature the proteins and the progress was
monitored using the CD ellipticity at 222 nm. Data was recorded on a Photophysics
Chirascan using a 5 mm pathlength cuvette held in a thermostated holder set at 10
oC.
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4.3.9.3.1 Comparison of CTPRy2 with CTPR2 and CTPR2∆S
Figure 4.24A shows the normalised chemical denaturation curves for CTPRy2, CTPR2∆S
and CTPR2. The data for CTPRy2 can be qualitatively compared to data for the
other CTPR2 mutants by fitting to a two-state two-sloping baselines equation 4.2.
The mid-points of the fit of the data can be used to compare the stability of the
different proteins. As with all other constructs the denaturations show one major
reversible unfolding transition with increasing GuHCl. As predicted for CTPRy2,
this transition has a lower midpoint than CTPR2, showing it is less stable. More-
over, there is an observable change in the slope of CTPRy2’s folded baseline in
comparison to CTPR2, Figure 4.24B. CTPR2’s baseline is essentially flat, whereas
CTPRy2’s slopes towards the first transition. In addition, the midpoint of CTPRy2
is the same as that seen for CTPR2∆S. This indicates that the CTPRy2 unfolds its
C-terminal helix before the first the main transition, as it was designed to do.
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4.3.9.3.2 Chemical Denaturation of CTPRy2 in MOPS
Denaturation experiments performed in MOPS buffer (instead of phosphate) all
showed a shift in the mid-point to a lower concentration of GuHCl. To confirm that
this trends also applies to CTPRy2 the denaturation was repeated in 50 mM MOPS
pH 7, Figure 4.25. As with all the other proteins examined in this chapter, there
was a shift in the mid-point to a lower concentration of GuHCl by approximately
0.15 M GuHCl.
Figure 4.25: Normalised chemical denaturation curves for CTPRy2, in 50 mM
MOPS pH 7 (black) and in 50 mM phosphate pH 7 (red). All data sets show that
the protein undergoes a single reversible transition from the folded to unfolded state.
The MOPS denaturation shows the same transition, but has a lower mid-point. This
shift of approximately 0.15 M GuHCl is in agreement with the changes observed with
the other CTPR proteins. Initially, the data was fit using a two-state two-sloping
baselines equation (Section 2.9). However, to allow for easier comparison the data
has been normalised (using Equation 4.1) to account for the variation that arises
in concentration between data sets. Data was fit using linear regression analysis in
Kaleidagraph 4.0. Experimental conditions were: 5 µM protein in either 50 mM
MOPS pH 7 or 50 mM phosphate pH 7. GuHCl was used to denature the protein
and the progress was monitored using the CD ellipticity at 222 nm. Data was
recorded on a Photophysics Chirascan using a 5 mm pathlength cuvette held in a
thermostated holder set at 10 oC.
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4.3.9.4 2D NMR of CTPRy2 and CTPR2
N15 labelled CTPRy2 and CTPR2 were expressed and purified as described in Sec-
tion 2.3.7.2. Samples were prepared for analysis in the same way as for CTPRy3,
see Section 4.3.8.4 for details. Figure 4.26 shows an overlay of the spectra for both
proteins.
Figure 4.26: 2D HSQC NMR spectra of CTPR2 (blue) and CTPRy2 (red). Buffer
conditions were 50 mM phosphate pH 6.8, 150 mM NaCl, with 10% (v/v) of D2O.
4.3.9.4.1 Assignment of CTPRy2 and CTPR2 spectra
Spectra were processed using TopSpin 2.1 patch level 6. Cross-peaks for CTPR2
were assigned by comparing spectra collected for CTPR2 with published assigned
data, 77 peaks were assigned out of 86 residues. CTPRy2 was assigned by comparing
CTPRy2 with the CTPR2 data, 62 peaks were assigned out of 86 residues. Figure
4.26 shows an overlay of the two spectra for CTPR2 and CTPRy2 at 0 M GuHCl.
There is very little difference between the two spectra confirming that CTPRy2
adopts the desired CTPR fold.
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Figure 4.27: (A) 2D NMR HSQC data for CTPR2 in 0 M GuHCl (blue) and 0.8
M GuHCl (red). (B) 2D NMR HSQC data for CTPRy2 in 0 M GuHCl (blue) and
0.8 M GuHCl (red). Buffer conditions were the same for both samples: 50 mM
phosphate pH 6.8, 150 mM NaCl. Data was recorded at room temperature.
The proteins were partially denatured with GuHCl and the 2D NMR HSQCs recorded
again, Figure 4.27. The assignment of the partially denatured data (red) was ac-
complished through comparison with the 0 M sample (blue).
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4.3.9.4.2 Comparison of CTPR2 and CTPRy2 2D NMR spectra
The HSQC spectra for both CTPR2 and CTPRy2 were well dispersed and showed
little change between the two constructs. However, when the proteins were dena-
tured with 0.8 M GuHCl, 6 % of cross-peaks were lost from the CTPR2 spectra
(5 out of 77), compared with 10 % of cross-peaks (6 out of 62) were lost from the
CTPRy2, Figure 4.28. The response of the C-terminal helix in CTPR2 showed that
13 % of peaks were lost (2 out of 15). The C-terminal helix of CTPRy2 was found
to undergo greater structural changes, 29 % of cross-peaks were lost (2 out of 7
peaks).
Figure 4.28: Changes in the HSQC spectra (between 0 M and 0.8 M GuHCl)
mapped onto the structure of CTPR2 (A) and CTPRy2 (D) (1NA3) . Cross-peaks
that are absent from the 0.8 M spectra are marked using a red sphere. CTPR2 (B
and E) loses 5 peaks, where as CTPRy2 (C and F) loses 6 peaks.
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Chemical shift perturbations (CSP) values were used to quantify the changes ob-
served for individual cross-peaks between the two spectra. For each cross-peak, the
change in chemical shift for both the N15 and the H1 spectra is calculated. These
values are used in Equation 4.8 to calculate the CSP values. CSP values were calcu-
lated for each of the cross-peaks that were present in both the 0 M and 0.8 M GuHCl
HSQC spectra, Figure 4.29. These values were plotted against the number in the
protein sequence (that the cross-peak relates too) to provide a visual illustration of
the changes that are occurring in the protein. The CSP value is considered to be sig-
nificant if it is greater than the average of the values plus 1 standard deviation [120].
Each CSP value is shown as a solid coloured bar in Figure 4.29 for CTPR2 (blue)
and CTPRy2 (red). Where a cross-peak was present in the 0 M spectra but ab-
sent from the 0.8 M spectra there is a unshaded coloured bar with a value of 0.20.
Where there was no cross-peak to assign in the either spectra a small black bar
with a value of 0.05 has been added. We can see that the CTPR2 shows only small
changes in the CSP values when compared with CTPRy2, indicating that CTPR2
remains folded at 0.8 M GuHCl. The larger perturbations that are seen throughout
CTPRy2 suggest that the whole protein structure begins to ‘flex’ in response to 0.8
M GuHCl.
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Figure 4.29: Chemical Shift Perturbation values for each cross-peak in CTPR2
(A) and CTPRy2 (B). The CSP values were calculated to quantitatively compare
the change in chemical shift for each cross-peak, that was observed on addition of
0.8 M GuHCl. Each solid coloured bar is the CSP value calculated for each specific
amide cross-peak. The CSP values are calculated by inputting the change (i.e. the
difference between the 0 M and 0.8 M GuHCl) in chemical shifts for each cross-peak
into Equation 4.8. Thus each CSP value represents a change in chemical shift for
an assigned cross-peak. The unshaded coloured bars signify cross-peaks that are
present in the 0 M spectra but absent from the 0.8 M spectra. The black bars are
residues for which there is no cross-peak to assign in either spectra. The higher a
CSP value is the greater the change in chemical shift. A significant change in CSP
values is defined as a value higher than ‘the average of the shifts plus 1 standard
deviation’. The horizontal black line marks this point. In the data for CTPR2 the
value is 0.062 and in CTPRy2 it is 0.073. We observe that there are almost the
same number of cross-peaks that display a significant change. However there is a
larger perturbation in general in the cross-peaks throughout the CTPRy2 protein,
suggesting that the whole protein structure of CTPRy2 begins to ‘flex’ in response
to 0.8 M GuHCl.
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Figure 4.30: Residues for which there is not a corresponding cross-peak have been
mapped onto the structure of CTPR2 (1NA3) as a grey sphere for CTPR2 (A) and
CTPRy2 (B). There are 11 less peaks in the CTPRy2 spectra than there are present
in CTPR2. The most noticeable difference is that there are 8 less peaks in the C-
terminal helix in the spectra of CTPRy2 compared with CTPR2. This means that
more than 50 % of the C-terminal helix is not visible in the NMR experiments.
The main limitation when observing the response of CTPRy2 to GuHCl is that there
are so few cross-peaks for the C-terminal helix even at 0 M GuHCl. In comparison,
CTPR2 has cross-peaks for all residues in the C-terminal helix. Figure 4.30 shows
the residues that are not visible in the 2D NMR spectra at 0 M GuHCl. Here we
can see that there are fewer probes available in the CTPRy2, especially in the C-
terminal helix. The consequence of this is using 2D NMR to probe the structural
response of CTPRy2 to denaturant is severely hindered.
4.3.9.5 Conclusions
When we look at the response of CTPRy2 using CD equilibrium unfolding we can
see that there is a difference in the folded baseline compared with CTPR2 and
CTPR2∆S. This indicates that the C-terminal helix is unfolding. 2D NMR data
shows that CTPRy2 displays the same structure as CTPR2. However 2D NMR
(under the conditions used) was not suitable to probe the structural changes that
CTPRy2 undergoes.
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4.3.10 Comparison of the Switching Ability of CTPRy3 and
CTPRy2
When we compare the response of the CTPRy2 to the CTPRy3 we see that there
is a much greater response from the CTPRy3. We are able to achieve an 83 %
loss of structure in the solvating helix whilst maintaining a core structure that only
sees a loss of 23 %. However, with the CTPRy2 the response at low concentrations
indicates some switching ability, increasing the denaturant concentration doesn’t
increase the loss of the solvating helix but does increase the loss of cross-peaks
associated with the core of the protein. We can conclude that the core of the
protein structure begins to ‘flex’ following the significant loss of structure due to the
unfolding of the C-terminal helix.
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4.4 Conclusions
In this chapter I have described how a series of deletion mutants was used with
a Heteropolymer Ising model to design a ‘switching’ system. The newly designed
protein, CTPRy3, reversibly populates a partially folded stable intermediate. The
thermodynamic switch was designed to selectively unfold the C-terminal S helix
(S-switch). This was chosen as the target for 3 reasons: (a) we have previously
shown that proteins that lack the C-terminal helix are stable (Chapter 3); (b) we
already had a potential way of destabilising the C-terminal helix, as from previous
work we know that the NN→RS mutation is destabilising and (c) removal of this
helix reveals a potential dimerisation interface. This is important if we want to
induce oligomerisation following partially unfolding the CTPR, as for this to occur
a potential stacking interface needs to be exposed.
Whilst there were several possible strategies for unfolding the S helix, it seemed
logical to start with a mutation that is known to reduce stability in the CTPR pro-
teins. The construct CTPRy3 combines the more stable core of the CTPR series
with the less stable inter-loop region of the CTPRa series, placed after the final
repeat but before the C-terminal helix. As CTPRy3 is a combination of these two
extensively studied protein series, we have been able to use the Heteropolymer Ising
model to simulate the response to chemical denaturation. When modelled, the new
CTPRy3 construct showed more potential as a thermodynamic switch than either
CTPR3 or CTPRa3.
To test the predictions made by the Heteropolymer Ising model, the proteins CT-
PRy3 and CTPRy2 were cloned and expressed. When these proteins were thermally
and chemically denatured the data showed a reduction in overall stability compared
with CTPR2 and CTPR3. Further analysis via 2D NMR has revealed that the
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CTPRyn proteins can selectively unfold the S helix at a low GuHCl concentrations
whilst the core of the protein remains folded. We have found the CTPRy3 protein
to exhibit a more defined ‘switch’ than the CTPRy2 construct, it is likely that this is
due to the added stability gained from CTPRy3 being 1 repeat longer than CTPRy2.
As increasing the number of repeats increases stability in both CTPR/CTPRa se-
ries therefore having an extra repeat will give added stability to the partially folded
intermediate.
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Chapter 5
Photoisomerisable Azobenzene
Crosslinker
In this chapter, I will describe the development of a light-sensitive protein switch.
This conformational switch will use the photoisomerisable azobenzene linker; 3,3’-
Bis(sulfo)-4,4’-bis chloroacetamidoazobenzene (referred to as AB-photolinker). This
is bonded to a CTPR3 scaffold through two cysteines in the C-terminal helix. When
exposed to UV light at 365 nm the isomerisation of the linker will unfold the C-
terminal helix.
5.1 Azobenzene linker
Azobenzene molecules can undergo a reversible cis-trans isomerisation, see Figure
5.1. The trans→cis isomerisation is accomplished using a specific wavelength of
light, that is dependent on any substituents on the phenyl rings and the solvent
conditions. The reverse cis→trans isomerisation can be accomplished using either
UV light or heat. The trans conformation is more thermodynamically stable so the
cis→trans conversion will occur over time if the sample is left in the dark [121].
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Figure 5.1: Shows the trans to cis isomerisation of the AB-photolinker (3,3’-
Bis(sulfo)-4,4’-bis chloroacetamidoazobenzene), using UV light at 365 nm. The
reverse reaction is achieved thermally.
When crosslinked through 2 side chains, azobenzenes have been used to cause a
conformational change in biomolecules. One azobenzene linker was used to in-
hibit the activity of ion channels, by either blocking the channel or causing a
conformational change that deactivated the channel [122]. The azobenzene linker
used for this project was 3,3’-Bis(sulfo)-4,4’-bis chloroacetamidoazobenzene (AB-
photolinker), Figure 5.1. It was chosen as it had been shown to disrupt the helical
content of an α-helical peptide [123].
The AB-photolinker has been modified through the addition of the 2 sulfonate
groups. As a result, the AB-photolinker is soluble in water whilst maintaining a
similar size to the non-sulfonated linker. Interestingly, the addition of the sulfonate
group was found to increase the half-life of the cis→trans isomerisation [123]. This
is beneficial as it increases the time available to detect any change in the protein
structure. The AB-photolinker used in this experiment has a half-life of 35 minutes
at room temperature.
5.2 Experimental Approach
Four CTPR3 mutants were designed to possess 2 cysteine mutations in the C-
terminal helix. Sites were selected to allow attachment of the AB-photolinker. These
mutants were cloned, expressed and purified. The AB-photolinker was ligated to
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the CTPR3 scaffold via the cysteine residues. UV wavelength scans and Circular
Dichroism scans were used to investigate if the isomerisation of the linker results in
a conformational switch in the proteins.
5.3 Motivation for creating a photo-switchable
CTPR
In Chapter 4 I described how a conformational switch was designed into CTPR2
and CTPR3. This switch used GuHCl to trigger the structural change. Here we
aim to accomplish the same switch but under the control of UV light. Figure 5.2
shows the proposed mechanism for the conformational switch that is initiated by
the AB-photolinker.
Figure 5.2: The AB-photolinker is attached through 2 cysteines on the C-terminal
helix (blue) in the trans conformation. After partial denaturation using heat the
C-terminal helix partially unfolds. UV light at a wavelength of 365 nm is used to
isomerise the AB-photolinker into the cis conformation, keeping the C-terminal helix
unfolded. Constructed from 1NA0.
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5.4 Results
5.4.1 Selection of Mutation sites
The trans isomer of the AB-photolinker requires a spacing of 10-11 residues between
the cysteines to which it will be linked. In addition to the spacing, mutation sites
were selected so that both cysteines are solvent exposed. Four constructs were
proposed (see Figure 5.3). The sequences of the C-terminal helices for each mutant
are listed below. Two variations of each cysteine mutant were produced: one with
the destabilising PNN-PRS mutation and one without. As we have shown in chapter
4, the PNN-PRS mutation destabilised the C-terminal helix relative to the rest of the
protein and by adding it here we aimed to increase the percentage of the population
that undergoes a conformational change.
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Figure 5.3: (A) Four double cysteine mutants were designed, the sequence of the C-
terminal helix is shown with the WT CTPR3 sequence. Structure of CTPR3 (1NA0)
with the mutations highlighted for each construct: (B)CTPR3i4 (C)CTPRy3i4
(D)CTPR3i11 (E)CTPRy3i11. The residues mutated to cysteine are highlighted
in yellow. The PRS mutation is highlighted in red.
5.4.2 Cloning, Expression and Characterisation of Cysteine
Mutants
The four double cysteine mutants were cloned as described in Section 2.1 and Table
2.1. The mutations were achieved through Site-directed Mutagenesis as described
in Section 2.2.2. The mutations were confirmed via DNA sequencing. Proteins were
expressed and purified under native reducing conditions as described in Chapter
2.3.2. All give high yields of approximately 10 mg/L of culture. All proteins were
monomeric as judged by the chromatograms for the size exclusion purification (data
not shown).
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5.4.2.1 Denaturation of CTPR3i11 and CTPR3yi11
To assess the effect of the cysteine mutations on the stability of the protein a chemical
denaturation was performed as described in Section 2.5.2.2. The data was fit to
a two-state model as described in Section 2.9, Figure 5.4. When compared with
CTPR3 the cysteine mutant (CTPR3i11) is less stable as it has a lower mid-point.
However it is interesting to observe that the CTPRy3i11 protein is more stable than
the CTPRy3 construct, Table 5.1. As the constructs have similar stabilities to the
CTPR3 and CTPRy3 scaffold we can be sure that conformational changes observed
as a consequence of the AB-photolinker are not due structural changes as a result
of the cysteine mutations.
Table 5.1: Comparison of Chemical denaturation data
Construct Chemical Denaturation Data
a [D]50% a m-value b ∆GH2OD−N
(M) kcal−1M−1 kcal−1
CTPR3 3.29±0.01 3.61±0.13 11.9±0.4
CTPRy3 3.17±0.01 2.65±0.07 8.4±0.2
CTPR3i11 3.30±0.01 2.64±0.07 8.7±0.2
CTPRy3i11 3.25±0.01 2.96±0.08 9.6±0.3
Errors are calculated from the fit of the graph.
a Calculated from Equation 4.2
b Calculated from Equation 4.3
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5.4.3 Ligation of the AB-photolinker onto the CTPR3 scaf-
fold
The protein was dialysed into 50 mM Tris pH 8, 2 mM TCEP. A concentrated stock
solution of 5 mM AB-photolinker in ddH2O was prepared immediately before use.
In total, 500 nmol of linker was reacted with 90 nmol of protein (approximately a 5
fold excess of linker). The linker was added to the 900 µl of protein (100 µM) in 3
aliquots (30, 30 and 40 µl) with an incubation of 20 minutes between each addition.
The reaction was performed in the dark, at room temperature, with shaking, this
was to ensure the linker was in the trans conformation. The linker was added in 3
aliquots, to reduce the likelihood of intermolecular cross-linking.
5.4.3.1 Determining labelling efficiency using Ellman’s reagent test for
free thiols
The efficiency and yield of AB-photolinker attachment was assayed using Ellman’s
reagent. The test involves the use of the thiol reactive compound 5,5’-dithiobis-
2-nitrobenzoic acid (DTNB). If free thiols exist in the protein, the DTNB reacts
in a 1:1 ratio, releasing 1 mol equivalent of yellow 3-thio-6-nitrobenzoate (TNB),
Figure 5.5. The TNB absorbs at 412 nm, therefore the number of free thiols can
be calculated by using the Molar Extinction Co-efficient (14 150 M-1cm-1) of TNB
and the Beer-Lambert law. When proteins CTPR3i4, CTPRy3i11 and CTPRy3i11
were crosslinked with the AB-photolinker, the Ellman’s test showed that >80 % of
the cysteines had reacted compared to the unlinked protein.
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Figure 5.5: Reaction scheme of DTNB with a free thiol. The reaction produces 1
mol equivalent of the yellow TNB ion.
5.4.3.1.1 Mass Spectrometry to confirm linking
The linking reaction was confirmed using MALDI-TOF mass spectrometry. The
samples were desalted using a Millipore C18 Zip-tip. The samples were mixed with a
saturated Sinapinic acid solution in a 1:1 ratio before a 3 µl aliquot was spotted onto
the MALDI plate. MALDI mass spectrometry of the AB-photolinked CTPRy3i11,
CTPR3i4 and CTPR3i11 confirmed that the linker was attached (data not shown).
However, unlinked protein was also observed on the spectra.
5.4.4 Isomerisation of AB-photolinked CTPR3
5.4.4.1 Isomerisation protocol
The isomerisation was accomplished using a 6 Watt 365 nm UV lamp. Initially the
sample was heated at 50-60 oC for 5-10 minutes before isomerisation, as we believed
the linker could not drive thermodynamic helix unfolding. However, this was found
to be unnecessary and isomerisation could be achieved simply by exposure to UV
light at 365 nm for 10-15 minutes.
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5.4.4.2 UV Absorption characterisation
5.4.4.2.1 Methodology
UV absorbance wavelength scans were performed on a U-3010 Spectrophotometer
scanning between 200-600 nm at room temperature. The protein concentration was
between 15-25 µM in 50 mM Tris pH 8. Samples were measured in a 10 mm path-
length cuvette. The trans isomer absorbs at 350 nm, thus the isomerisation reaction
was monitored by observing the change in absorbance at this wavelength.
5.4.4.2.2 Results and Discussion
The UV spectra of CTPR3i4, CTPR3i11 and CTPRy3i11 all showed a decrease in
the absorbance at 365 nm after exposure to UV light, Figure 5.6A, B and C. This
indicates that the linker was isomerising from trans to cis. Figure 5.6D is the UV
wavelength scan of the free AB-photolinker, showing how the linker behaves when
not ligated to a protein. The absorbance at 365 nm significantly decreases by 70 %.
All the AB-photolinker proteins show a percentage decrease of approximately 50 %
Published data in reference [123], shows a higher decrease of approximately 70 %.
However, in this example the linker is attached to a single helix.
5.4.4.3 Circular Dichroism characterisation
The UV absorbance spectra shows that the AB-photolinked protein is undergoing a
trans→cis isomerisation. In Chapter 4 we used Circular Dichroism (CD) to identify
changes in the structure of CTPRs, specifically the unfolding of the C-terminal
helix at a specific concentration of GuHCl. In this chapter we are still investigating
the unfolding of the C-terminal helix, albeit by the AB-photolinker rather than
GuHCl, thus we consider CD a suitable detection method. The half-life for the
relaxation of the AB-photolinker back to the trans conformation is 35 minutes at
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room temperature. As the time taken to perform a CD wavelength scan is less than
5 minutes, the relaxation of the linker should have a negligible effect on the CD
signal.
5.4.4.3.1 Methodology
Samples were diluted to a concentration of either 5 µM or 10 µM. The sample buffer
was 50 mM Tris at pH 7 or pH 8. A 5 mm pathlength cuvette was used in a
thermostated cuvette holder held at 10 oC. All CD scans were performed between
200-300 nm. An initial scan was performed in order to measure helical content of
the fully folded protein. The sample was then isomerised using UV light at 365 nm
as described in the previous section and another wavelength scan performed. The
α-Helical content of the protein was analysed by observing the Ellipticity at 222
nm.
5.4.4.3.2 Results and Discussion
The isomerisation was conducted for the proteins: CTPR3i4, CTPR3i11 and CT-
PRy3i11. Figure 5.7 shows two indicative spectra for CTPRy3i11, which are rep-
resentative of the other data sets. When the isomeriation was performed at pH 7
the CTPRy3i11 protein showed a reduction of 7.5 % of the CD signal. When the
experiment was repeated at pH 8 a reduction of 4.2 % was recorded. The ideal
theoretical reduction in CD signal would be 14 % but this would assume that 100
% of the protein population fully unfolds the C-terminal helix. These data show
that there is a reduction in the CD signal at 222 nm which is indicative of a loss of
helical structure as a result of the isomerisation of the AB-photolinker.
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5.4.4.4 2D NMR
2D NMR was used to further investigate if there are any structural changes occurring
in the AB-photolinked protein. This can give a picture of any structural changes on
a residue by residue basis. This was performed in a similar manner as described in
Chapter 4 Section 4.3.8.4.
5.4.4.4.1 Methodology
N15 labelled CTPRy3i11 was prepared as described in Section 2.3.7.2. The AB-
photolinker was ligated to the protein as described in Section 5.4.3. The photolinked
protein was dialysed into 50 mM phosphate pH 6.8, 150 mM NaCl. The protein was
concentrated to 500 µM. The isomerisation of the AB-photolinker was performed
as described in Section 5.4.4. The isomerisation of the linker was confirmed by a
decrease in the absorbance at 365 nm. The isomerised sample was kept at 4 oC with
illumination from a UV lamp, until the NMR data was recorded. The sample was
left at room temperature in the dark for approximately 5 hours, in order for the
linker to thermally relax back to the trans configuration.
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5.4.4.4.2 Results and Discussion
Figure 5.8: 2D HSQC for CTPRy3i11 before (blue) and after isomerisation (red).
Buffer conditions were 50 mM phosphate pH 6.8, 150 mM NaCl, with 10% (v/v) of
D2O.
The NMR data showed no changes in the spectra between the cis and the trans
configuration of the AB-photolinker. Although a change in the UV spectra was
observed (0.263 before UV exposure and 0.171 after exposure) there was no change
in the NMR spectra. There were two potential reasons why no significant change
in the either the CD ellipticity or NMR data was observed: (1) the linker is only
isomerising a small number of the protein population or (2) the linker is isomerising,
but is not causing a large enough change in the helical structure of the C-terminal
helix to be observable. It seems likely that the isomerisation of the linker results in
some disruption of the terminal helix but that there is not enough of a change to be
visible either through CD or NMR.
To determine if the lack of change in the CD signal was the result of no struc-
tural changes in the proteins a new method of detection was devised. This involved
producing a mutant of CTPRy3i11 with a cysteine in the last C-terminal repeat at
200
position I97. This was intended to show that the new cysteine residue is hidden
in the core of the protein when the C-terminal helix is folded. However, when the
C-terminal helix is unfolded the cysteine is exposed. This reaction was followed
using Ellman’s reagent.
5.4.5 Cysteine mutant CTPRy3i11 I97C
This mutant was designed so that the Ellman’s Reagent could be used to identify
if the C-terminal helix was unfolding in response to the trans to cis isomerisation
of the AB-photolinker. The I97 residue was selected for mutation as it was cal-
culated to have a large change in Solvent Accessible Surface Area (SASA) upon
changing from CTPR3 to CTPR3∆S. It was predicted that the cysteine residue
would be inaccessible when the C-terminal helix is folded and exposed when the
helix is unfolded. Upon exposure the cysteine will be free to undergo reaction with
the Ellman’s Reagent, which can be followed by measuring the absorbance at 412
nm.
201
Figure 5.9: The CTPRy3i11 I97C protein. The double cysteine mutations that
are for the ligation of the AB-linker are highlighted in yellow. The I97C mutation
is highlighted in green. Constructed from 1NA0.
5.4.5.0.3 Methodology
To avoid wasting the AB-photolinker, which is not commercially available, maleimide
was used to simulate the linker attachment to the surface cysteines. GuHCl was used
to produce the specific unfolding of the C-terminal helix as described in Chapter 4
to simulate the isomerisation of the linker.
The maleimide attachment was performed at 4 oC and 25 oC to investigate the tem-
perature dependence of the folded state of the C-terminal helix. Excess maleimide
was removed using a PD-10 column. A control sample was prepared at the same
concentration but was not reacted with maleimide. All 3 samples were partially
denatured using the following concentrations of GuHCl: 0, 0.8, 1.6, 2 and 4 M. The
samples were incubated on ice for a minimum of 30 minutes before addition of the
Ellman’s reagent. The UV absorbance was measured for each sample, baselined
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Table 5.2: UV absorbance at 412 nm for CTPRy3i11 I97C at different concentra-
tions of GuHCl.
Sample GuHCl Concentration
0 M 0.8 M 1.6 M 2 M 4 M
No maleimide 0.289 0.276 0.282 0.291 0.308
4 oC -0.005 -0.001 0.002 0.016 0.013
25 oC -0.001 -0.001 0.001 0.005 0.005
against an equivalent concentration of GuHCl.
5.4.5.0.4 Results and Discussion
The absorbances for both the 4 oC and the 25 oC samples were identical at all
concentrations of GuHCl. This indicates that the maleimide has reacted with the
I97 cysteine, and is solvent accessible. In the control sample there was a small
increase (approximately 6 %) in the absorbance between the 0 M and the 4 M
samples. At 4 M GuHCl the protein will be fully denatured, thus there should be a
50 % increase in the absorbance observed. As this was not the result, we conclude
that the cysteine at position 97 is solvent accessible. Although the I97C mutation
was not suitable as a detection method for the unfolding of the C-terminal helix,
there are other residues that could be suitable.
5.4.6 Conclusions
UV absorption spectra show that the AB-photolinker does undergo a trans→cis
isomerisation, when attached to the C-terminal helix of a CTPR. We were unable
to observe a significant change in the helical content of the protein via NMR. We
only observed a small change in the CD spectra. Other studies using similar linkers
reported only small changes in helicity. In one paper, a 50 % decrease in CD signal
was observed for a single α-helical peptide, where the whole structure was being
disrupted by a photolinker [123]. In the system described here, full unfolding of
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the C-terminal helix would produce a 14 % decrease in signal (assuming all the
AB-photolinker isomerises). We observed a 7 % decrease in CD signal, therefore we
believe folded structure of the helix is being distorted.
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Chapter 6
Conclusions and Further Work
In this thesis I have shown how the CTPR scaffold can be engineered with a view to
creating biomaterials. In Chapter 3, I described the design of a system for creating
self-assembling fibres from CTPR3∆S monomers using Native Chemical Ligation.
In Chapter 4, the unfolding characteristics of a series of deletion mutants was studied
and this data fit to a Heteropolymer Ising model. This led to the successful design
and implementation of a thermodynamic switch into the CTPR2 and CTPR3 pro-
teins. Finally, in Chapter 5, we explored the use of a photoisomerisable linker to
unfold the C-terminal helix of CTPR3.
6.1 Self-Assembly of CTPR Modules
The aim of this chapter was to create a self-assembling system using recombinant
CTPR units. We have demonstrated that we can make fibres from CTPR monomers
that have been covalently bonded together using Native Chemical Ligation. Using
this reaction we were able to create structures ranging in size from short oligomers
to fibres up to microns in length. Our system is the first example of NCL being used
to link repeat protein monomers into fibres. We used a modified pTWIN expression
vector to produce a monomer (His-Xa-CTPR3∆S-thioester) that undergoes NCL
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when triggered by the Factor Xa cleavage of the N-terminal His-tag. The protein
successfully oligomerised into long oligomers. We followed the reaction using SDS-
PAGE, size exclusion chromatography, MS, CD and TEM. Using TEM we were able
to observe fibres that were formed as a result of the oligomerisation.
We found that the oligomerisation was sensitive to the reaction conditions. The
addition of NaCl to the reaction buffer resulted in an increase in the rate of reac-
tion. This is potentially because the addition of salt provides a more favourable
environment for the initiation step (Factor Xa cleavage). After observing many
polymerisation reactions, it has become clear that the initiation step is the rate
limiting step. This process is limited by the concentration of Factor Xa. Whilst this
effect could be overcome by increasing the concentration of Factor Xa, this would
vastly increase the cost of making the fibres. Instead of using Factor Xa to initiate
the reaction, we could redesign the protein to use a modified thrombin or TEV site
that still leaves the required cysteine at the N-terminus. As we observed that the
Factor Xa cleaved at an alternative site to the designed one, changing the enzyme to
thrombin or TEV would eliminate both the problem of cost and improper cleavage.
In addition to increasing the yield of fibres, there are two other developments that
could be made: adding functionality to the fibres and controlling the polymerisation
process. Functionality could be created by engineering peptide binding sites into the
CTPR monomers. Currently, work being conducted by Joseph Harvey is exploring
the development of a system where there is controlled addition of the monomeric
units, in a similar way to solid state peptide synthesis. This would allow the length
of the fibres to be controlled and limited to a specific number. Individual control
over each monomer in the sequence would make it possible to create heterogeneous
fibres, containing CTPRs with different binding motifs.
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6.2 Introducing a Thermodynamic Switch into
CTPR2 and CTPR3
We investigated the chemical denaturation data for a series of deletion mutants for
both the CTPRan and the CTPRn series. This data was then fit to a Heteropoly-
mer Ising model. The model was able to calculate the change in free energy for 3
types of helices in the protein: N-terminal, C-terminal and internal. With this data
it was possible to simulate the unfolding curve of different combinations of helices.
We were also able to calculate the population of partially unfolded species.
The population of protein with the C-terminal helix unfolded but internal helices
folded (S-switch population) was calculated for each full length CTPR. The Het-
eropolymer Ising model was then used to calculate the S-switch population for a
chimera of the 2 CTPR series, i.e. a protein with the internal helices of CTPRn and
the C-terminal helix of CTPRan. The chimera of CTPR3 and CTPRa3 involves the
mutation of the final loop before the C-terminal helix from PNN to PRS. This protein
was termed CTPRy3 and was predicted to have an S-switch population of ≈ 50
% at 2.8 M GuHCl, with only ≈ 15 % of further helical unfolding. The chemical
denaturation curve of CTPRy3 corresponded well to the simulated curve showing
that the model is able to make accurate predictions. CTPRy3 was evaluated using
2D NMR and this showed that there was a conformational change in the C-terminal
helix at 1.6 M GuHCl. The same mutation was placed in CTPR2 to create CT-
PRy2. Whilst both CTPRy3 and CTPRy2 displayed a conformational change at a
specific concentration of denaturant, the switch in CTPRy3 was more defined. As
a result of identifying and characterising the effect of the PNN to PRS mutation, we
have incorporated it into the design of two of the AB-photolinker proteins.
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6.3 Photoisomerisable Azobenzene Crosslinker
Here we investigated using a photoisomerisable linker to disrupt the folding of the
C-terminal helix of CTPR3. Four double cysteine mutants of CTPR3 were designed.
A photoisomerisable linker was ligated onto the cysteine residues located in the C-
terminal helix. The linker reversibly isomerised when exposed to UV light at 365 nm.
The change in UV absorbance at 365 nm confirmed that the linker was isomerising.
We used CD to observe the structural changes as a result of the isomerisation.
We saw a small change in the ellipticity at 222 nm indicating that there is some
disruption of the folding of the C-terminal helix. We also employed 2D NMR to
further probe the structural changes occurring. However, we were unable to observe
any significant change in the HSQC spectra. This would have confirmed a structural
change in the C-terminal helix. We explored the possibility of masking a cysteine
under the C-terminal helix that, after isomerisation, is solvent exposed. However,
the cysteine mutation, I97C, was accessible to the solvent at all times. Further
investigations could identify a more suitable location for the masked cysteine.
6.4 Future Directions
6.4.1 Genetically-encoded Click Chemistry
We have demonstrated that it is possible to polymerise CTPRs by forming covalent
bonds between monomers following enzymatic cleavage. In chapter 4 we successfully
designed a thermodynamic switch into CTPR3 and CTPR2. The switch was de-
signed to reveal a dimerisation interface, however no oligomerisation was observed.
For polymerisation of CTPRs to take place, a stronger driving force is required
than simply the interaction between interfaces at the N and C-termini. We would
believe that we can combine these two processes: partial unfolding and covalent
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oligomerisation to create a system that partially unfolds, reacts and subsequently
oligomerises. One method we propose involves the use of our switching protein, CT-
PRy3, in conjunction with copper-free click chemistry to form the covalent linkages
between the monomers, Figure 6.1
A copper-free click reaction involves a cyclo-addition reaction between an azide and
a strained ring system, di-benzocyclooctyne (DBCO). The reaction is highly specific,
produces no harmful by-products and can be performed in aqueous solvents. Pre-
viously the azide containing groups had to be attached to proteins through ligation
to a side chain of an amino acid. However, it is now possible to incorporate azide-
containing non-natural amino acids (NNAA) at specific sites in proteins through
the use of orthogonal t-RNA synthetases. The process of incorporating a NNAA
involves placing an amber stop codon in the gene at the site of the desired mutation.
The gene is recombinantly expressed in the presence of a designed t-RNA synthetase
and the NNAA. When the amber stop codon is read on the bacterial ribosome, the
NNAA is added by the t-RNA synthetase. The DBCO functionality is incorporated
through the reactive groups of cysteine or lysine residues, using maleimide ot N-
hydroxysuccinamide respectively.
The proposed monomer would possess both click reactants. At the N-terminus,
a DBCO group will be ligated to an N-terminal cysteine. The C-terminal repeat
will contain an azide, that is prevented from reaction by the C-terminal helix. In the
reaction scheme, firstly the C-terminal helix unfolds to expose the reactive azide,
Figure 6.1B. A click reaction can then occur between the azide and the DBCO, to
create a dimer that is covalently linked together.
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Figure 6.1: (A) Schematic representation of a proposed click chemistry ready
monomer (constructed using 1NA0). A DBCO group is ligated onto a cysteine
residue at the N-terminus and para azidophenylalanine is protected from reaction
by the C-terminal helix shown in blue. (B) When exposed to heat or denaturant the
C-terminal helix is unfolded to expose the azide group to reaction with the DBCO
group on another monomer. (C) The click reaction locks the units together and
they can dock together though compatible interfaces to form an ordered polymer in
a specific head-to-tail manner.
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6.4.2 Protein Nanocages
We have shown that we can make fibres using CTPRs in a self-assembling sys-
tem. Now the focus of interest is in combining the CTPR scaffold with other self-
assembling proteins to extend the tool kit of monomeric building blocks. This will
allow a more diverse range of structures to be formed. The CTPR scaffold could
be used in the design and assembly of protein nano-cages. A protein nano-cage is
comprised of self-assembling units that associate to form an encapsulation with di-
mensions in the nanometre range. A two-component protein nano-cage contains one
type of protein that forms the vertices and another that forms the edges or sides of
the cage. In work that is currently ongoing, a CTPR3 unit will be used to form the
side of a cage. CTPRs are a good choice as the sides of a cage as they are structurally
rigid and the N and C-terminus can easily be functionalised without disrupting the
fold. The vertices of the proposed nano-cage involve the homo-trimer, Monofoil-4-P
(M4P) comprised of three 42 amino acid peptide subunits that spontaneously asso-
ciate [124]. The ability to associate will be exploited in the self-assembly process.
Like the CTPRs, the M4P has free termini that can be used to connect the M4P to
other proteins and peptides.
The designed CTPR3-M4P nano-cage involves the C-terminus of the CTPR3 unit
fused to the M4P, Figure 6.2. When the M4P associates, an open half-cage is formed.
By adding functionality at the N-terminus of the CTPR3 it will be possible to link
the units together and close the cage.
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Figure 6.2: Schematic of the formation of a CTPR3-M4P trimer (constructed from
1NA0 and 3OL0). The Monofoil-4-P forms a trimer with the CTPR3 units linked
via the C-terminus. By engineering functionality to the N-terminus of the CTPR3
it would be possible to form ’closed’ cages. Figure produced by James Wright.
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Appendix
7.0.3 Primers
7.0.3.1 CTPRy2 and CTPRy3
Primer
Forward 5’ CTTGAGCTCGATCCAAgatcTGCTGAAGCTAAACAG 3’
Reverse 5’ CTGTTTAGCTTCAGCAgatcTTGGATCGAGCTCAAG 3’
7.0.3.2 CTPR2∆S and CTPR3∆S
Primer
Forward 5’GAGCTCGATCCAAATAATtgaGAAGCTAAACAGAACCTG 3’
Reverse 5’CAGGTTCTGTTTAGCTTCTCAATTATTTGGATCGAGCTC 3’
7.0.3.3 Minus A Helix deletion mutants of CTPR2 and CTPR3
Primer
Forward 5’-TGCGAATACTACCAGAAAGCGCTGGAACTG-3’
Reverse 5’-CGCTTCGTCGTAGTCCCCCTG-3’
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7.0.3.4 Cysteine mutants of Photolinker construct i11PRS
Primer
Forward 5’-TGCGAATACTACCAGAAAGCGCTGGAACTG-3’
Reverse 5’-CGCTTCGTCGTAGTCCCCCTG-3’
7.0.4 Preparing Agarose gels
A 1 % Agarose gel was prepared by superheating 1g of Agarose in 100 ml of Tris-
Borate-EDTA (TBE) buffer (45 mM Tris Base, 45 mM Boric acid and 10 mM
EDTA at pH 8.3) until fully dissolved. Ethidium Bromide was added to a final
concentration of 1 µg/ml.
7.0.4.1 Gel preparation
Gels were all 100m x 100mm in size, with either 12 or 16 sample wells. 18% Gels
were the most commonly used, the volumes required to make 2 gels are shown in
table 7.1
Table 7.1: Volumes required to make 2 18% gels
Componant VolumeResolving Gel
Volume
Stacking Gel
Tris pH 8.8 5 ml N/A
Tris pH 6.8 N/A 0.75 ml
Acrylamide 12 ml 1 ml
ddH2O 2.6 ml 4 ml
10 % SDS 0.2 ml 60 µl
10 % APS 0.2 ml 60 µl
TEMED 8 µl 6 µl
7.0.4.2 Buffers
The buffers used in preparing the gels were: 1.5 M Tris pH 8.8, 1 M Tris pH 6.8, 10
% SDS (w/v), 10 % Ammonium Persulfate (w/v), 30 % Acryamide, The Running
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Buffer was prepared using: 144 g Glycine; 30 g Tris Base; 10 g SDS. Dissolved in
1 L ddH2O and corrected to pH 8.3. Loading buffer was a 2X concentrated stock,
containing: 100 mM Tris pH 6.8; 200 mM DTT; 4 % SDS (w/v); 20 % Glycerol
(w/v) and 0.2 % Bromophenol blue (w/v).
7.0.5 Gel of CTPR proteins
Figure 7.1: 18% SDS-PAGE gel showing lane 1;CTPRa3, lane 2;CTPRa4, lane
3;CTPRa5, lane 4;CTPRa6, lane 5;CTPRa8 and lane 6;CTPRa10. We can see that
as the proteins increase in length there is a smaller change in the size observed on
the gel.
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